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Abstract 
Bhanvi Mehta 
The Formation of Pharmaceutical Co-crystals by Spray Drying 
An Investigation into the Chemical and Physical Factors Affecting the 
Production of Pharmaceutical Co-crystals by Fast Evaporation and Spray 
Drying 
Keywords: Spray drying, rotavap, cocrystal, solubility, caffeine, 
carbamazepine, theophylline. 
Crystal engineering study using spray dryer was performed for scale-up and 
rapid, continuous crystallisation of co-crystals from solution. The study 
emphasise on developing co-crystals of two structurally similar compounds, 
caffeine (CAF) and theophylline (THEO) with various di-carboxylic acids. The 
incongruently soluble pair of CAF and THEO with di-carboxylic acids 
acquires large solubility difference which is important to consider for its utility 
in product development. Based on previous assumption that maleic acid 
(MAL) elevates CAF’s solubility; solubility of the two similar compounds was 
tested in various dicarboxylic acids. Other solubility enhancement strategies 
such as introduction of surfactant and binary solvents were also scrutinised. 
A kinetically similar bench-scale technique, rotary evaporator (rotavap) was 
investigated as a pre-screening tool for the production of co-crystals via 
spray drying. Furthermore, various process parameters within the spray 
dryer were optimised to control the kinetic conditions which influence co-
crystallisation and quality of the product. Another polymorphic co-crystal pair, 
ii 
 
CBZ (carbamazepine) and SAC (saccharin) was examined in various 
solvents and its degradation was evaluated over a period of few months. In 
this study, a two-step conversion of CBZ into its degradate was 
hypothesised. Rotavap delivered a true reflection of co-crystal favoured via 
spray drying apart from co-crystal pairs depicting polymorphism. Spray dryer 
offered a unique environment favouring metastable forms of co-crystals 
irrespective of the starting component stoichiometry; generating CAF:MAL 
2:1. However, due to process limitation and solubility constraint, the impurity 
of CAF in CAF:MAL 2:1 co-crystals could not be abolished.  
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CHAPTER1 
1. Figure/Tables 
INTRODUCTION 
Pharmaceutical industries generally focus on the design and development of drug 
products through important theories, advanced technologies and formulation 
strategies, to capitalise on compound’s perspective as a therapeutic. Conventionally, 
the solid-state of active pharmaceutical ingredients (APIs) can exist as either 
amorphous, crystalline, or solvate and hydrate forms with explicit regulatory 
schemes applied to all (FDA, 2013). These forms can be designed to achieve various 
physicochemical properties and therefore, influence characteristics such as, 
bioavailability, solubility, patient acceptance and stability under high relative 
humidity. Solubilisation approaches including micellar solutions, salt forms, 
micronisation, co-solvents, often used to improve the dissolution rate of the drug; 
have shown inadequate improvement in bioavailability due to their specific 
physicochemical nature. The utilisation of new crystal engineering approaches offer 
an alternative to the challenges of low aqueous solubility, dissolution rate and 
bioavailability, whilst preserving the required physical and chemical identity of the 
product (Yadav et al., 2009; Mirza et al., 2008; Blagden et al., 2007). 
Researchers have delved into the design and growth of distinguishable crystalline 
molecular solids, known as co-crystals as an alternative to salts and solvates. Co-
crystals are multi-component assemblies comprised of an API and one or more 
distinctive co-crystal formers (co-former) which by convention are solid at room 
temperature. Unlike ionic interactions in other solid-state forms such as salts, 
association of API with co-former is governed by non-ionic interactions (hydrogen 
bond or non-covalent interactions) within the same crystal lattice (FDA, 2013). 
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These co-formers are pharmaceutically acceptable neutral guest compounds, GRAS 
(Generally Recognised As Safe) which do not modify the pharmacological activity 
of API but possesses a distinct physicochemical profile (Blagden et al., 2008; 
Scultheiss and Newman, 2009; Sekhon, 2009). 
Recently, FDA (Food and Drug Administration) regulation has classified co-crystals 
as dissociable molecular complexes, “API-excipient” and suggests that it should be 
treated as a drug product intermediate. The current regulations require supportive 
information for new drug applications (NDA) and abbreviated new drug applications 
(ANDAs) of co-crystals stating: a) API and its excipient(s) exist in neutral states, 
that is, their ∆pKa (acid dissociation constant) <1 which confirms less than 
considerable proton transfer; if not, then orthogonal approaches using spectroscopic 
tools should be examined, and; b) results showing dissociation of an API and its 
excipient(s) before reaching the site of action (FDA, 2013). 
1.1. Co-crystal versus solvates and salts 
A pharmaceutical active ingredient can have polymorphs or can crystallise with 
another molecule to form a co-crystal or a salt, if both the components are solid at 
room temperature. The crystals formed with one of the components as liquid at room 
temperature, is designated as a solvate or a hydrate. The multi-component co-crystals 
and salts may further exist in hydrated or solvate forms and, in addition can have 
various polymorphs. For example, a new stable salt co-crystal of tiotropium fumarate 
with fumaric acid (a salt) together with co-former (co-crystal with stoichiometry of 
2:1:1) was developed and characterised (Pop, Sieger and Cains, 2009). On the other 
hand, though solvates have potential to increase dissolution rate, it acquires 
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toxicological consequences due to the presence of solvent and further loss of solvent 
over time may account for phase transformations (Yadav et al., 2009; Nauha, 2012).  
 
Figure 1.1. Possible crystal forms attained by an API (Nauha, 2012). 
 
 
Pharmaceutical development of the two multi-component structures, salt and co-
crystal retain their importance and may sometimes be confused. Though salts are 
chosen to improve the stability of an API, co-crystals have two intrinsic advantages. 
First, co-crystals can be formed from acidic, basic and non-ionisable molecules and 
second is its ability to form co-crystals with numerous potential co-formers (Yadav 
et al., 2009; Sekhon, 2009; Vishweshwar et al., 2006).  
Salts are formed by transfer of a proton from an acid to a base which is predicted 
from the pKa values of the two components. Whereas, in a co-crystal no such 
transfer takes place as it holds the components as neutral entities. Chemistry explains 
that a pKa difference of at least 2.7 units between the conjugate base and acid is 
required, i.e. [pKa (base)- pKa (acid) ≥ 2.7]  to form a stable salt. For example, 
succinic acid (pKa of 4.2) forms a co-crystal with urea base (pKa of 0.1), whereas a 
salt formation is favoured with L-lysine base (pKa of 9.5) (Figure 1.2). Most of the 
base pKa values observed are not high enough to allow proton transfer and hence, 
form co-crystals. Current studies on co-crystal growth use pKa profiles as a tool to 
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select co-crystal formers; however, this is not always appropriate (Qiao et al., 2011; 
Blagden et al., 2008; Sekhon, 2009). 
 
Figure 1.2. Co-crystal of succinic acid-urea comprising of two hydrogen bonds, i.e. between 
oxygen atom of urea and hydrogen in succinct acid; second one being, oxygen atom from 
succinic bonded to hydrogen atom from urea molecule (Sekhon, 2009). 
 
 
Moreover, molecular electrostatic potential surface calculations have been used to 
estimate the degree of transfer between the hydrogen bonded synthons to determine 
whether a molecular solid is a co-crystal or a salt. Recent studies reported that if the 
calculated charge on the hydrogen-bond acceptor surpassed a critical value, a salt 
form was expected, while a value too low did not account for co-crystal formation 
(Aakeroy, 2010). Further to this, Hammett substituent constant was used as a source 
model to predict the formation of co-crystals over salts. In an attempt, 90% of the 
system formed co-crystals from 32 acid/acid combinations of the substituted benzoic 
acids where co-formers acquire Hammett constants of opposite sign, while the ones 
with same sign produced only 25%. Therefore, the system was characterised by this 
direct relation observed between the substituent constants (also denoted by 
differences in pKa) to forecast the formation of co-crystals (Seaton, 2010; Brittain, 
2012). 
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1.2. Co-crystal design 
1.2.1. Physicochemical properties 
The investigation of physicochemical properties of a co-crystal is essential to 
improve the overall stability and development of APIs. Researchers have extensively 
studied and reviewed these properties, namely, solubility, dissolution, melting point, 
stability, crystallinity and bioavailability. As stated earlier, it has been assumed that 
API would retain its intrinsic properties, but there is no recent evidence to sustain the 
fact. Since, a compound will have its own unique properties pertaining to the 
situation, there are questions related to the property change with respect to formation 
of co-crystals (Schultheiss and Newman, 2009; Blagden et al., 2007). Some 
important physicochemical properties are as follows: 
Melting point:  
It is the temperature at which the solid phase is in equilibrium with the liquid phase 
and is an important aspect for drug development. The preferred technique for its 
determination is differential scanning calorimetry (DSC) which gives an additional 
data on the enthalpy of fusion, for example, to identify complex polymorphic pair 
(monotropic or enantiotropic) of solids. This physicochemical property is used to 
characterise compounds and is strongly correlated to their aqueous solubility and 
vapour pressure. In addition, studies reported that it holds a direct relation with the 
molecular packing within a co-crystal, which remains indefinable (Blagden et al., 
2007). Therefore, in a multicomponent system, each component has its own 
properties that can influence the factors contributing to the melting point and making 
it difficult to draw conclusions (Schultheiss and Newman, 2009). 
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Staton and Bak (2008) reported the melting points of 10 co-crystals to an insoluble 
molecule vanilloid receptor 1 antagonist, (AMG517) where the melting points fell 
between that of the API and their co-formers. In another survey, 50 co-crystallised 
samples were analysed and it was deduced that co-crystals alter the melting points of 
an API which results in a product whose melting point falls either between or lower 
than the API and co-former. Moreover, high melting points may lead to poor 
solubility of co-crystals, therefore further extensive studies are required using large 
number of samples (Schultheiss and Newman, 2009; Qiao et al., 2011).  
Stability:  
There are four different aspects of stability testing: relative humidity stress, thermal 
stress, chemical stability, and solution stability which depend on the structure and 
characteristics of the molecule developed. The relative humidity test is used to 
determine the stability of the solid with respect to atmospheric moisture uptake 
during processing, storing, handling and packaging. Water sorption and desorption 
experiments of indomethacin-saccharin co-crystals have shown that relative 
humidity is not a major concern due to negligible amount of water sorbed (Basavoju 
et al., 2008, Qiao et al., 2011). Another study involves the humidity stability of 
anhydrous caffeine with respect to co-crystals formed with series of dicarboxylic 
acids. It was observed that co-crystals did not form hydrate but were unstable and 
underwent polymorphic transformation. The only stable form caffeine/oxalic acid 
co-crystal displayed better stability than anhydrous caffeine (Blagden et al., 2007). 
The study on the effect of thermal stress and chemical stability is very limited, but 
can   provide information based on physicochemical stability under accelerated 
conditions such as 40°C/75% RH and 60°C/75% RH. Other studies discuss DSC 
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data of non-stoichiometric co-crystals and their conversion after losing the guest 
molecule. Solution stability is also an important aspect to determine if the co-crystals 
will dissolve in the GI tract, that is, stays in the solution without getting crystallised 
(Schultheiss and Newman, 2009).  
Further advancement in the field of photo-stability and mechanical-stability has 
demonstrated improvement in various aspects of both formulation and 
manufacturing. An increased physicochemical stability and photo-stability was 
observed in nitrofurantoin, an antibacterial drug used for oral treatment of urinary 
tract infections; by co-crystallising with 4-hydroxybenzoic acid (Vangala et al., 
2011). Another study involved two model 1:1 profen-nicotinamide co-crystals 
(ibuprofen-nicotinamide and flurbiprofen-nicotinamide) prepared by rotary 
evaporation exhibiting greater tabletting properties than the individual components 
(Chow et al., 2012). A further example of bioactive agent, andrographolide, forms 
co-crystal with salicylic acid suppressing its chemical transformation into an inactive 
form (andrographolide sulphate metabolite) (Suresh et al., 2013; Smith et al., 2011). 
Solubility: 
Solubility can be increased by both salt and co-crystal in case of a free acid or base, 
but the two forms are not always distinguished easily. Solubility can either be 
determined by an observation at a set time point (kinetic solubility) or when it 
reaches equilibrium over a long period of time (thermodynamic solubility). The 
equilibrium solubility requires a number of measurements to determine the residence 
time for the drug in the stomach and intestines.  Factors such as, particle size, 
changes in the drug form, solution media (acidic or basic) and the changing pH of 
the media can affect the dissolution properties. Therefore, it is recommended that 
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each observation should be tested at various time points (Schultheiss and Newman, 
2009). Recent studies by Good and Rodriguez-Hornedo (2010) reported a time 
saving method to select and formulate a co-crystal depending on the ratio of 
concentrations of co-crystal components in the solution at the eutectic point. Further 
studies explained solubility of co-crystals with acidic, basic, zwitterionic and 
amphoteric moiety as ionisation constant of the components, product solubility and 
solution pH (Qiao et al., 2011). Modulation of solubility by cocrystallisation in case 
of extensively studied flavanoid; quercetin with caffeine, caffeine and methanol, and 
isonicotinamide produced drastic increase in its bioavailability (Smith et al., 2011). 
Intrinsic Dissolution: 
This parameter is independent of formulation effects (for example, particle size) and 
determines the in-vivo performance of APIs as a function of dissolution media 
properties. APIs belonging to the BCS (Biopharmaceutics Classification System) 
class II drugs, with high permeability and low solubility are studied for co-
crystallisation to enhance their properties. The drug is pressed into a disk and the 
solution concentration is measured over time and XRPD (X-ray powder diffraction) 
data is obtained to check for any major form changes. In an experiment, intrinsic 
dissolution of fluoxetine HCl co-crystals was conducted in water (Figure 1.3). The 
dissolution rate couldn’t be measured accurately due the rapid increase, but a three-
fold increase in the dissolution of 2:1 fluoxetine HCl/succinic acid cocrystal was 
observed compared to the API. Whereas, 1:1 co-crystal of fluoxetine HCl/benzoic 
acid and 2:1 fluoxetine HCl/fumaric acid were half and same as that of the API 
respectively. These results may become complicated with co-crystals, therefore, 
further studies need to recognise various factors to interpret the intrinsic dissolution 
data correctly (Schultheiss and Newman, 2009; Qiao et al., 2011). 
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Figure 1.3. Dissolution profiles of fluoxetine HCl and its co-crystals in water at 100
o
 C: 1) 
fluoxetine HCl/succinic acid co-crystal (Top ♦); 2) fluoxetine HCl (middle ■); 3) fluoxetine 
HCl/fumaric acid co-crysta (middle ▲); 4) fluoxetine HCl/benzoic acid co-crystal (bottom 
●) (Schultheiss and Newman, 2009). 
 
 
Recently, poor aqueous solubility of an API, niclosamide (HNic) was modulated by 
introducing four new salt co-crystals with sodium and potassium salts, where both 
the neutral and ionic forms were present in continuance. The new idea of salt co-
crystals worked as a reliable method to achieve high intrinsic dissolution rate 
(Grifasi et al., 2015). 
Bioavailability:  
Bioavailability is the measurement of absorption of the unchanged administered drug 
into the systemic circulation and is the ultimate goal for co-crystal investigation. 
These studies are performed during early development to determine the 
pharmacokinetics data in animals. The animal bioavailability studies reported on co-
crystals so far are very limited. A pharmacokinetic study by McNamara et al., 2006 
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has shown a three-fold increase in bioavailability using the co-crystal over its API. 
However, it should be noted that the intrinsic bioavailability study reported the 
solubility increase of the co-crystal by 18 times due to the conversion into its parent 
form as revealed by XRD Even though, the co-crystal may have dissociated in the 
animal studies, it does show an increase in its bioavailability. Another study on 
indomethacin- sachharin co-crystal has also shown that the increase in bioavailability 
is significant (Jung et al., 2010). There has not been a direct correlation between in-
vitro/in-vivo studies as dissociated co-crystals in in-vitro have shown improved 
bioavailability in animals. Therefore, this area needs to be further explored 
(Schultheiss and Newman, 2009; Qiao et al., 2011). 
New strategies have involved supersaturated drug delivery systems such as 
suspension formulations of co-crystal with its maximum apparent solubility, a 
surfactant (TPGS, tocopheryl polyethylene glycol succinate) and a precipitation 
inhibitor (HPC, hydroxyproplycellulose) optimised using in-vitro powder 
dissolution; to successfully improve its bioavailability. It was observed that the 
danazol:vanillin co-crystal when administered to rats as unformulated traditional 
neat co-crystal suspension rapidly converted into low-solubility crystal form; 
depicting low absorption. In addition, the presence of danazol polymorph as 
suspension with excipient did not produce significant effect on bioavailability. 
Whereas, co-crystal combination of 1% TPGS surfactant and 2% HPC in in-vivo 
studies resulted in relative bioavailability of 100% suggesting synergy between the 
excipients (Childs et al., 2013). 
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1.2.2. Supramolecular chemistry in co-crystal formation 
Crystal packing and engineering has now advanced in the preparation or 
supramolecular synthesis of new solids. The concept of supramolecular chemistry 
lay particular emphasis upon the idea that the growth of crystalline compound is a 
manifestation of directed self- assembly of different components. Co-crystal 
components exist in a specific stoichiometric ratio and are constructed through 
intermolecular interactions such as hydrogen bonding, p-stacking, and vander Waals 
forces (Yadav et al., 2009; Qiao et al., 2011, Khan, 2010; Zukerman- Schpector and 
Tiekink, 2008). These studies are associated with CSD (Cambridge Structural 
Database) statistics followed by experimental work to design a new compound after 
detailed understanding and exploitation of supramolecular synthons. The selection of 
an appropriate co-former is determined by the detailed knowledge of the functional 
groups present in the molecule (Shan and Zaworotko, 2008). The most commonly 
used co-formers that can co-crystallise with APIs include carbohydrates, alcohols, 
amides, carboxylic acids and amino acids (Figure 1.4). Out of these, carboxylic acid 
has been extensively studied as a self-complementary hydrogen bond donor and 
acceptor, amenable to formation of heterosynthons (i.e. bonds between different but 
complementary functional groups) over homosynthons. The carboxylic acid- amide 
heterosynthons are more favoured over both carboxylic acid and amide homodimer 
as in the case of indomethacin-saccharin (IND-SAC) co-crystals (Figure 1.5) 
(Vishweshwar et. al., 2006; Qiao et al., 2011). 
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Figure 1.4. Hydrogen bonding in crystal engineering: (a) acid-acid, (b) amide-amide 
homosynthons; (c) amide-acid, (d) pyridine-acid, (e) pyridine-hydroxyl and (f) halogen 
bonding heterosynthons (Nauha, 2012). 
 
 
 
 
(1)               (2) 
Figure 1.5. Indomethacin-saccharin co-crystal structure. (1) acid dimer bonded with weak 
N-H---O interaction; (2)acid-imide dimer synthon (Qiao et al., 2011). 
 
 
However, a conclusion derived in accordance to the empirical rules fall short in the 
case of IND-SAC co-crystal, where a weak N-H---O bond between indomethacin 
carboxylic acid synthon interacts with sachharin imide dimer synthon rather than the 
expected heterodimer between the two synthons (Basavoju et al., 2008). 
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The designing or packing of the hydrogen bonded synthons in a co-crystal is based 
upon the structural fit between the components and empirical rules developed by 
Etter (Etter, 1990; Etter, 1991; Sekhon, 2009). These guidelines use graph set 
descriptors to propose and classify hydrogen bonding rules as follows: 
1) Hydrogen bonding uses all good proton donors and acceptors.  
2) Six-membered ring intramolecular hydrogen bonds form in preference to 
intermolecular hydrogen bonds. 
3) The best proton donor and acceptor remaining after intramolecular hydrogen 
bond formation form intermolecular hydrogen bonds to one another (but all 
acceptors and donors may not interact with each other) (Etter, 1990; Blagden 
et al., 2008).  
Etter et al., 1990 gave rules to explain that detailed work on specific functional 
groups and the further need for determination of hierarchies of hydrogen bonding. A 
study based on the hierarchy of hydrogen bond  (as per CSD) in a pyridine moiety 
observed that the strength of carboxylic acid hydroxyl and alcoholic hydroxyl donor 
groups were comparable, while pyridine-hydroxyl synthon was achieved in the 
presence of cyano acceptor (Shattock et al., 2008; Bis et al., 2007). CSD database is 
a good source to find new useful synthons, but may sometimes be biased towards 
known repetitive results (Nauha, 2012). 
Crystallisation is influenced by other factors such as close packing of molecules, 
weaker interactions and kinetics. In contrary to Etter’s third rule of supramolecular 
synthon polymorphism, experiments using 4-hydroxybenzoic acid and 2, 3, 5, 6-
tetramethylpyrazine produced a polymeric Form I (acid-acid homosynthon) from 
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acetone and a more stable Form II (acid-pyridine heterosynthon) from acetonitrile- 
methanol. In addition, Form I transformed into Form II at room temperature which 
explains for the possible kinetic behaviour (Sreekanth et al., 2007; Nauha, 2012). 
1.2.3. Computational approaches 
Crystallisation can be influenced by various factors such as process parameters, 
crystallisation medium composition and supersaturation within a process. Screening 
is a method used to understand and predict the effects of these variables that promote 
crystal nucleation and growth, in order to identify a robust procedure to develop a 
desired product (Morissette et al., 2004). Procedures involved in pharmaceutical 
companies can be expensive and time-consuming. Therefore, it demands for simple 
pre-screening methods to predict crystal structures. Selection of co-crystal former is 
an important initial step to co-crystal screening. One of the methods anaylsed 131 
molecular descriptors such as, size, shape, hydrogen bond donor and acceptor to 
predict for co-crystals found in CSD (Fabian, 2009). The study found similar shapes 
and polarity of coformers, but no relation between the size of molecules or the 
number of hydrogen bond donor and acceptor was observed. Another study used 
Hansen solubility parameter (Mohammad, Alhalaweh and Velaga, 2011) as a model 
to postulate that co-crystal formation is enhanced by the miscibility of the two 
starting compounds. Therefore, these findings could be used as pre-screening step 
prior to co-crystal development (Nauha, 2012). 
 
1.3. Co-crystal screening 
Traditionally, solid forms were synthesised and studied by using different process 
methods coupled with modern analytical tools of characterisation. Methods 
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employed for screening such as combination of solvent recrystallisation (Mirza et 
al., 2008), mechanochemistry and thermal analysis are slow and the small fraction of 
process space can contribute to form diversity. Predictive methods to estimate the 
crystalline packing arrangement (e.g., hydrates, solvates, co-crystals) and assess their 
polymeric behaviour has become difficult. Manual screening strategies to explore 
diversity of a compound discovery cannot be used as a well-established method. 
Therefore, in order to understand the link between processes that control nucleation 
and crystal growth, high-throughput (HT) crystallisation systems have been 
developed. Three steps involved to design these experiments are: design of 
experiment (DOE), execution and analysis of data, using both hardware and software 
to track the progress of experiment and store data. These small scale methods help to 
perform large number of experiments whilst reducing the material demand. In 
addition, it can create a larger pool to identify functional parameters responsible for 
forming co-crystal, minimising process modification, risk of form change and 
evaluate their properties to obtain patent protection (Morissette et al., 2004). Further 
to this, binary and ternary phase diagrams are described below to explain the suitable 
phases required to for the reproduction of co-crystals. 
1.3.1. Scale up of co-crystal hits 
The two main issues faced while constructing a solid phase selection strategy for 
API forming co-crystals are: first, how to implement phase screening in a large space 
to identify combinations of co-crystals; second, scaling up of the co-crystal hits for 
pharmacokinetic evaluation. Therefore, ternary phase diagrams (TPD) are 
constructed to define the equilibria between the solid phase and the chosen solvent. 
TPD allows the understanding of thermodynamic outcome of co-crystal formation by 
describing the three phase behaviour of a system [for the components (A and B), co-
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crystal (A-B) and given solvent (S)] (Figure 1.6) (Naura, 2012; Blagden et al., 2008; 
Leung et al., 2012). 
 
 
Figure 1.6. TPD of components A and B forming 1:1 co-crystals in solvent S; a) when 
solbilities for the two components are quite similar, b) when the solubility of A is far lower 
than that of B. Measurements in mole fraction (Nauha, 2012). 
 
 
Ternary phase diagram is an equilateral triangle with mole or weight fraction of each 
of the three phases as shown in the figure above. The phase space region within the 
equilateral triangle depends on the component solubilities, as differences can alter 
their location and size. This TPD represents six zones for a system with one co-
crystal for A and B. Zone 1 has components, A and B dissolved in the solvent and is 
in a homogenous liquid phase. In zone 2 and 6 there is a solid component A and B, 
respectively in a liquid phase. Zone 3 has solid component A and 5 has component 
B, alongside solid co-crystal A-B and a liquid phase. Whereas, zone 4 is the main 
zone of concern with co-crystal AB and the solvent. The solvent is in equilibrium 
with A and the co-crystal at point E1, and with B and the co-crystal at point E2. As 
seen in the figure above, the difference in the system is due to the two types of 
component dissolution, that is, congruent and incongruent dissolution.  Figure 1.6a) 
shows congruent system, where the components possess similar solubilities, and b) 
where the second component crystallises as the first one dissolves due to the lower 
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solubility of A (incongruent system). Therefore, in a congruent system, solution 
evaporation of equimolar ratio of A and B to the solvent will form 1:1 co-crystal as it 
goes up the line (Nauha, 2012). Whereas, incongruent mixture in solvent may result 
in a mixture of co-crystal and single component phase as it either passes through 
zone 5 (mixed phase) or zone 6 (single phase) (Blagden et al., 2008; Nauha, 2012). 
A TPD is constructed by measuring the solubility curves of A, B and the co-crystal 
(xA, xB, xAB) thereby explaining the stability of a co-crystal in the solvent (Figure 
1.7). The eutectic points E1 and E2 are the points where the solubility curves of the 
components coincide with the solubility curve of the co-crystal. Straight lines are 
drawn from these eutectic points to the solid phases A, B and the midpoint on the 
bottom of the triangle (in case of 1:1 co-crystal). The solubility of the co-crystal with 
the change in the ratio of the two components is determined by the curve connecting 
E1 and E2 (Nauha, 2012; Leung et al., 2012). 
 
Figure 1.7. Phase diagram formed by the solubility curves of A, B and the co-crystal in the 
solvent S, as xA, xB andxAB respectively (Nauha, 2012). 
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Current work has discovered two new co-crystal forms of compound 1, a GPR119 
agonist (API for treatment of type II diabetes) with benzoic acid (BA) and maleic 
acid (MA) with a new high throughput screening approach. The critical region in the 
TPD was rapidly mapped and the co-crystals (1-MA and 1-BA) were scaled up by 
the addition of an anti-solvent. The critical points, E1, E2 and a new third critical 
point (at the base of the triangle) which did not change with solvent composition, 
were determined for a binary solvent mixture (Leung et al., 2012; Szewczyk et al., 
2011).  
Ternary phase diagrams can be complicated when there is more than one form of co-
crystals and is restricted to one solvent at a time. An experiment constructed a 
reference diagram for a solvent using a calorimetric method to circumvent this issue. 
The solubility data of A and B, and the slope of the co-crystal curve extracted from 
the reference diagram were used to estimate the phase diagrams for other solvents 
(Ainouz et al., 2009). Guo et al., 2010 attempted to discover co-crystal system 
(phase diagram) for caffeine and maleic acid which produces two co-crystals with 
different stoichiometries (1:1 and 2:1). The study failed to determine a single crystal 
of 2:1 co-crystal through this thermodynamic measurement. However, they could 
reproduce 1:1 co-crystals from acetone in which the solubilities were quite similar, 
but still showed an incongruent system. Hence, the observation of new polymorphs 
of co-crystals or the components implies that the nucleation phase could have been 
kinetically driven (Blagden et al., 2008).  
Further study was conducted for the stoichiometrically diverse co-crystal systems of 
caffeine and maleic acid. It explains that co-crystal zone for 1:1 in the TPD depends 
on the solubility product of the two components and may disappear if the 
components acquire different solubilites. However, this does not mean that 1:1 co-
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crystals do not occur as it can still be favoured kinetically. The spontaneous 
crystallisation of 2:1 phase was reported in ethyl acetate solution where the relative 
solubility was reduced from 40 to 7, compared to that in acetone. This was the first 
study to investigate the importance of choice of solvent not only on TPD but also as 
a kinetic screening method of phase nucleation for stoichiometrically diverse co-
crystal (Leyssens, 2012).  
 
Figure 1.8. Schematic representation of a) phase solubility diagram, illustrating 
concentration dependent solubility of A and B, and the solubility of co-crystal AB; b) binary 
phase diagram (Nauha, 2012). 
 
 
In addition to ternary phase diagrams, phase solubility diagram (PSD) and binary 
phase diagram (BPD) have been used to depict the phase behaviour of the 
components and co-crystals. PSD represents the solubility curves of A, B and co-
crystal AB dependant on the solution concentration of A and B (Figure 1.8a). For 
example, a decrease in the solubility of (carbamezapine) CBZ and (Nicotinamide) 
NCT co-crystal was observed with an increase in the concentration of NCT. These 
findings represent the effect of equilibria between solution concentration and solid 
phases, and solubility product to induce co-crystal formation (Nehm, 2006). The 
DSC thermal data of the pure samples and their mixtures are used to construct an 
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ideal binary phase diagram as shown in Figure 1.8b). It is given by a plot of the 
melting points of mixture of starting material as a function of the mole fraction of the 
components. The points for the eutectics between each phase and the number of co-
crystalline phases within a system are included. A BPD gives information for solid-
state contact between the two components to form co-crystals through a melt 
interface. However, it cannot be employed for solution crystallisation (Blagden et 
al., 2008; Nauha, 2012). 
 
Figure 1.9. Region of techniques on phase diagram. Green arrow: solution crystallisation 
from a stoichiometric solution. Purple arrow: reaction crystallisation. Yellow ellipse: slurry 
crystallisation. Blue ellipse: sonochemical co-crystal formation area. Red ellipse: grinding 
area (Nauha, 2012). 
 
 
Moreover, it is not reasonable to conduct phase diagrams for a screening a large 
number of coformers. The co-crystal synthesis methods will be discussed further 
beginning from the solvent crystallisation, solution-mediated transformation, 
mechano-chemical, and other liquid assisted techniques. Results interpreted in 
another experiment as η (the ratio of solvent volume to the sample weight) was used 
to compare techniques such as liquid-assisted grinding and slurry followed by 
sonication (Friscic et al., 2009). These quantities can be incorporated into the phase 
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diagram (Figure 1.9) to determine the area of experimentation explored so far 
(Nauha, 2012). 
1.3.2. Solution based crystallisation 
The most common technique used for polymorph screening is solution based 
crystallisation (Zhang et al., 2007). This method is of great importance due to the 
possibility of attaining co-crystals for structure determination by single crystal X-ray 
diffraction (SXRD). The experiments performed using solution crystallisation begin 
from zone 1 in the TPD as shown in figure 1.9. In practice, solution crystallisation 
can be performed by two strategies. First, using evaporation technique which 
involves co-crystallisation via stoichiometric evaporation of components from 
various solvents. TPD explains that equimolar components with similar solubilities 
in a solvent produce 1:1 co-crystal upon evaporation. The use of complex solvent 
mixtures in case of incongruent dissolution system hinders the formation of solvates 
and is therefore recommended over congruent systems. However, system with 
solvent mixtures of varying rate of evaporation lack control and can be hard to 
handle. Second, use of non-stoichiometric solutions in order to obtain co-crystal 
stability region as explained by TPDs, using non-congruently saturated solvents. In a 
study by Childs et al., 2008, CBZ added to saturated solutions of 18 coformers 
attained pure co-crystals (Qiao et al., 2011). This is also known as reaction 
crystallisation which begins with a saturated solution of more soluble component 
(zone 1) to less soluble component (zone 4) (Nauha, 2012).  
Cooling crystallisation is another solution method which has attracted more attention 
for industrial application. This involves heating and varying the temperature of the 
crystallisation system by cooling it down. TPD in conjunction with cooling 
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crystallisation can be used to predict co-crystals, though it can change 
asymmetrically with temperature. When the solution mixture (zone 4) gets 
supersaturated with respect to co-crystals upon cooling the thermodynamically 
expected product is a co-crystal (Qiao et al., 2011). But, there might be another 
kinetic or thermodynamic product at higher temperature that might crystallise out. 
To overcome this problem, seeding can be utilised in the system (Naura, 2012). An 
analysis of CBZ/NCT slurry used an in-situ ATR-FTIR (Attenuated total reflectance-
Fourier transform infrared spectroscopy) probe to determine the effect of 
superstauration and kinetic pathway for cooling crystallisation (Gagniere et al., 
2009). 
Supercritical fluid (SCF) technology has been recently applied to the area of 
pharmaceutical co-crystallisation. It was initially developed to avoid the problems of 
aggregation and agglomeration observed in case of micronisation, enhancing the 
drug properties. SCF was discovered as a potential technique to develop 
indomethacin-saccharin co-crystal by using three steps: solvent power, supercritical 
anti-solvent technique and fast atomisation of the solution (Padrela, 2009, Sekhon, 
2009; Llinas and Goodman, 2008).  
Moreover, spray drying has been suggested as an alternative to obtain pure co-
crystals from incongruently saturated systems. It is believed that the co-crystals 
formed via spray drying were mediated by an amorphous phase formation, which is 
often observed in case of spray drying of pure components. This kinetically 
controlled route has been suggested to reduce the effects of thermodynamics. The 
mechanism involved in spray-drying process is not completely understood, therefore 
further knowledge is required to scale up (Valega and alhalaweh, 2010; Brittain, 
2012). Similarly, rotary evaporator (rotavap) has been used as fast solvent 
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evaporation technique and quick screening tool for new co-crystals forms (Bag et al., 
2011). 
Pagire et al., (2013) introduced the concept of spherical crystallisation to form 
CBZ/SAC co-crystals and studied the role of kinetics and thermodynamics in this 
process favouring its two forms; Form I (stable) and Form II (metastable). This 
process involves solution of the two components in a good solvent added to a bad 
solvent, leading to crystallisation and then forming agglomerates with an immiscible 
bridging liquid added drop-wise to the solution being stirred (Figure 1.10). The 
degree of supersaturation depending on variables such as solvent selection, solvent 
proportions, higher stoichiometric ratio of components and, immediate and delayed 
addition of the bridging solvent acts as a deciding factor favouring one of the two co-
crystal forms. 
 
Figure 1.10.  Spherical co-crystallisation process, where bridging solvent leads to 
agglomeration in stages: coalescence of wetted co-crystals, squeezing of bridging solvent 
and compression due to agitation (Pagire et al., 2013b). 
 
24 
 
For instance, high amount of good solvent favoured Form I; high amounts of 
saccharin favoured Form II; 2:9 ratio of good to bad solvent favoured Form II, and 
bridging liquid added 10 minutes after pouring good solvent into bad, resulted in 
Form II (Pagire et al., 2013b).  
1.3.3. Solution-mediated transformation 
Solution mediated phase transformation (SMPT) is a technique that involves 
conversion of an API into co-crystal utilising a liquid phase (slurry or suspension 
equilibration). The mechanism uses minimal amount of solvent required to dissolve 
the mixture of A and B, represented in the lowest solvent percentage area of TPD 
(Blagden et al., 2008). The solution mediated transformation occurs when the 
solvent becomes saturated with co-crystal which then crystallises out, dissolving 
more of A and B until it becomes undersaturated. Some cases might show the 
emergence of pure A or B alongside co-crystal lying in zone 3 or 5. The main kinetic 
barrier observed in slurry SMPT is the time taken to attain nucleation of co-crystals 
(Naura, 2012). SMPT combined with phase diagram was used to detect polymorphs 
of carbamezapine-isonicotinamide co-crystals. The kinetic barrier helped to identify 
the formation of a metastable polymorph before it could convert into a more stable 
one (Horst et al., 2008).  
An earlier study reported microwave irradiation to illustrate the importance of 
nanostructures for enabling chemical transformation by sonocrystallisation, forming 
nano-cocrystals of aminonitropyridines and benzenesulfonic acids (Sekhon, 2009). 
Sonochemical cocrystal processing method utilises ultrasound to the slurries of co-
crystal components. The ultrasound augments the mixing of components, reducing 
the amount of solvent required. This process assists in dissolution and nucleation of 
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the co-crystal at a faster rate. Friscic et al., 2009 compared two methods, 
sonochemical and mechano-chemical utilising liquid as a transformation phase, but 
differing in the amount of solvent and means used to obtain co-crystal. The study 
deduced the volume of liquid phase in µL mg
-1
 required for the design of co-
crystallisation experiment in each case. The observed results favoured the formation 
of co-crystal when the amount of solvent was lowered, as expected when the solvent 
is saturated with respect to the reactants. Moreover, mechano-chemical co-
crystallisation (i.e. grinding or milling) was chosen over sonochemical due to lower 
levels of solvent achieved (Naura, 2012).  
In the above experiment, thickness of the slurry (lower values of η) was observed to 
initiate co-crystal formation. The application of ultrasound on the solution affects the 
nucleation rate due to the presence of cavitation energy. This event of cavitation 
encourages nucleation at lower supersaturation levels, thereby reducing the induction 
time and the metastable width. Hence, ultrasound was identified to overcome the 
challenge of supersaturation in a conventional solution mediated technique, when 
two components exhibit a distinct variation in their solubilities. Successful studies 
performed ultrasound assisted solution co-crystallisation (USSC) to produce co-
crystals from non-congruent soluble pair of caffeine and maleic acid in methanol. 
This technique obtained pure 2:1 co-crystals of caffeine-maleic acid which was 
unsuccessful in the case of slurry sonication and solvent cooling. Further 
understanding of the nucleation mechanism involved in USSC is still required (Aher 
et al., 2010).  
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1.3.4. Mechanochemistry 
a) Neat or solvent assisted grinding 
Over past few years co-crystal preparation via grinding has been a fast and 
convenient way of screening that involves very little or no solvent. Co-crystals are 
formed by two different techniques: neat or dry grinding and mechanical liquid-
assisted grinding (LAG). Dry grinding consists of mixing of stoichiometric 
components either manually (using mortar and pestle), or by mechanical means 
(vibratory mill or ball mill) (Figure 1.11) (Qiao et al., 2011; Mirza et al., 2008). Co-
crystals obtained from solid-state grinding are more consistent compared to that from 
solution techniques. This may be due to crystallisation conditions, uncontrolled 
solvent effects and characteristics of hydrogen-bond connectivity. Most of the co-
crystals can be developed by both solution and grinding methods, but a few were 
generated in either of the conditions. Co-crystals developed by solution method has 
solvent as a stabilising factor for their molecular structure, which may not be feasible 
while grinding due to the stability of their primary phases. On the other hand, recent 
technique of adding small amount of solvent during grinding process (liquid-assisted 
grinding), has an enhanced kinetic effect to facilitate co-crystal formation (Blagden 
et al., 2007). For example, Weyna et al., (2009) discovered 25 new co-crystals via 
solvent-drop grinding which is green and cost-effective method of production. 
 
Figure 1.11. Co-crystals prepared using grinding technique: grinding (mortar and pestle), 
and ball milling of A and B before, during and after milling. A and B represented by blue 
and green grow into a purple co-crystal (Nauha, 2012). 
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Grinding studies have not completely illustrated its mechanism and have different 
assumptions. To date mechanisms used to describe neat grinding are molecular 
diffusion, eutectic formation and amorphous phase acquiring higher energy or 
mobility for the reactant molecules. This can occur through one of the distinct 
intermediate bulk phases (a gas, a liquid or an amorphous solid) (Friscic and Jones, 
2009). For example, diffusion through gas phase (appropriate vapour pressure) on 
the surface of the crystals followed by shearing force of grinding, where the reactant 
molecules develop higher energy with respect to their starting crystalline forms. The 
mechanism in LAG is supported by solution mediated transformation provided the 
compounds are soluble in the solvent used. When a solvent in which neither of the 
components are soluble, kinetic enhancement does not take place and the liquid 
behave as a diffusion medium. The development in kinetics was justified by 
additional degrees of orientation and conformational freedom open to the molecules 
at the various interfaces thereby boosting the chances for molecular collision. 
Another possibility is the prediction of tiny seeds for co-crystals formed during LAG 
increasing the rate of co-crystallisation (Trask et al., 2004; Qiao et al., 2011; 
Blagden et al., 2007).  
In addition, the change in the composition of the starting material while grinding 
seem to control the co-crystal stoichiometry. For example, three of the co-crystals of 
nicotinamide and five dicarboxylic acids formed in the stoichiometric ratio 1:1 and 
2:1, showed reversed stoichiometry upon the addition of excess of nicotinamide. 
Whereas, two of the co-crystals were more stable as their stoichiometry changed in 
one direction. Besides the mechanisms explained above, choice of solvent may also 
control the polymorphic outcome in LAG. It was observed that the nature of solvent 
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had a profound effect in obtaining two polymorphs of the caffeine co-crystal with 
glutaric acid (Naura, 2012; Qiao et al., 2011).  
b) Twin-screw extrusion 
Twin-screw extrusion is a viable mechano-chemical method similar to grinding, 
which produces co-crystals without the use of solvents. The twin screw extruder 
consists of two parallel screws rotated in different directions to enable mixing and 
movement of the final product (Figure 1.12).  The parameters that influence co-
crystal formation are temperature and the extent of mixing. It is an efficient, 
environmental friendly and scalable process that overcomes the challenges of 
solution crystallisation, hence avoiding the cumbersome measurements using TPD. 
This process has been used to demonstrate the continuous solvent-free production of 
co-crystals such as, caffeine-oxalic acid (Daurio et al., 2011) and ibuprofen –
nicotinamide (Dhumal et al., 2010). Additional work has been performed in 
monitoring the co-crystal formation using high temperature NIR (near infra-red) 
probe as a PAT (process analytical technology) tool, in order to envisage the real-
time effect of parameters and process understanding as demanded by quality by 
design (QbD) (Kelly et al., 2012). 
 
Figure 1.12.  Pictorial representation of a twin screw extruder enhancing co-crystal 
formation (Nauha, 2012). 
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c) Microwave-assisted co-crystals 
Microwave-assisted co-crystal is another emerging green technology employed for 
the synthesis of co-crystals in a short span of time. The study proposed that 
microwaves enhance the co-crystallisation process by increasing the mobility of the 
molecule, thereby maintaining the saturation state at the crystal interface. This is 
explained by the dielectric heating induced by the microwaves which depends on the 
material properties such as, ability to absorb and convert electromagnetic radiation 
into heat, and to undergo polarisation within the electromagnetic field (Figure 1.13). 
Pure 1:1 co-crystals of non-congruent pair of caffeine- maleic acid was developed in 
the presence of water and methanol. An additional form II of 1:1 caffeine-maleic was 
observed in methanol. Hence, the results deduce that the factors affecting co-crystal 
formation via microwave radiation are the dielectric properties and the solubility of 
the components in the solvent (Pagire et al., 2013a). 
 
 
Figure 1.13.  Saturated caffeine/maleic acid 1:1 co-crystals under microwave irradiation 
(Pagire et al., 2013a). 
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1.3.5. Thermal screening 
Thermal screening is a good visual technique for early screening of thermally stable 
and non-volatile compounds. It can either be performed by using a hot-stage thermal 
microscopy method (also known as Kofler technique) or with a multi-component 
DSC screening. Hot-stage microscopy has been used historically as a route to access 
the thermodynamic landscape within the binary phase diagram, in order to visualise 
the melting profile of a co-crystal system. It utilises the methodology of mixed 
fusion (or contact), to obtain a zone of mixing by first melting and solidifying one 
component (high melting point) on the slide, followed by melting the other 
component (lower melting point) touching the first one, causing simultaneous 
melting of a portion of first component. This is then viewed and reheated under 
polarised light to identify the number of phases present and the melt temperatures. 
The co-crystal production results in two eutectic melting zones on the sides of the 
zone of mixing, whereas only one eutectic melting zone is observed when no co-
crystals are formed (Figure 1.14) (Qiao et al., 2011; Nauha, 2012). Further to this, it 
can be used to observe any polymorphic transition within the individual component 
and the co-crystals. In a study, the seeds of co-crystals collected from the mixing 
zone were used to enhance co-crystallisation via solution methods (Blagden et al., 
2008). 
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Figure 1.14. Schematic diagram of mixed fusion method. a) both the eutectics melt leading 
to zone A, B and co-crystal formed whereas, b) one eutectic melt, hence no co-crystal 
(Nauha, 2012). 
 
 
Thermal screening applying a DSC can be performed on the mixtures of components 
A and B in different molar ratios, whilst heating. Here, formation of a co-crystal is 
indicated by the appearance of two consistent endotherms, representing eutectic 
melting followed by co-crystal melting. The method uses little material and no 
solvent, however, can be difficult to predict when polymorphs of either of the 
components exist (Nauha, 2012). 
 
1.4. Co-crystal characterisation 
1.4.1. Crystal characterisation 
Characterisation of co-crystals involve physicochemical properties determined by 
various analytical techniques such as, infrared (IR) spectroscopy, single crystal X-
ray diffraction (SXRD), powder X-ray diffraction (PXRD), Raman spectroscopy, 
solid state nuclear magnetic resonance spectroscopy (SSNMR), differential scanning 
calorimetry (DSC), scanning electron microscopy (SEM), tetrahertz and mass 
spectroscopy (MS). These techniques help in the structural investigation of crystal 
formation, that is, checks for crystal purity, any polymorphic transformation or 
degradation, interaction between the components, mass of the complex and thermal 
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profile. SXRD is an important technique required to determine the structure of co-
crystals at an atomic level, provided a single co-crystal is produced. This condition is 
hard to achieve in all cases, therefore, PXRD is rather an adopted method to confirm 
the presence of co-crystals. However, PXRD cannot discriminate co-crystals from 
other phases that may develop, for example, solvates, hydrates, and polymorphs 
(Miroshnyk et al., 2009; Qiao et al., 2011).  
To further understand the solid-structure, spectroscopic rules have been developed 
for distinguishing between salts and co-crystals. Studies engaged in sodium salt 
formation of different acids and 1:1 co-crystals formed by free acids realised that 
these systems can be distinguished using IR spectroscopy The energy of carbonyl 
group in methods involving carboxylic acid, could be used to distinguish co-crystals 
from salts. When a salt is formed, free acid absorption band found in the frequency 
range of 1680-1690 cm
-1
 is replaced by anion band at a frequency between 1550- 
1600 cm
-1
.  Whereas, when a co-crystal is formed, a small shift of absorption band is 
observed to a higher frequency range of 1700-1730 cm
-1 
(Brittain, 2012). In addition, 
Raman spectroscopy can be applied to obtain the low frequency vibrational mode 
and understand the formation of supramolecular synthons. It has many applications 
in identifying characteristic peaks of co-crystals (Aher et al., 2010), and has been 
further applied as an in-situ observational tool in the high-throughput screening of 
slurries (Kojima et al., 2010).  
High-resolution SSNMR is another powerful technique for the characterisation of 
co-crystals, hard to achieve by SXRD. Various types of NMR chemical shifts can 
enable element-specific observation of unique nuclei and distinct chemical sites 
present (Khan et al., 2010). A green and automated thermal method, DSC was 
recently developed for rapid screening of co-crystals (carbamezapine-nicotinamide) 
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(Lu et al., 2008). This technique produces additional thermal data besides melting 
point, that is, enthalpy of melting. SEM is another important analytical method that 
produces images by means of a high-energy electron beam generating information 
on sample’s surface topography. Another highly sensitive technique compared to 
Raman known as terahertz time-domain-spectroscopy (THz-TDS), can identify 
chiral and racemic hydrogen-bonded co-crystals similar in supramolecular structure. 
Therefore, integration of different types of spectroscopic methodologies can 
elucidate better understanding of co-crystalline materials, saving cost and time (Qiao 
et al., 2011). 
1.4.2. Particle characterisation 
In relation to the effective use of co-crystal as a formulation product post crystal 
characterisation, other testing tools such as particle size and surface energy analyser 
can be applied. The particle size of a powder determines its flow and compaction 
properties (Horiba Scientific, 2014). The shape and size depends on the technique 
and process parameters involved. The most widely used technique to detect the 
particle size from submicron to millimeter size is by laser diffraction, which 
measures the angular scattering of laser beam interacting with dispersed particulate 
sample. Large spherical particles diffract the light at relatively small angles 
compared to the smaller particles. The intensity of the angular scattered light is then 
analysed to obtain the size of particles (Sympatec GmbH, n.d.; Malvern, 2009). The 
control of particle size distribution is important for reasons such as better dissolution, 
absorption rates, aerosolisation to penetrate into lungs, suspension and emulsion 
stability (Horiba Scientific, 2014). 
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Another technique, surface energy analyser (SEA) involves inverse gas-phase 
chromatography (iGC) for characterising surface and bulk properties of powder, 
films, fibres and semi-solids. The principle works by injecting known volumes of 
gas over the packed solid material in a cylindrical column at a constant flow rate, 
where it gets absorbed at the surface of the material (Figure 1.15). The FID (flame 
ionisation detector) measures the time taken by the gas pulse to elute down the 
column. Different gas phase probe molecules are used to determine wide range of 
physicochemical information, for example, dispersive and polar surface energy, 
acid/base interactions, entropy of adsorption, permeability, solubility etc. (Surface 
Measurement Systems, 2014a). 
a)   
b)  
Figure 1.15.  Schematic diagram of: a) conventional gas chromatography (GC); and the 
reverse, b) iGC followed by SEA (Surface Measurement Systems, 2014b). 
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1.5. Challenges in co-crystallisation 
New strategies are being examined thoroughly for the development of compounds 
with suitable physicochemical properties. The complexity of developing molecules is 
ever increasing with co-crystals that offer more extensive range of co-formers. 
Introduction of new pharmaceutical engineering processes needs exploration of 
process variables for discovery of new phases or enhancement in drug’s properties. 
A lot of thermodynamic and kinetic information which is method dependent has 
been unnoticed. Factors such as type of co-former, the API to co-former ratio, 
temperature, pressure, technique, solvent, solvent mixtures play an important role in 
the selection of desired properties (Dafratec, n.d.). Relative solubility of the co-
crystal components appear as an important parameter when utilising solution-
mediated approaches. For example, highly polar solvent such as acetone shows 
congruent solubility for curcumin (CUR) and phloroglucinol (PHL); hence 
producing phase-pure CUR-PHL 1:1 co-crystals. If the solubility of the two 
components differ a lot; the less soluble component may crystallise out first upon 
solvent evaporation prior to reaching the co-crystallisation zone (Chow et al., 2014). 
Co-crystals are known to exhibit enhancement in solubility and hence, dissolution 
compared to the drug’s crystalline and amorphous forms. The crystalline forms have 
an advantage of being stable compared to the amorphous state. The “spring and 
parachute” effect for the dissolution of amorphous drug has been related to 
pharmaceutical co-crystals (Figure 1.16) (Babu and Nangia, 2011). 
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Figure 1.16. The spring and parachute concept: 1) Low solubility of the crystalline (stable) 
form; 2) amorphous phase with quick transformation to crystalline form (minutes to hours); 
3) Wide metastable zone (hours) maintained by highly soluble forms (Babu and Nangia, 
2011). 
 
 
The “spring” effect is known to occur due to the quick dissociation of weak 
hydrogen bonds of co-crystals compared to salts; into amorphous form. The same is 
observed in case of amorphous drug dispersing from a polymer matrix. The 
“parachute” phenomenon is maintained over long time-periods due to the 
transformation of high-energy amorphous form into a metastable form (which 
possess higher solubility), and then to the stable crystalline form (low solubility) 
following the Ostwald’s Law of Stages (Babu and Nangia, 2011). But, this is may 
not be a true observation in every co-crystal case. As explained earlier in a study; the 
conventional aqueous solution of danazol: vanillin co-crystal converted into a low-
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soluble crystal form and therefore, it was modified with combination of surfactant 
and polymer to achieve high absorption levels (Childs, Kandi and Lingireddy, 2013). 
 
1.6. Polymorphism of co-crystals 
Polymorphism is an ability of a compound in its solid state, whether it is single or 
multiple component (co-crystals, salts, hydrates, etc.), to subsist in different 
crystalline forms bearing same chemical composition (European Medicines Agency, 
2014). Polymorphs in solid-state pharamceutics have been an important issue in 
particular with the development of co-crystals, since they can attain different 
properties. One of the main properties of concern, that is, solubility can affect drug’s 
bioavailability, efficacy and safety. In addition, polymorph can spontaneously 
convert from a less stable (metastable) form to a stable form, with the most stable 
form being least soluble. Therefore, efforts are taken to characterise the most stable 
form first during the discovery phase, so that it could be used for further testing. A 
polymorph could be developed in various circumstances such as, change in 
equipment, manufacturing process, storing conditions etc (Linas and Goodman, 
2008; Sekhon, 2009).   
Co-crystal provides an opportunity for additional polymorphs with enhanced 
formulation properties and a rise in patent protection. The growth of the crystals 
occurs in two steps: first, formation of crystal nuclei; second, growth of these nuclei 
into a larger single crystal. As explained by Ostwald’s rule, the metastable form 
should exist first. The solution in the metastable state is normally used to produce a 
single crystal. The width of this metastable region is useful and explains the 
conditions over which supersaturation can be achieved. Hence, it is used to control 
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the crystallisation in order to form single crystals over fine precipitates. The figure 
below shows the time dependant production of polymorphs in various systems, that 
is, metastable polymorphs observed in a fast process (Linas and Goodman, 2008).            
 
Figure 1.17. Timescales favouring crystallisation of stable or metastable polymorphs in 
different techniques (Linas and Goodman, 2008). 
 
 
Co-crystal polymorphs of 1:1 caffeine and glutaric acid were observed from solvent 
evaporation using chloroform. The two forms (Form I and Form II) crystallised 
simultaneously differing in the torsional angles within the carbons on the methyl 
group from the acid. On the other hand, both the forms were observed separately in 
mechanical grinding. Form I was observed with a non-polar solvent, whereas, Form 
II (stable) was found in a more polar solvent. Form I was unstable under high humid 
conditions and transformed into Form II in a day. This explains for the stability 
affected by different polymorphic forms. Further example confirms two polymorphs 
of 1:1 carbamezapine and saccharin co-crystals. In this case, high-throughput 
screening was conducted on Form I including 480 experiments using various 
solvents and their mixtures. In addition, other techniques such as, solvent assisted 
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grinding and slurry conversion, were performed and characterised using PXRD and 
Raman spectroscopy. But none seem to produce any additional form of co-crystals. 
The Form II of the above co-crystal was only found in the case of polymer 
heteronuclei crystallisation, despite of the deep insight into solution techniques. 
Unlike the above examples, forms of 1:1 piroxicam and 4-hydroxybenzoic acid 
cocrystals were distinguished by the tautomeric form present and the hydrogen bond 
interaction. These were the first discovered forms of co-crystal synthon 
polymorphism, where one form is present as non-ionised tautomer and other as 
zwitter-ionic tautomer (Sekhon, 2009; Schultheiss and Newman, 2009).  
1.7. Co-crystals as intellectual property 
The importance of patents on pharmaceutical co-crystals covers different areas, such 
as, formulation, method used and the process involved in manufacturing. An 
invention should qualify three criteria for covering a patent; novelity, utility and non-
obviousness. The utility of a co-crystal is not an issue for applications, since there 
have been many examples illustrating enhanced properties on the therapeutic effects 
of the API. Furthermore, co-crystals have limited prior art, due to the absence of 
publications on crystallisation performed with co-former and API. This is an 
advantage and hence, secures its novelity. The third area of non-obvious is linked to 
predictability, which is true for co-crystals as crystal engineering and computational 
analyses are not reliable and therefore, cannot always predict properties and 
structures. Co-crystals appear to cover a large patent space, even though its 
predictability is limited. This is accounted due to the fact that there is large number 
of co-formers, its use as product improvement, chemical structures, and various 
forms (hydrates, solvates, polymorphs, etc.) discovered (Sekhon, 2009; Schultheiss 
and Newman, 2009).  
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Table 1.1. Examples of co-crystal of pharmaceutical interest. 
 
API Co-crystal former Preparation 
method 
Enhanced property (if 
known) 
Reference(s) 
Aceclofenac Chitosan Solvent change 
approach using 
bio-polymer - 
Chitosan 
Enhanced dissolution Mutalik et al., 
2008 
Aspirin 4,4’-dipyridil Slurry conversion  Walsh et. al., 
2003 
Caffeine Oxalic acid 
Glutaric acid 
Solvent-assisted 
grinding 
Physical stability Trask et. al., 
2005 
Carbamezapine 
(CBZ) 
(Tegretol®) 
Saccharin (1:1) 
 
 
 
 
 
Nicotinamide (NIC) 
Solution cooling 
crystallisation ; 
Solvent drop 
grinding 
 
 
Dihydrate CBZ 
co-milled with 
NIC 
Physical stability; favourable 
dissolution 
 
 
 
 
Stability during storage 
Hickey et al., 
2007; 
Wyena et al., 
2009 
 
 
Chieng et al, 
2009 
Cytosine Oxalic acid (4:1) 
Malonic acid (2:1) 
Succinic aicd (2:1) 
Solvent drop 
grinding; Solution 
crystallisation 
 Brittain, 2012 
Fluconazole Maleic, glutaric, 
fumaric acid 
Solvent 
evaporation 
 Brittain, 2012 
Fluoxetine 
hydrochloride 
(Prozac®) 
 
Benzoic acid (1:1) 
Succinic acid (2:1) 
Fumaric acid (2:1) 
Conventional 
solvent 
evaporation 
Aqueous solubility: 
Decrease by 50% 
Two-fold increase in 5 mins 
Slight increase 
Childs et al., 
2004 
Ibuprofen 4,4’-bipyridine 
Nicotinamide 
 Higher melting point 
Racemic form and S-
enantiomer 
Walsh et al., 
2003; Berry et 
al., 2008 
Indomethacin Saccharin Slow evaporation; 
Liquid-assisted 
grinding ; 
Super-critical 
fluid 
Faster dissolution rate Jung et al., 
2010; 
Basavoju et 
al., 2008; 
Padrela et al., 
2009 
Itraconazole 
(Sporanox®) 
1,4-dicarboxylic 
acid: L-malic acid 
Solvent 
evaporation 
Crystalline, stable form; 
Improved dissolution rate 
Remenar et 
al., 2003 
Mefloquine Several co-formers  Enhanced solubility, 
dissolution rate; resist 
conversion into hydrate 
Brittain, 2012 
Norfloxacin Isonicotinamide 
Succinic acid 
Malonic acid 
Maleic acid 
 
Solvent 
evaporation 
Solubility Basavoju et. 
al., 2006 
Paracetamol 4,4-dipyridyl 
 
Oxalic acid, 
Theophylline, 
Naphthalene, 
Phenazine 
Solvent 
evaporation 
 
Liquid-assisted 
grinding 
 
 
 
Improved mechanical 
properties/ Enhanced 
compressibility 
Oswald et. al., 
2004 
 
Karki et.al., 
2009 
Sulfacetamide 
(antibiotic for 
ocular infections) 
Isonicotinamide, 
Caffeine 
Liquid-assisted 
grinding 
Reduced solubility for better 
therapeutic action 
Goud, Khan 
and Nangia, 
2014 
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1.8. Techniques 
1.8.1. Rotary evaporator (rotavap) 
Scientist and engineers continue to execute the removal of solvents using an 
unavoidable process known as rotary evaporation. Rotary evaporators have been 
extensively used for single batch and continuous processes. It involves removal of 
solvents from a solution by heating (Sigma-Aldrich, 2015a). A blanket of vapour 
persists above a liquid which has a saturation vapour pressure. This pressure 
increases with temperature until the solution reaches its boiling point; when it 
becomes similar to the surrounding atmospheric pressure (1 bar) (Monk, 2004, 
p.188).  When assisted with a vacuum, it lowers the surrounding pressure above the 
solution by getting rid of the vapours and hence, reducing its boiling point.  
Therefore, it can make evaporation process rapid at lower temperatures under a 
vacuum. The vacuum levels differ for different solvents in a system. At an optimum 
vacuum and temperature, the solvent vapours re-condense in the receiving flask with 
hardly any vapours collecting in the pump. But, if operated at pressures lower than 
the optimum, the vapours could pass through condenser and condense in the vacuum 
pump, degrading its performance (Welch vacuum, n.d.). 
The figure below shows a rotary evaporator with four major components: hot bath, 
rotor, condenser, and solvent trap; with an additional vacuum pump which promotes 
rapid evaporation of solvents with higher boiling points at low pressure conditions 
(ChemWiki, n.d.). 
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Figure 1.18.  Description of advanced vacuum controlled rotary evaporator (Sigma-Aldrich, 
2015b). 
 
 
1.8.1.1. Evaporation rate of solvent 
This is determined by three different variables: flask rotation speed, bath 
temperature, and pressure in the flask. The most important variable of concern is the 
vacuum level as pressure below one atmosphere lowers the boiling point of a 
solvent. Therefore, the system’s functioning could vary depending on the vapour 
pressure as follows: 
1) When pressure is similar to the solvent’s vapour pressure at boiling point, the 
condition set is optimal as most of the solvent condenses out in the condenser 
without any loss into the pump.  
2) When the pressure set is bigger than the solvent’s vapour pressure at boiling 
point, the evaporation slows down. 
3) When the pressure is less than solvent’s vapour pressure at boiling point, it 
boils vigorously making the solvent foam and causing considerable loss of 
the solvent vapours into the pump (Welch vacuum, n.d.). 
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1.8.1.2. Determining the optimum pressure 
The settings for an optimum pressure level for a given solvent are provided by some 
manufacturers based on various equations such as Reckhard’s (equation 1a), where 
the vapour pressure (P) in mm Hg can be obtained for a given solvent at temperature 
(T) (Rekhard,  1958). 
      𝐿𝑜𝑔 𝑃 = 2.8811 −
[𝑇𝐴−𝑇]
[𝑏𝑇]
                                       ( Eq. 1a) 
TA  = Boiling point (K) at 1 atmosphere or 760 mm Hg 
T = vapour pressure temperature (K) at pressure P (mbar) 
b  = Reckhard’s constant 
2.8811 = Adjusting factor for pressure in mm Hg 
 
Table 1.2 represents calculated vapour pressures of solvents at three different 
temperatures. 
Table 1.2 Reckhard’s equation used to measure optimum pressures for solvents at various 
temperatures (Welch vacuum, n.d). 
 
Solvent Constant b Boiling point 
at 760 mm Hg 
(
o
C) 
Absolute 
Pressure (mm 
Hg)  for 
Boiling Point 
at 25 
o
C 
Absolute 
Pressure (mm 
Hg)  for 
Boiling Point 
at 40 
o
C 
Absolute 
Pressure (mm 
Hg)  for 
Boiling Point 
at 60 
o
C 
Acetone 0.196 56 224 417 N/A 
Diethyl ether 0.200 35 517 N/A N/A 
Ethanol 0.159 78 58 131 348 
Methanol 0.167 65 119 253 618 
Water 0.167 100 24 54 145 
 
 
Another equation used to illustrate the relationship between boiling point of the 
liquid and surrounding pressure is the Clausius-Clapeyron’s equation. It states that 
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vapourisation curves of most solvents show a similar relationship between pressure 
P, temperature T and enthalpy of vaporisation ∆Hvap, where pressure gradually 
increases with the increase in temperature as shown below, 
                                    𝑃 = 𝐴𝑒𝑥𝑝(
−∆𝐻𝑣𝑎𝑝
𝑅𝑇
)
                                               (Eq. 1b) 
(University of Waterloo, n.d.) 
In this equation, R is a gas constant (8.3145 Jmol-1K-1) and A is an unknown 
constant. It also calculates the vapour pressure at a different temperature, if enthalpy 
of vapourisation and vapour pressure is known for a temperature, using the following 
equation, 
                                      𝐿𝑛
𝑃1
𝑃2
=
∆𝐻𝑣𝑎𝑝
𝑅
.
1
𝑇2
−
1
𝑇1
                                       (Eq. 1c) 
where, P1 and P2 are pressures corresponding to two temperatures, T1 and T2 
(Turanyl, 2014;University of Waterloo, n.d.). Due to deviation in Clausius-
Clapeyron equation at high pressure, a three-parameter, Antoine’s equation has been 
consistently applied to obtain vapour pressure. It involves three “Antoine 
coefficients”, A, B and C which varies depending on substance and is measured over 
restricted temperatures. The equation is as follows: 
                      𝑃 = 10𝐴−
𝐵
𝐶+𝑇                                  (Eq. 1d) 
where, P is the pressure in mmHg and T is temperature utilised in 
0
C (General 
chemistry online, 1997-2010). 
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1.8.1.3. Applications 
a) General laboratory use 
Rotavap was developed to overcome the problems of overheating and charring 
caused by conventional distillation systems. With a vacuum system attached, it can 
help recover solvents at lower pressure and temperatures from temperature sensitive 
substances. In laboratories; it has been used to obtain clean solvents from used 
solvents, extraction of essential plant oils, separation of non azeotropic mixtures 
such as water-acetone, and achieve maximum distillation for low boiling point 
solvents. New rotavaps have introduced an inert gas supply into the condenser to 
prevent any conversions during distillation process (IKA, n.d.). However, very low 
pressure conditions may result into foaming of the solution also referred to 
‘bumping’, which may result into loss of material. Therefore, careful regulation of 
the vacuum and bath temperature is necessary or a special trap combined with fritted 
funnel can prevent solid material from passing through (Buchkremer and Brinker, 
1990). 
b) Co-crystal 
A lot of investigation needs to be initiated to understand the role of thermodynamics 
and kinetics in cocrystallisation. This rising curiosity has led to the use of rotavap as 
vital technique for screening and manufacturing co-crystals besides narrowing the 
knowledge gap between other forms of crystalline products. A recent study 
demonstrated the existence of suspected cocrystal of curcumin (CUR) and 
phloroglucinol (PHL) employing rotavap. This form wasn’t synthesised by other 
general methods and was only generated under kinetically favourable conditions 
using fast solvent evaporating process. The most phase pure form was observed with 
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highly polar solvent such as acetone, aiding congruent solubility for both the 
components (Chow et al., 2014).  
Another study utilised rotavap to test formation of paracetamol (PCA) and oxalic 
acid (OX) 1:1 co-crystal which was only generated by mechanochemical methods. 
Attempts to form co-crystals using solvent assisted grinding and from solution failed 
to produce PCA: OX 1:1. Surprisingly, rotavap favoured the formation of PCA: OX 
from solution mixture of chloroform and methanol. Therefore, the high evaporation 
rates and supersaturation levels observed in rotavap, seem to play an important role 
in screening of new co-crystals (Bag, Patni and Reddy, 2011). 
 
 
1.8.2. Spray drying 
Spray drying is a well proven technique for the generation of dry particulates from a 
solution or suspension by rapid evaporation of the solvent sprayed within a hot 
gaseous medium (Figure 1.19). It has been applied in pharmaceutical technology to 
obtain dry particles with distinct properties such as increased aqueous solubility, 
modified release profiles and enhanced bioavailability. This method was first used to 
obtain dry homogenous powders of thermolabile plant extracts without undergoing 
decomposition. The complex fluid dynamics and the drying behaviour of the product 
within the instrument can alter the drug characteristics which can be controlled by 
various process parameters, namely inlet temperature, feed rate, feed concentration, 
aspirator flow rate and atomisation (Sollohub and Cal, 2010).  
Pharmaceutical industry has utilised spray drying as an emerging technique with 
inexhaustible applications explored. Studies involving particle processing techniques 
apply milling and spray drying as a standard means for particle-size reduction. Spray 
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drying was considered as an efficient method for particle engineering over milling 
and lyophilisation due to its ability to control powder characteristics. Numerous 
viable spray dried forms such as nanosuspensions for dry powder inhalers (DPI), 
microspheres and microemulsions possess higher dissolution and inhalation 
properties than mechanically micronised particles. Recently, this well-characterised 
unit operation has been incorporated into co-crystals (Alhalaweh et al., 2013; 
Sollohub and Cal, 2010; Daggupatti et al., 2011). 
 
Figure 1.19.  Set up for the LU-228 spray dryer with an open loop (Deshmukh, n.d.). 
 
 
1.8.2.1. Application in co-crystals 
Most of the conventional screening methods used for developing co-crystals are not 
suitable for scale-up production. This becomes even difficult in the case of non-
stoichiometric systems where careful consideration of the crystallisation factors is 
required. Methods such as SCF, hot melt extrusion, ultrasound (Aher et al., 2010) 
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and microwave (Pagire et al., 2013) have been utilised in order to overcome these 
challenges. Further need to scale-up and prepare co-crystals from complex systems 
has involved the use of fast, continuous, ‘in-process’ crystallisation using spray 
drying. Current studies using spray drying found that the co-crystals formed in the 
case of CBZ-GLT (carbamezapine- glutaric acid) and IND-NIC were similar 
regardless of congruent and incongruent stoichiometric conditions. This study further 
demonstrates supersaturation in incongruent systems by TPD (as explained in 
Chapter1, Fig.7), leading to the production of mixed phases. Whereas, formation of 
pure and uniform co-crystals in case of solvent evaporation of congruent conditions. 
In contrast, the results obtained by spray drying of incongruent systems do not 
comply with TPD which could be due to the processing conditions altering the solid-
state behaviour and hence, require further understanding (Alhalaweh and Velaga, 
2010; Alhalaweh et al., 2013).  
Another study used liquid assisted grinding to plot phase diagrams for 
carbamazepine and nicotinamide co-crystal (CNC); to explain the crystallisation 
pathway involved in producing CNC from incongruently saturating systems. The 
solution stoichiometry of carbamazepine (CBZ) and nicotinamide (NIC) was varied 
from 1:1 to 2:1 or 1:2; as agreed with TPD Zone 1(Figure 6). The spray dried 
product generated was CNC with impurity of either of the two components 
illustrating the path from Zone 1 to Zone 3 or 5. It is believed that the kinetics 
involved here is dependent on the solution stoichiometry. Hence, 1:1 solution 
stoichiometry was used to produce pure CNC co-crystal (Zone 1 to Zone 4) via spray 
drying. Optimised process parameters were varied and successfully produced co-
crystals without any impurity; overcoming batch to batch variation (Patil et al., 
2014). 
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1.8.2.2. Process parameters 
Various conditions set up inside a spray dryer have a significant effect on the drying 
process and the particle formed. On the other hand, these operating conditions may 
vary depending on the drying characteristics of the drug and the final product 
required. Therefore, it is essential to optimise the system for the desired output. The 
main process parameters are as follows:  
a) Atomisation 
This is the first phase where the liquid feed is reduced into tiny droplets suspended in 
drying gas that leads to immediate solvent evaporation forming dry particles. The 
dispersion of these droplets occurs in microseconds within the drying gas, thereby 
increasing the surface area. This encourages heat transfer from the gas to the droplets 
resulting in evaporation of solvents in seconds and simultaneous mass transfer back 
into the system. Therefore, the substance never approaches the inlet temperature, 
making this process desirable for drying heat sensitive materials. To further explain 
the droplet-drying kinetics, this quick process first takes place at the droplet surface 
it surrounds, increasing the solid concentration and further depends on the drying 
conditions set within the spray dryer (Dobry et al., 2009; Cal and Solohub, 2010; 
Arpagaus and Schwartzbac, 2008).  
Atomisation can be enhanced by different forms of energy integrated into devices 
(Figure 1.20) such as: 
1) Rotary atomisers – These horizontal disc shaped devices are in motion by an 
electrically driven motor to which the feed is supplied. The centrifugal force 
generated causes the feed at the centre project towards the brim of the disc 
forming fine droplets. These discs may be designed with different shaped 
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grooves to maximise the dispersion properties. Its use is limited because of 
the deposits formed around the wall of the drying chamber. 
2) Pressure nozzle – These are one-fluid hydraulic nozzles where a fluid flows 
under pressure into a converging channel and out through the orifice of 0.4-
4mm in diameter. These nozzles are not appropriate for drying highly viscous 
feeds.  
3) Two-fluid (pneumatic) nozzle – This multi-fluid nozzle operates using a 
compressed gas which collides with the feed at the tip of the nozzle, resulting 
in the dispersion of the feed. This nozzle can produce nanoparticles with 
enhanced absorption and solubility properties of the material. These nozzles 
have an in-built unblocking needle driven by compressed air in order to 
overcome in-process clogging of the nozzle.  
4) Ultrasonic nozzle – These can be used to atomise high viscosity fluids by 
applying high electric signal causing vibrations via transducers and further 
amplified by a nozzle tip. In addition, the droplet size can be controlled by 
altering the frequency and also produces narrow particle size distribution (Cal 
and Solohub, 2010). 
 
Figure 1.20.  Types of atomisers: a) Rotary  atomiser; b) Pressure nozzle; c) Pnuematic 
nozzle (Cal and Solohub, 2010). 
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b) Inlet temperature/ outlet temperature 
The feed gets transported by peristaltic pump to the atomisation devices and the 
heated gas in the drying chamber where evaporation takes place. Each droplet 
formed inside the chamber is exposed to different local temperature points due to 
non-laminar gas flow. Factors such as change in atmospheric air humidity, shape of 
the chamber may also affect the drying conditions. Therefore, in order to accomplish 
optimal drying conditions and maximum outlet humidity, inlet temperature has to be 
optimised (Kent and McLeod, 2007; Cal and Solohub, 2010). Moreover, evaporation 
takes place due to the gradient between the wet surface and not the gas, enabling 
temperatures not higher than the boiling point of the solvent and hence no thermal 
load (Buchi, 1997-2002).  
The mixing of the spray and the dry gas is an important aspect and influences the 
properties of the final product. The different modes in which air-droplets contact can 
be characterised as shown in Table 1.3. 
The resulting temperature of the gas carrying dry solid particles after heat and mass 
exchange inside the chamber is known as the outlet temperature.  Thus, this 
temperature cannot be regulated and is a consequence of the combinative result of 
parameters such as inlet temperature, atomisation, feed rate and feed concentration. 
The particles are regarded to possess the same temperature as the outlet before it 
enters into the separating device or cyclones. Moreover, the difference between inlet 
and outlet should be as small with high inlet maintained in order to achieve 
minimum residual moisture in the product (Cal and Solohub, 2010; Buchi, 1997-
2002). 
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Table 1.3. Three types of construction to distinguish air –droplets contact (Cal and Solohub, 
2010). 
 
Type Co-current Dryer Counter-current Dryer Combined Flow Dryers 
Image 
 
 
 
Functioning Material spray and hot gas 
flow in the same 
direction. 
Opposite flow. Hot gas 
upwards and material 
spray falls downwards. 
Product sprayed upwards 
(counter-current to the 
drying air) stays in hot 
zone for a short time. 
Immediately, pulled 
down by gravity into 
cooler zone. 
Product ─No exchange of the hot 
gas with the surrounding.  
─Product exposed to 
sudden evaporation and 
heated least as drying gas 
energy is lost in 
evaporation. 
─Air stream lose some 
heat in its path. ─Droplets 
hit the coldest gas first and 
then the hottest.  
─No residual moisture. 
Product extremely hot. 
─Fair-size particles 
obtained in a small 
chamber. 
Drawback ─Droplets may not dry 
completely before 
reaching the chamber 
walls. 
─Suitable for thermally 
stable products. 
─Produces porous 
powders and 
agglomeration. 
─Mixture of the moist 
and the dried product 
while descending down. 
─Suitable for thermo-
stable substances. 
 
c) Other process parameters 
The drying gas supply rate is controlled within the system by the aspirator in either 
suction or injection mode. A system with suction mode undergoes a slight under 
pressure effect. The speed of gas been sucked can be regulated to change the amount 
of heated drying gas, affecting the drying performance of the system. The low 
aspirator speed will decrease the degree of separation in the collecting cyclones and 
raise the exposure time of the drying gas thereby, reducing the moisture content in 
the product (Cal and Solohub, 2010; Buchi, 1997-2002).  
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Another important process control parameter, the solution feed rate, is managed by a 
peristaltic pump that directs the solution to the nozzle. This parameter has a major 
influence on the inlet and outlet temperature of the system. A lot more energy is 
required to evaporate the solvent in case of high feed rates, thereby decreasing the 
outlet temperature and increasing the difference between the two temperatures. This 
may also lead to the formation of sticky product on the walls of the chamber. In 
addition, feed properties such as its viscosity, concentration and the tubes drawing 
the feed can vary the conditions. Therefore, optimum setting and understanding of 
the collective effect of the parameters is essential to enhance its efficiency and obtain 
the desired product (Cal and Solohub, 2010; Buchi 1997-2002).  
The product characteristics such as particle size distribution, bulk density, moisture 
content, morphology, and different forms (granulate, powder and agglomerate) are 
the dependant variables. These variables can be managed by altering the independent 
variables, that is, the process parameters to derive the desired quality of the product 
(Daggupatti et al., 2011). For example, a study using gum Arabic (wall material) to 
form microencapsulated flaxseed oil optimised the spray drying process to obtain the 
minimum oil on the surface of the dried particles. The inlet temperature condition, 
solid content and the oil concentration were observed as the critical parameters 
(Tonon et.al., 2011).  
1.8.2.3. Process understanding via fundamental models 
a)Williams-Landel-Ferry (WLF) kinetics 
The product under spray drying conditions may undergo phase transformation from 
amorphous to crystalline solid depending on the drying kinetics and material 
physical properties. It was suggested that this transformation was governed by 
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Willaims-Landel-Ferry (WLF) kinetics. Where, the equation explains that the 
increase in the difference between the particle temperature (Tp) and the glass 
transition temperature (Tg), would increase the rate of particle cyrstallisation. 
Therefore, during spray drying, increase in the inlet temperature may enhance the 
crystallisation rate as observed in the case of lactose which possess high glass 
transition temperature (Islam and Langrish 2010; Islam, Langrish and Chiou, 2010). 
In addition, recent studies on co-crystals also imply its formation driven by kinetic 
factor (high rate of supersaturation) and glassy state of the material (Alhalaweh and 
Velaga 2013). 
b) Computational fluid dynamics (CFD) models 
The process engineering models are based on quality by deisgn (QbD) approach to 
speed up the development timelines and reduce the amount of API used. These 
studies employ mass- balance and energy –balance calculations to determine the 
spray-drying drying space. This involves prediction of ranges of inlet conditions to 
obtain a continuum of outlet conditions (Dobry et al., 2009; Salem, 
Ahmadlouiedarab and Ghasemzadeh, 2011). A study involved CFD modelling to 
elaborate drying kinetics inside spray dryer affecting the particle morphology. The 
figure below shows that in the case of hot and fast drying; the droplet reaches the 
boiling point of the solvent, creating vapour pressure which keeps the film forming 
polymer inflated and hence, produces hollow-sphere morphology. Whereas, the 
particle collapses into “raisin” morphology when under cold and slow drying 
conditions, as shown in figure 1.21 (Dobry et al., 2009). 
55 
 
 
Figure 1.21.  Images of droplets arising from pressure-nozzle atomisation subjected to 
various drying conditions: a) hot/fast drying conditions and b) cold/ slow drying conditions 
when a film-forming polymer is used (Dobry et al., 2009). 
 
c) COST (“Changing One Separate factor a Time”) approach and Design of 
Experiment (DoE)  
COST is an instinctive method is used for the screening of the parameters. A study 
involved this approach to select optimum parameters to coat particles with a 
plasticiser using spray dryer. The most critical parameters observed from this method 
were selected and further optimised by a second approach, DoE. The parameters 
considered for DoE analysis were, inlet temperature, feed rate and atomisation. A 
three level – three factor factorial design was applied and optimised particles were 
produced (Bilancetti et al., 2010). Another simplistic DoE approach utilising 
fractional factorial experiment designs (FFED), comprises of a fraction of the 
complete runs from a full-factorial design. Other statistical tools such as Box 
Behnken design can also be used to predict the variables involved for attaining 
specific quality of product (Zhang and Youan, 2010).  
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d) Multi-variate data analysis 
The QbD guidelines lay emphasis on considering critical quality attributes (CQA) 
and critical process parameters (CPP) to understand the influence of process 
parameters on the product. CQA involves real-time monitoring of the process using 
an efficient in-line, online or at line PAT (Process Analytical Technology) tool. A 
multivariate study exploited NIR (Near infrared) and FTIR (Fourier transform 
infrared) to compare the amount of residual phenol in spray-dried and freeze-dried 
insulin formulations combined with DoE. The spectral data obtained was analysed 
by principal component analysis (PCA) and the projections of PLS (partial least 
squares). NIR spectra based PLS model was preferred over FTIR, which utilised 
three components to elucidate the amount of residual phenol/ insulin ratio in both the 
methods (Maltesen et al., 2011). 
e) A new distributed parameter model 
This model was used to investigate spray drying of a multi-component system, 
different stages of drying and the optimum conditions for the segregation of the 
components within the particle. Factors such as feed concentration, solubility of the 
components and the diffusion coefficients were considered as parameters in this 
method. The normal two stages of drying explained in earlier studies were: 
formation of outer solid crust due to the evaporation at the surface of the droplet and 
diffusion of water vapour through the pores of the solid crust causing mass loss. In 
this study, the second stage of drying was modified where the droplet is divided into 
shells of same size with respect to the solute concentrations (Figure 1.22a). The 
outermost shell or the crust is formed by one or more solutes if their concentrations 
reach beyond the value of its solubility during the drying process. Moreover, it was 
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assumed that the solid crust does not diffuse into the wet core, as the solute 
molecules are bigger compared to water molecules which diffuses during the course 
of evaporation (Figure 1.22b) (Gac and Gradon, 2013).  
 
Figure 1.22. Multi-shell model of a) dried droplet with N number of uniform shells and b) 
Wet particle with solid crust (Gac and Gradon, 2013). 
 
 
This model was used for insoluble nanoparticles (small components) which can 
diffuse easily through convective mechanism. The degree of segregation was 
dependant on their solubility in the solution and occurred when the components had 
different diffusion coefficients. For highly soluble components, small particle was 
formed and the segregation was negligible. On the other hand, in the case of low 
soluble components, the outer layer can be distinguished where the component with 
lower diffusion coefficient is at higher concentration compared to the second 
component present inside the other portion of the particle. The kinetics of 
crystallisation and inlet temperature also affects the thickness of the outer layer. 
Moreover, in a system with solutes of different solubility, a component with higher 
solubility will have a lower diffusion coefficient, forming higher concentration in the 
outer layer. In contrast, the concentration of the second component is almost constant 
in the entire particle space (Gac and Gradon, 2013). 
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1.9. Aims and objectives 
To date, an immense amount of work has been performed on the fundamentals and 
chemistry supporting the formation of co-crystals; overlooking the challenges that 
exist in scaling up of these methods. Scalability of conventional methods such as 
ball-milling, solid-state grinding, LAG is not viable. These mechano-chemical 
processes require energy that surpasses the supramolecular interactions within the 
molecules in order to form co-crystals. Therefore, in terms of scalability, these 
methods lead to homogeneity issues, phase transformation and degradation caused 
by friction induced within energetic material. On the other hand, solvent based 
approaches are known to enhance the reaction kinetics by driving the equilibrium to 
co-crystal formation. Although solution co-crystallisation may be amenable to 
scalability, limitations such as solubilities of the multiple components and solvate 
formation, hinder its production on a large scale (Ende, Anderson and Salan, 2014). 
One of the studies examined a green solvent-free continuous co-crystallisation 
approach, (SFCC) by using twin screw extruder for scale-up of carbamazepine 
(CBZ) and saccharin (SAC) co-crystals. The optimised process parameters required 
temperatures above the eutectic temperature of the mixture (133
o
C) to facilitate co-
crystallisation. Moreover, the high shear at the mixing zones under elevated 
temperatures induced additional heat which caused degradation and polymorphic 
transformation of the material (Joshi, 2012). Thus, additional routes must be adopted 
in order to overcome these challenges during scale-up. Current work in terms of 
scale-up has also introduced spray drying as a continuous, one-step and fast 
evaporating process for producing co-crystals from incongruently soluble pairs; 
overcoming the issue of contamination and control over stoichiometry (Alhalaweh, 
and Valega, 2010). However, selection of solvents can be a major obstacle.  
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Aim 
This project aims to investigate the formation of co-crystals using spray drying with 
the intention of making it a green process i.e. from aqueous media. This research is 
based on the hypothesis that rotavap could be used as a pre-screening tool and a 
platform for co-crystallisation amenable to large-scale spray dryer.  
Objectives 
● To establish solubility for the selected pair and successfully form their aqueous 
solutions. 
● To test co-crystal formation by rotavap as a pre-screening tool. 
● To devise a spray drying method for scale-up of co-crystals from aqueous systems.  
● To optimise the system by varying different parameters such as the inlet 
temperature, feed rate, feed concentration, feed temperature and aspirator. 
Understanding the effect of these variables on the quality of product. 
● To successfully employ characterisation techniques such as XRD and DSC to 
confirm the expected product and its purity.  
● To understand the relation between complex formation and high supersaturation 
levels achieved using these fast evaporation techniques generating co-crystals. 
 
1.9.1. Rationale for selection of model compound 
Caffeine (CAF) and maleic acid (MAL) was used as a model system due to their 
incongruent solubility and diverse stoichiometry. This pair exists in stoichiometric 
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ratios of 1:1 with two polymorphs, form I and II; and 2:1 (Leyssens et al., 2012). 
Moreover, the solid state properties of anhydrous caffeine revealed the existence of 
two polymorphs (Trask, Motherwell and Jones, 2005) and a hydrate form which 
makes it a challenging pair. CAF is a nitrogen containing alkaloid, known as 
methylxanthine and is represented as a poorly soluble biopharmaceutical 
classification system (BCS) class II drug (Figure 1.23). Therefore, it is very crucial 
to obtain a solubility enhancement technique. 
 
 
 
Figure 1.23. Chemical structure of caffeine. 
 
 
Interestingly, Guo et al., (2010) observed that the presence of MAL in solvent 
further increased the solubility of CAF due to complexation. Such compounds can 
also be referred to as hydrotropes if they aid in solubilisation of a hydrophobic 
compound in aqueous solution (Kumar, Raja and Jayakumar, 2013). Various studies 
were involved in its co-crystal formation with di-carboxylic acid (Figure 1.24) in 
order to increase its physical stability under all RH (relative humidity) conditions 
(Trask, Motherwell and Jones, 2006). 
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Figure 1.24. Dicarboxylic acids; a) maleic acid; b) glutaric acid; c) malonic acid; d) oxalic 
acid; e) succinic acid; f) tartaric acid. 
 
 
Therefore, MAL and other dicarboxylic acids such as malonic acid (MO), oxalic acid 
(OX), glutaric acid (GLU), tartaric acid (TAR) and succinic acid (SUC) were 
examined for their hydrotropic nature and successful scale-up as co-crystals using 
spray drying as a green technique.  
1.9.2. Overview of thesis structure 
Chapter 1 provides an introduction to co-crystals as an alternative to other solid-state 
forms in medicinal product with enhancement in various properties of the active 
ingredient. It further explains various techniques utilised in development of these co-
crystals and the challenges faced.  
Chapter 2 briefly describes the materials and methods utilised in this project.  
Chapter 3 scrutinise solubility enhancement of the incongruently soluble pair: CAF 
and MAL, and co-crystallisation results obtained using rotavap and spray drying. It 
also observes the effect of process parameters on the quality of product. The 
limitation faced by the technique and the challenges of the selected pair were 
discussed. 
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Chapter 4 examines another chemical analogue of CAF, theophylline (THEO) 
forming its co-crystals with di-carboxylic acids in aqueous solution and compare 
results obtained from the two fast evaporating techniques.  
Chapter 5 explains the findings for a congruently soluble pair, carbamazepine (CBZ) 
and saccharin (SAC) when subjected to rotavap and spray drying. 
Chapter 6 comprises of general conclusion and proposition for future work, followed 
by references and appendix 
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CHAPTER 2 
2.  
EXPERIMENTAL 
2.1. Materials 
2.1.1. Chemicals 
Caffeine, maleic acid (99%), malonic acid (99%) and oxalic acid (≥99%) were 
obtained from Sigma Aldrich; glutaric (99%) from Acros; L-(+)-tartaric acid 
(≥99.7%) from SAFC and succinic acid (≥99%) from Acros were used as supplied. 
Theophylline was sourced from Kores (India) Ltd; Carbamazepine USP 34 from Jai 
Radhe Sales (India) and Saccharin (99%) from Sigma Aldrich. Sodium Lauryl 
Sulphate (SLS) (85%) was purchased from Medical Export Co. Ltd., UK. All 
compounds were initially characterised by PXRD. Iminostilbene (97%) for stability 
studies was purchased from Sigma Aldrich. Further details of the above compounds 
are shown in the table below: 
Table 2.1 List of chemicals used and their physical properties (Chemicalland21, 2013). 
 
Name  Structure Properties  
Caffeine 
 
Formulae: C8H10N4O2 
Molar mass: 194.19 
M.P.:235
o
C 
Solubility in water: Slightly soluble 
 
Maleic acid 
 
Formulae:C4H4O4 
Molar mass: 116.07 
M.P.:130-2
o
C 
Solubility in water: Soluble 
Malonic acid 
 
Formulae: C3H4O4 
Molar mass:104.06 
M.P.:135-6
o
C 
Solubility in water: Miscible 
Glutaric acid 
 
Formulae:C5H8O4 
Molar mass:132.12 
M.P.:95-98
o
C 
Solubility in water: 430g/L 
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Oxalic acid 
 
Formulae:C2H2O4 
Molar mass:90.03 
M.P.:102-3
o
C 
Solubility in water:1.35g/L 
L- Tartaric Acid 
 
Formulae:C4H6O6 
Molar mass: 150.09 
M.P.:171-4
o
C (L or D) 
Solubility in water:    Soluble 
Succinic Acid 
 
Formulae:C4H6O4 
Molar mass:118.09 
M.P.:187-9
o
C 
Solubility in water: Moderately 
soluble 
Theophylline 
 
Formulae:C7H8N4O2 
Molar mass:180.16 
M.P.:270-4
o
C 
Solubility in water: Soluble in hot 
water 
Carbamazepine  
 
Formulae:C15H12N2O 
Molar mass:236.27 
M.P.:191-2
o
C 
Solubility in water: 17.7mg/L 
Saccharin 
 
Formulae:C7H5NO3S 
Molar mass:183.18 
M.P.:226-9
o
C 
Solubility in water:3.45g/L  
SLS 
 
Formulae:NaC12H25SO4 
Molar mass:288.37 
M.P.:204-7
o
C 
Solubility in water:150g/L 
Iminostilbene 
(5H-
Dibenz[b,f]azepi
ne) 
    
       
 
Formulae: C14H11N 
Molar mass: 193.25 
M.P.: 197-9
o
C 
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2.1.2. Solvents used  
1. Deionised water was obtained from SG Series Compact water system by 
Triple Red Limited with purity of 18.2 Mohm/ cm. 
2. Some of the selected solvents used were: methanol (99.8%), acetone (99.5%), 
ethylacetate (99.5%), ethanol (99.8%), chloroform (99%), dimethyl 
sulphoxide (DMSO) and 1,2-dichloroethane (99.8%). 
3. Formic acid (≥ 95%) and acetonitrile (HPLC grade) were used for CBZ: SAC 
stability studies.  
4. Series of alkane probes such as heptane, octane, nonane, decane, undecane 
with ≥ 99% purity were used for surface energy determination.  
5.   Karl Fischer reagent, Hydranal®-Composite 5 (methanol free) from Fluka   
       Analytical was used for moisture content determination.  
2.2. Methods 
This section will give an overview of general methods used and their data described 
later in relevant chapters. Spray drying, rotavap and some characterisation tools were 
used in common for all the co-crystallising pairs. Additional methods performed are 
listed further. 
2.2.1. Solubility 
a) Aqueous 
Prior to aqueous solubility determination, two stock solutions of initial concentration 
(C0) 0.1 i.e., 100µg/mL were prepared using caffeine and theophylline. Further six 
solutions at decreasing concentration (0.02 C0, 0.04 C0, 0.06 C0, 0.08 C0, 0.1 C0, and 
0.15 C0) were formed from the above solution and their absorbance value was 
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recorded using a UV (ultra-violet) spectrometer (Jasco V-730 spectrometer).  The 
absorption maxima for caffeine and theophylline were 272 and 271 nm, respectively. 
A standard curve of light absorbance versus concentration of solution was created to 
quantify the concentration of the unknown solution. 
An excess amount of weighed caffeine/ theophylline was added to water and 0.04 M 
co-former solutions. It was then stirred at 500 rpm for 24 hours in closed vials placed 
inside a jacketed vertical diffusion cell (Copley HDT10) at the desired temperatures. 
After reaching the suitable equilibrium, stirring was stopped. The solution was then 
filtered via PTFE filter 0.45 µm within 10 minutes and further diluted to measure its 
UV absorbance. The excess solid after filtration was dried and its PXRD results 
observed. The solubility of the compound was determined by exploiting the 
calibration curve and the average results reported.  
b) Organic solvent 
Excess amount of caffeine and theophylline were added to selected solvents and 
stirred at room temperature at 500 rpm for 24 hours to check for their solubility 
using UV spectrometer. All samples were run in duplicates.  
2.2.2. DEC (di-electric constant) 
Di-electric constant is also referred to relative permittivity and is defined as the ratio 
of absolute permittivity of the material (Ԑ) compared to permittivity in vacuum (Ԑ0) 
(Eqtionu 2a). It is denoted by symbol, Ԑr.  
                                                Ԑ𝒓 =
Ԑ
Ԑ𝟎
                          (Eq. 2a) 
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The concept is based on a material made up of atoms with charged particles 
behaving as dipoles (positive and negative charge ends); when placed between two 
oppositely charged plates, aligns itself so that the dipole moment opposes the 
external electric field (E) between the plates normally under vacuum  (Figure 2.1). 
The net reduced electric field is dependent on factors such as temperature, frequency 
and humidity. For a solvent, its permittivity is measured in terms of its polarity 
(Maxwell’s equations, 2012). This parameter is important for correlating the 
solubility of ionisable solute in solution or mixture of solutions with varying 
dielectric properties (Fakhree et al., 2010). Earlier studies observed a correlation 
between the solubility parameter and DEC where solvents had shown association 
with the solute via H-bonding. It was assumed that a linear correlation exists 
between DEC and solubility parameter (Gorman and Hall, 1964). DEC is also 
indicative of thermodynamics of mixing such as Gibbs free energy of mixing in case 
of binary mixtures where the properties of the two components vary due to factors 
such as pressure, temperature and composition (UC DavisChemWiki, n.d.; Tripathy 
and Swain, 1991). 
Procedure 
Prior to DEC measurements, three-term calibration was performed at the tip of the 
open-ended co-axial probe using three standards: air, a short circuit, and de-ionised 
water. The probe (E5071C, Agilent technologies) was then immersed in solvents or 
mixtures ensuring no bubble formation at the surface. DEC results were processed 
by Agilent network analysers and software85070E using frequency range from 300 
kHz to 2GHz at room temperature. 
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Figure 2.1. a) Two plates with equal opposite charge and electric field, E under vacuum; b) 
water molecule as a dipole; c) random course of molecules in absence of the electric field; 
when water molecules placed between the two plates, d) dipoles arrange according to the 
charges on the plate and electric field due to dipoles oppose external electric field, E 
(Maxwell’s equations, 2012).  
 
 
2.2.3. Preparation of co-crystals via rotavap 
Stoichiometric ratios of the API and coformer were dissolved in chosen solvents 
contained in a round bottom flask. The solvents were evaporated rapidly at optimum 
vacuum and water bath temperature conditions. The solid product was collected from 
the flask and dried in the oven at 40
o
C for 5 hours and then stored in a dessicator. 
Dried samples were gently triturated into fine powder with pestle and mortar before 
characterisation.  
2.2.4. Preparation of co-crystals by spray-drying 
Co-crystals of the selected pairs were prepared by spray drying. Experiments were 
conducted in a laboratory scale spray dryer LabUltima LU-228 (Figure 2.2), with a 
0.7 mm nozzle and main chamber of 1500 mm x 500 mm. A peristaltic pump was 
used to feed the solution into the main chamber. The aqueous solutions were spray 
69 
 
dried in an open loop configuration with atmospheric air as the drying gas in a co-
current manner to the cyclone separators. The organic solutions were evaporated in 
an inert environment using nitrogen in a closed loop. The experiment was designed 
varying the main process conditions (Table 2.2): feed rates were between 1- 3 
mL/min; aspiration rate between 50 to 70 m
3
/h and inlet temperatures varied for 
water was between 110 and 170
o
C. The air flow used was 1.5 bar and the outlet 
temperature varied depending on the process variables set. The resulting solids were 
analysed by various characterisation tools. For organic solvents, an inert or closed 
loop was used with re-circulating nitrogen gas which passes through an oxygen 
monitoring device, ensuring any leakage of ambient air into the system (Figure 2.3). 
The inlet temperature utilised for organic solvents varied and was slightly above 
their boiling point.  
                      
Figure 2.2. LU-228 advanced spray dryer. 
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Table 2.2. Experimental design for spray drying CAF co-crystals with dicarboxylic acids. 
 
Co-
crystal 
solution 
Ratio Feed 
Concentration 
(%) 
Inlet 
Temperature 
(oC) 
Aspirator 
(m3/h) 
Feed Rate 
(mL/min) 
Batch 
No. 
CAF:MAL  1:1 6.7% @45oC 110 60 1 1a 
6.7% @45oC 150 60 1 1b 
3.4 110 60 1 1c 
3.4 150 60 1 1d 
2:1 6.7% @45oC 110 60 1 1e 
6.7% @45oC 150 60 1 1f 
3.4 150 60 1 1g 
3.4 150 60 3 1h 
2.5 150 60 3 1i 
1.7 110 60 1 1j 
1.7 @45oC 150 60 1 1k 
1.7 150 40 1 1l 
1.7 150 60 1 1m 
1.7 150 60 3 1n 
1.7 170 60 1 1o 
1 150 60 1 1p 
1 150 60 3 1q 
CAF:GLU 1:1 5 150 60 3 2a 
3.4 150 60 3 2b 
1.7 150 60 3 2c 
CAF:MO 2:1 3.4 150 60 3 3a 
1.7 150 60 3 3b 
CAF:OX 2:1 1.7 150 60 3 4c 
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Figure 2.3. Set-up for the LU-228 spray dryer (inert loop).  
 
 
2.3. Characterisation 
2.3.1. Powder X-ray Diffraction (PXRD) 
The PXRD patterns were observed using a powder diffractiometer, Bruker D8 with 
CuK alpha radiation (λ = 0.154nm), and the operating conditions were 40 kV and 40 
mA. Data was collected from 5
o
 to 30
o
 2θ with continuous step size of 0.02o 2θ and 
stem time of 2s. The data was evaluated using DIFFRAC
plus
 EVA (Version 11.0) 
software. 
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2.3.2. Crystal structure data and PXRD patterns 
Cambridge structural database (CSD) was used to obtain crystal structure data and 
PXRD patterns for the APIs and their reported co-crystal forms. Mercury, version 
3.0 software was used to visualise the crystal structures. All experimental results 
were compared to the reference patterns collected from CSD.  
2.3.3. Thermal analyses 
a) Differential Scanning Calorimetry (DSC) 
DSC thermograms were generated using Q2000 from TA instruments. 
Approximately weighed sample (2-4 mg) was enclosed in a sealed aluminium pan 
and scanned from 25°C to 200°C~300
o
C (depending on the melting point of the 
components) at heating rate of 10°C/min under nitrogen atmosphere. The results 
were analysed using TA Universal analysis software version 4.5A.    
2.3.4. Raman spectroscopy 
Raman spectra of the samples were obtained using a Raman microscope (Renishaw 
Plc., UK) with 785 nm stabilized diode excitation. A 100x objective lens was used to 
focus laser spot at the sample placed on aluminium holder. Spectra were obtained in 
the region 100cm
-1
 and 1800cm
-1
 with 100% laser power acquiring 10 
accumulations. The data was acquired for CBZ: SAC FI and FII using Grams/AI 
version 9.1 spectroscopic software.  
2.3.5. Fourier-Transform Infrared (FTIR) Spectroscopy 
Infrared absorption spectra for CBZ: SAC co-crystal was obtained using 
PerkinElmer Spectrum 100 FT-IR. The samples were scanned from 500 cm
-1
 to 4000 
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cm
-1
 with an average of 4 scans. The data was acquired using Universal ATR 
(attenuated total reflectance) accessory.  
 
2.4. Additional methods 
2.4.1. Water content by Karl Fischer (KF) titration 
Samples prepared by spray drying in aqueous solutions were tested for its moisture 
content by performing volumetric titration using 701 KF Titrino KF titrator from 
Metrohm. The system was calibrated with 25 μL of water. Approximately 100 mg of 
sample was weighed and poured into methanolic solution till the first excess iodine 
content was detected. The used volume of iodine containing Karl Fisher solution 
generated moisture content in the samples. Each sample was analysed in duplicate. 
2.4.2. Particle Size Distribution (PSD) 
The particle size distribution of spray dried material was analysed by laser 
diffraction (Sympatec GmbH, Helos Disperse) where sample were sieved using 180 
μm sieve and placed in a dry powder disperser (RODOS/M). A reference 
measurement was taken before running each sample for 5sec at 2% optical 
concentration. The results were obtained at pressures (1 bar and 4 bars) in duplicates 
using lens, R1 (0.18-0.35μm). The data was collected using HELOS sensor and 
analysed using Windox5 software.  
 
Microscopic visualisation of particle size 
The sieved samples were lightly spread on glass slide and viewed under microscope 
(Zeiss-AxioCam MRc 5). The images were taken using the software, AxioVision  
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2.4.3. Scanning Electron Microscopy (SEM) 
SEM was used to characterise and visualise morphology of co-crystals. The samples 
were placed on aluminium stubs (Agar Sceintific, Stansted, UK) with self-adhesive 
carbon mounts. All samples were gold plated with deposition of 10 mm gold using 
electric current of 25 mA. Sample images were collected using FEI Quanta 400 
scanning electron microscope (Cambridge, UK) under high vacuum and working 
distance of 10mm at various magnification levels utilising XTM microscope control 
software V 2.3.  
 
2.4.4. Stability study  
The spray dried CBZ: SAC co-crystal samples were placed in a dessicator at room 
temperature with drying agent (silica gel) to protect the samples from moisture and 
its degradation examined using HPLC (High performance liquid chromatography).  
 
HPLC 
The experiment was performed on a Waters e-2695 system (Aligent Technologies, 
1200 series) equipped with a PDA 2998 detector and degasser. The mobile phase 
was composed of acetonitrile with 0.1% v/v formic acid and water with 0.1% v/v 
formic acid. A gradient method was used varying organic phase from 2% to 98% in 
10 minutes; to 2% in next 2 minutes and constant for further 2 minutes; separating 
CBZ and its degraded product (iminostilbene). The sample volume was 10 μL 
injected by autosampler and scanned at 219, 253 and 285 nm using 1.2 mL/min flow 
rate. A Waters symmetry C18 column with dimensions of 4.6 x 250 mm and particle 
size of 5 μm was employed. Column temperature was set at 25oC and results 
observed using Empower 3analysis software.  
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a) Calibration curve for iminostilbene 
Two stock solutions of iminostilbene with initial concentration (C0) 0.1 i.e., 
100µg/mL were prepared in acetonitrile. Further six dilutions: 0.01 C0, 0.02 C0, 0.03 
C0, 0.04 C0, 0.05 C0, 0.06 C0were formed. These were then analysed using HPLC 
method stated above to obtain area under the curve values. The calibration curve of 
concentration versus area under the curve was constructed to get a linear plot. The 
linear equation generated from the plot was used to calculate the unknown amount of 
iminostilbene present in the spray dried CBZ: SAC samples.   
b) Sample preparation  
Sample solutions of 500 μg/mL concentration were prepared in acetonitrile and 
filtered through 0.45 µM nylon filter membrane to obtain a clear solution. The 
unknown amount of iminostilbene was determined under HPLC analysis and results 
were exracted with the aid of calibration curve.  
2.4.5. Surface Energy Analyser (SEA) 
Surface Measurement System-iGC 2000, UK Ltd was used to measure the dispersive 
surface energy of CBZ: SAC co-crystals processed via spray drying using three 
different feed rates (1mL, 2mL and 3 mL). The samples were weighed and packed 
into salinised glass columns (2mm ID) with glass wool covering sample at either 
side of the column. SEA was set at 30
o
C column temperature and 0% relative 
humidity. Columns were pre-conditioned with methane for 3 hours to nullify dead 
volume. BET (Brunauer-Emmett-Teller) values were obtained by passing octane at 
flow rate of 10 sccm (standard cubic centimetres per minute) to calculate the surface 
heterogeneity (Table 2.3; Figure 2.4). Series of linear alkane probes (heptane, octane, 
nonane, decane) were injected to analyse dispersive component of surface energy 
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(Table 2.4) using Dorris and Gray method. The data was analysed using SMS Cirrus 
Plus software.  
Dorris-Gray method: 
Dorris and Gray demonstrated that the adsorption of an ideal gas phase on solid is 
independent of the n-alkane chain length, and that the surface covered by CH2 group 
is the same as cross-sectional area it acquires in bulk liquid with parallel layout of n-
alkane series. This method is less dependent on probe input parameters, where the 
retention of dispersive probes does not rely on injection size (Gamble et al., 2012).  
It is based on the theory that the absorption dispersive free energy of a methylene 
group can be estimated from the slope of a line of adsorption free energy from series 
of n-alkane probes against the carbon number, n. The equation is as follows: 
                                    ∆GCH2 =  −𝑅𝑇. ln (
VN,n+1
VN,n
)                                           (Eq. 2b) 
where ∆GCH2 is the dispersive free energy, R is the gas constant, T is the temperature 
in Kelvin (K), VN,n is the retention volume of the probe with n carbon number (Shi, 
Wang and Jia, 2011).  
 
 
 
 
 
 
77 
 
Table 2.3. Experimental details for calculating BET values. 
 
 
 
Table 2.4.  Experimental set-up for determining the surface heterogeneity of the samples 
(each solvent was run 6 times). 
 
Solvents % 
Coverage 
Column 
Temperature 
(oC) 
Flow 
(sccm) 
Flow time 
(minutes) 
FID gain 
Hexane; 
Heptane; 
Octane; 
Nonane 
0.015 30 10 5 10x 
0.05 30 10 5 10x 
0.09 30 10 5 10x 
0.16 30 10 5 10x 
0.26 30 10 5 10x 
0.3 30 10 5 10x 
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a)  
b)  
c)  
 
Figure 2.4. Linear plots of surface heterogeneity of samples processed at feed rates a) 
1mL/min; b) 2ml/min and c) 3mL/min.  
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2.4.6. CBZ: SAC 1:1 Form I co-crystal (prototype)  
Equimolar ratios of CBZ and SAC were weighed and dissolved in 62.5/37.5% v/v 
ethanol / methanol mixture and heated to 70
o
C for 1 hour under reflux. The 
temperature was lowered in increments of 10
o
C and the precipitated co-crystals were 
filtered, dried and characterised. 
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CHAPTER 3 
3.  
CAFFEINE AND DI-CARBOXYLIC ACIDS 
COCRYSTAL RESULTS 
 
This chapter explores the application of spray dryer in generating co-crystals of 
CAF primarily with MAL, an extensively studied pair; and other dicarboxylic acids. 
CAF’s increased solubility in dicarboxylic acid was examined in aqueous solution 
with an intention of making it a green technique for scale-up of incongruently 
soluble mixtures. Rotavap has been used as a pre-screening tool to establish if co-
crystals could be predicted prior to utilisation of large-scale spray dryer. This study 
achieves almost phase pure metastable CAF:MAL 2:1 which has been hard to 
generate via several solution-based methods to date. Various attempts such as 
process optimisation and solubilisation were made to attain highly pure co-crystals.  
3.1. Crystal data 
3.1.1. Caffeine  
CAF is a nitrogen containing alkaloid, known as methylxanthine and is used as a 
psychoactive drug, smooth muscle relaxant and an analgesic. The anhydrous solid 
form of CAF can exist as two forms, the most stable being, β over α which was used 
during this study. The unit cell belongs to Cc space group with a=43.04 Å, b= 15.07 
Å, c= 6.95 Å, α = 90o, β = 99.03o and γ = 90o (CSD Ref: NIWFEE03). The crystal 
structure and calculated PXRD pattern are shown below: 
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Figure 3.1. Crystal structure of caffeine (CSD Ref: NIWFEE03). 
 
 
  
 
Figure 3.2. Calculated PXRD pattern for caffeine with a characteristic peak at 12
o
 2θ  
(obtained from CSD). 
 
3.1.1.1. Caffeine monohydrate 
This compound is prone to hydrate formation under high RH conditions. Conversely, 
this hydrate form can transpose back to β-caffeine at lower RH with 61% RH being 
the dehydration line. Every mole of this non-stoichiometric hydrate crystalline 
structure contains 0.8 moles of water (Trask, Motherwell and Jones, 2005). The 
dimensions of the unit cell are: a = 14.8 (1) Å, b= 16.7 (1) Å, c = 3.97 (3) Å, α= 90o, 
β= 97 (5)o and γ= 90o with space group P21/a. The crystal structure and PXRD 
pattern are shown in the figures below. 
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Figure 3.3. Crystal structure of caffeine monohydrate (CSD Ref: CAFINE).  
 
      
Figure 3.4. Calculated PXRD pattern for caffeine monohydrate with characteristic peak at 
10.5
o
 2θ (CSD Ref: CAFINE). 
 
3.1.2. Maleic acid 
MAL encloses localised C=O and C-OH groups which act as hydrogen bond donor 
and acceptor to form intermolecular H-bonding. These two groups have significant 
difference in their bond lengths i.e. C=O ~ 1.205Å and C-OH ~ 1.311Å. The 
molecule skeleton holds itself in cis conformation and locks into a planar 
conformation by intramolecular hydrogen bonding (Audet et al., 1990). The unit cell 
shows a Pc space group with a = 3.69, b = 7.48, c = 8.59, α = 90o, β = 102.2o and γ = 
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90
o 
(CSD Ref: MALIAC13). The figures below show the crystal structure and 
calculated PXRD patterns adopted from CSD. 
   
 
Figure 3.5. Crystal structure of maleic acid (CSD Ref code: MALIAC13). 
 
           
 
 
Figure 3.6. Calculated PXRD pattern for maleic acid (collected from CSD). 
 
3.1.3. Caffeine maleic acid co-crystals 
3.1.3.1. CAF / MAL 1:1 co-crystal, Form I  
Caffeine has a pKa of 3.6 as a result of weakly basic imidazole nitrogen present in 
the structure. Therefore, the potential salt-complex formation ability is limited to 
strong acids. The basic imidazole nitrogen and two carbonyl oxygens of CAF act as 
hydrogen bond acceptors. It exist as a neutral co-crystal with di-carboxylic acids 
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forming hydrogen bonds between unionised imidazole nitrogen and the carboxylic 
acid; i.e. an expected [R2
2(7)] heteromeric synthon with strong O-H----N and weak 
C-H---O hydrogen bonding (Trask, Motherwell and Jones, 2005).  
The cis orientated maleic acid of CAF:MAL 1:1 Form I shows an intramolecular 
[S1
1(7)] hydrogen-bond motif along with intermolecular heterosynthon [R2
2(7)] 
between CAF-MAL dimeric units (Leyssens et al., 2012). The crystal structure and 
calculated PXRD pattern for CAF:MAL 1:1 Form I are given below. 
    
 
 
Figure 3.7. Crystal structure of 1:1 caffeine / maleic acid co-crystal Form I (CSD Ref: 
GANYEA). 
   
           
 
 
Figure 3.8. Calculated PXRD pattern for CAF / MAL 1:1 Form I (obtained from CSD).  
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3.1.3.2.  CAF / MAL 1:1 co-crystal, Form II  
The CAF:MAL  1:1 Form II exists as a triclinic crystal with two CAF and two MAL 
molecules in a unit cell. The intramolecular hydrogen bonding is absent in this 
polymorph which is mutilated by 80
o
 torsion of O-C-C-C. There is an intermolecular 
heterosynthon between the CAF-MAL dimer. The two dimmers are further 
connected by a [R2
2(8)] homosynthon between two adjacent carboxylic acid groups 
forming four component strand. Though a strong COOH homosynthon is present, 
this polymorphic state depicts reduced stability due to the distortion of maleic acid’s 
planar structure which explains its low density. Also, the expand in N---(H)O 
distance from 2.51 Å to 2.73Å demonstrate a weakly bonded [R2
2(7)] heterosynthon 
(Leyssens et al., 2012). The crystal data and calculated PXRD pattern for this crystal 
form are shown in Figure 3.9 and Figure 3.10, respectively. 
     
  
Figure 3.9. Crystal structure of 1:1 caffeine / maleic acid co-crystal Form II (CSD Refcode: 
GANYEA01). 
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Figure 3.10. Calculated PXRD pattern for 1:1 caffeine / maleic acid co-crystal Form II with 
characteristic peaks at 7.52, 11.94, 13, 15 and 17.5
o
 2θ (collected from CSD). 
 
3.1.3.3. CAF / MAL 2:1 co-crystal  
This crystal form acquires a monoclinic system where each unit cell is composed of 
two dimeric 2:1 CAF-MAL strand, i.e., 8 CAF molecules. No intramolecular 
hydrogen bonding is observed as seen in 1:1 Form I. The carboxylic acid groups of 
mal acid are twisted to give unstable trans orientation, forming two 
intermolecular [R2
2(7)] heterosynthon with CAF. Hence, the deformation of MAL 
and increase in N---(H)O distance to 2.98Å explains for lower density of 2:1 CAF-
MAL (Leyssens et al., 2012). The crystal structure and calculated PXRD pattern for 
this crystal form are demonstrated in Figure 3.11 and Figure 3.12, respectively. 
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Figure 3.11. Crystal structure of 2:1 caffeine / maleic acid co-crystal (CSD Ref: 
GANYIE01). 
 
 
Figure 3.12. Calculated PXRD pattern for 2:1 caffeine / maleic acid co-crystal with 
characteristic peaks at 8.9, 10.2, 13.14, 13.5 and 16
o
 2θ (obtained from CSD). 
 
3.1.4. Malonic acid 
MO is known to exist as five different polymorphs: α, β, γ, δ and ε with the 
difference in their packing patterns. It can form hydrogen bonding as it holds two 
proton acceptors and donors. For all the forms, the molecules are arranged in similar 
inclined zigzag fashion with carboxylate groups forming dimers by 𝑅2
2(8) hydrogen 
linkage. The triclinic β form is stable at room temperature with two non-equivalent 
cyclic hydrogen bonded dimers, which at higher temperatures (360 K), transforms 
into equivalent bonded structure, orthorhombic α form. With the increase in 
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temperature from 13-371 K, first order two phase transition was observed from γ to β 
and β to α. No unit cell dimensions were reported for orthorhombic δ form. Unlike β 
form, the new ε form has alternating carboxylate dimmers along and parallel to the 
planes down the column (Figure 3.14) (Reddy, Delori and Foxman, 2013). The 
crystal structure and PXRD pattern of malonic acid are shown in the Figure 3.13 and 
Figure 3.15, respectively.  
 
   
Figure 3.13.Crystal structure of malonic acid (CSD Ref: MALNAC03) 
                   
 
Figure 3.14.  Structural arrangement of malonic acid polymorphs: a) α-form: equivalent 
cyclic hydrogen bonded dimeric units; b) β-form: non-equivalent cyclic hydrogen bonded 
units; c) γ-form: H bonding between symmetry dependent molecules within the asymmetric 
unit; d) ε-form: alternating inclined carboxylate dimers along and parallel to the planes 
below the column (Reddy, Delori and Foxman, 2013).  
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Figure 3.15. Calculated PXRD pattern for malonic acid (CSD Ref: α-form (MALNAC03), β-
form (MALNAC) and γ-form (MALNAC07)). 
 
3.1.5. Caffeine malonic acid co-crystal 
CAF: MO 2:1forms orthorhombic crystal system with space group Fdd2 and unit 
cell dimensions: a=30.39 (12) Å, b=31.28 (16) Å, c= 4.67 (2) Å, α=90o, β=90o and 
γ=90o. The trimeric unit (caffeine-acid-caffeine) is held together by intermolecular 
hydrogen bonding between two carboxylate groups of each acid molecule with 
imidazole nitrogens of two caffeine molecules. This trimeric arrangement shows a 
V-shaped geometry appearing as a “kinked dumbbell” (Figure 3.17) (Trask, 
Motherwell and Jones, 2005). The crystal structure and PXRD pattern of CAF: MO 
co-crystal is shown in Figure 3.16 and Figure 3.18, respectively. 
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Figure 3.16.Crystal structure of CAF: MO 2:1 cocrystal (CSD Ref: GANYAW). 
 
 
 
 
Figure 3.17. Angled view: V-shaped geometry of trimeric CAF: MO 2:1 co-crystals 
processed in Mercury 3.5 (CSD Ref: GANYAW). 
 
 
 
 
Figure 3.18. PXRD pattern of CAF:MO 2:1 co-crystal obtained from CSD. 
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3.1.6. Oxalic acid 
OX molecule has a single carbon-carbon bond length and is planar in structure with 
carbonyl groups in trans-form (Figure 3.19). The structure exists as α (orthorhombic) 
and β (monoclinic) polymorphs based on their molecular orientation while forming 
intermolecular hydrogen bonding (Naumovet al., 1996). The PXRD pattern for OX 
is illustrated in Figure 3.20. 
       
 
Figure 3.19. Crystal structure of oxalic acid (CSD Ref: OXALAC11). 
 
 
 
Figure 3.20. Calculated PXRD pattern for oxalic acid (extracted from CSD). 
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3.1.7. Oxalic acid dihydrate 
Oxalic acid as α and β arrangement can incorporate water molecules placed 
asymmetrically between the C=O groups forming dihydrate. The α polymorph is 
formed by a short linear bond between acid proton and lone pair of water oxygen (II) 
and long bonds (I, III) formed between acid oxygen lone pair and water proton. 
Whereas, β polymorph only exists as a deuterated form with bond II bisecting the 
lone pair orbital on water oxygen (Figure 3.21) (Ebisuzaki and Angel, 1981).  
 
Figure 3.21. Oxalic acid dihydrate: a) depicts the different bond arrangement between 
oxalic acid and water (W) molecule: long (I and III) and short (II) hydrogen bonds; b) α 
polymorph with linear short bond II; c) β deuterated dihydrate polymorph with acid proton 
dissecting the lone pair orbital on water oxygen (Ebisuzaki and Angel, 1981).  
 
The crystal structure and PXRD pattern for OX dihydrate is shown in the figures 
below: 
 
 
Figure 3.22.Crystal structure of oxalic acid dihydrate (CSD Ref: OXACDH26). 
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Figure 3.23.Calculated PXRD pattern for oxalic acid dihydrate (adopted from CSD). 
 
3.1.8. Caffeine oxalic acid co-crystal 
CAF:OX 2:1 co-crystal is a flat trimeric structure forming heterodimeric synthon as 
observed in CAF:MO but differs in its crystal packing, i.e. “dumbbell-shaped” 
(Figure 3.25) (Trask, Motherwell and Jones, 2005). The crystal has a space group of 
P21/c and unit cell dimensions: a=4.41 (10) Å, b=14.77 (5) Å, c=15.91 (6) Å, α=90
o
, 
β=96.49o (10) and γ=90o (CSD Ref: GANXUP). The crystal structure and PXRD 
data for CAF:OX co-crystal is displayed in Figure 3.24 and Figure 3.26, 
respectively. 
 
 
Figure 3.24. Structural data for bis (caffeine) oxalic acid (obtained from CSD). 
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Figure 3.25. Angled view of CAF:OX 2:1 planar trimeric unit processed using Mercury 3.5 
(Trask, Motherwell and Jones, 2005).  
 
 
 
Figure 3.26. PXRD pattern of CAF:OX 2:1 collected from CSD.  
 
3.1.9. Glutaric acid 
GLU is a dicarboxylic acid with an odd number of carbon atoms and exists as two 
polymorphs: α and β. The transformation of β to metastable form (α) was favoured at 
higher temperatures with transition temperature of 63
o
C and also at relative humidity 
above 60% (Yueng, Ling and Chan, 2010). The thermodynamically stable form, β 
has a distinctive space group, C 2/c, creating a monoclinic system with β= 145.04o. 
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The molecules bind to each other by double or “cyclic” hydrogen bonds creating 
long chains. Each unit cell contains four non-equivalent molecules (Flakus and 
Miros, 1999). Whereas, α form leads to crystal destruction and reduced unit cell. The 
crystal structure and PXRD pattern for glutaric acid are depicted in the figures 
below. 
 
 
Figure 3.27.Crystal data for glutaric acid (CSD ref: GLURAC12).  
 
 
 
 
Figure 3.28.Calculated PXRD pattern for glutaric acid (collected from CSD). 
 
 
3.1.10. Caffeine glutaric acid co-crystal 
CAF: GLU 1:1 exhibit similar hydrogen bonding similar to CAF: MAL 1:1, where 
the heteromeric interaction (O-H---N) is only observed with one of the two 
carboxylic acid group. This indicates that GLU molecule may have a weak second 
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carboxyl group that did not favour H-bonding to caffeine imidazole nitrogen, 
producing 1:1 co-crystal. The 1:1 CAF: GLU also shows two polymorphic forms, I 
and II which are conformational in nature due to different torsion of the aliphatic 
chain (Trask, Motherwell and Jones, 2005). The crystal structure, crystal 
arrangement and PXRD pattern of two polymorphic forms of CAF: GLU 1:1 is 
shown in figures as follows: 
 
Figure 3.29.Crystal data for CAF: GLU 1:1 co-crystal (CSD Ref: EXUQUJ).  
 
 
 
 
 
Figure 3.30  Sheet of CAF: GLU ribbon processed in Mercury 3.5 (Trask, Motherwell and 
Jones, 2005). 
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Figure 3.31.Calculated PXRD patterns for CAF: GLU 1:1 Form I (bottom) and II (top) 
(extracted from CSD). 
 
3.1.11. Tartaric acid  
TAR is an enantiomer with no heavy atoms and low symmetry. It can exist in three 
forms: D-, L- and meso- form. The combination of the left and right-handed crystal 
forms a racemate, i.e. d-(l)-tartaric acid. The d-(l)-tartaric acid is a monoclinic crystal 
with space group P-1 and unit cell dimensions: a= 7.73Å, b=5.96Å, c=6.18Å, α=90o, 
β=100.35o and γ=90o (Stern and Beevers, 1950; Friscic et al., 2006). The figure 
below shows the crystal data for d-(l)-tartaric acid.  
   
 
Figure 3.32.Crystal data for d-(l)-tartaric acid (CSD ref: TARTAL01). 
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Figure 3.33. PXRD for d-(l)-tartaric acid obtained from CSD ref: TARTAL01. 
 
3.1.12. Caffeine tartaric acid co-crystal 
CAF and TAR can form 1:1 co-crystals via an intermolecular heterosynthon between 
the nitrogen of CAF and hydroxyl molecule of TAR (OH----N) as shown in Figure 
3.34 (Friscic et.al., 2006). The PXRD pattern for CAF:D-TAR is illustrated in Figure 
3.35. 
 
 
Figure 3.34.Crystal structure of CAF: D-tartaric acid. (CSD Ref: NEXWUJ). 
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Figure 3.35.PXRD pattern for 1:1 CAF:D-tartaric acid (CSD Ref: NEXWUJ) 
 
 
3.1.13. Succinic acid  
It exhibits two polymorphs: a triclinic (α) and monoclinic (β) form with different 
patterns of H-bonding within the crystal lattice. α form was observed in 
supersaturated solutions over β polymorph which prevailed in low saturated 
solutions. Also, factors such as nature of the solvent may also influence this 
conversion (Yu et al., 2012). The PXRD patterns below show characteristic peak at 
22
o
 and 27
o
 for α polymorph (Figure 3.37). The crystal structure of SU is shown in 
Figure 3.36.  
 
Figure 3.36 Crystal structure for succinic acid (CSD Ref: SUCACB07).  
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Figure 3.37. PXRD patterns for SU: a) alpha polymorph; b) beta polymorph c) anhydride 
form. (CSD Ref: SUCACB06, SUCACB07, and SUCANH).  
 
3.1.14. Caffeine succinic acid co-crystal 
No structural information available for this simple binary co-crystal.  
Instead, a study attempted co-crystallisation of CAF and SU by creating host 
inclusion lattice in the presence of guest molecules such as CHCl3 (chloroform) and 
CHBr3 (bromoform). The CAF and SU molecules were combined to form a 
heteromolecular host framework forming a structure depending on the properties of 
the guest molecule and their bonding ability (i.e. hydrogen and halogen bond). The 
guest molecules favoured different host frameworks which determined the 
stoichiometric ratio of CAF and SU. The two frameworks formed were with 
stoichiometric ratios of 1:1 and 4:1 in presence of CCl4 (carbon tetrachloride), and 
CHCl3 as guest molecules, respectively (Friscic et al., 2008). The PXRD pattern for 
CAF: SU: CHCl3 host-guest induced co-crystal is shown in figure below. 
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Figure 3.38. PXRD for CAF:SU: CHCl3 co-crystal (CSD Ref: 2.(CHCl3)2). 
 
3.2. Solubility 
For proficient screening and scale-up of co-crystals, determination of the 
component’s solubility could offer a significant influence in drug development. In 
this study, we investigated solubility in water, aqueous co-former solutions and 
selected organic solvents to deduce whether the incongruently soluble co-crystal 
pairs can be generated by a green approach.  
3.2.1. Aqueous solubility 
A calibration curve was constructed according to Beer-Lambert Law to determine 
CAF’s solubility in various solutions. The linear equation was obtained as shown in 
figure below. 
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Figure 3.39. Beer-Lambert calibration curve for CAF concentration against UV 
absorbance. 
 
The mole fraction solubilities (x) of caffeine in water (Table 3.1) and 0.04 M di-
carboxylic acid solutions were measured from 294 to 323 K as summarised in Table 
3.2. The dicarboxylic acid concentration of 0.04M was based on the highest 
concentration of mal holding CAF in water at room temperature and hence, used for 
other acids to test for solubility and compare results. It must be noted that succinic 
acid took several hours to dissolve in water until it gave a clear solution before 
solubility tests were performed. The solubility measurements in di-carboxylic acid 
solutions were correlated as a function of temperature (Figure 3.40) from equation 3a 
(Hu, Wang and Cai, 2009) and a plot of ln x vs 1/T was generated.  
                                    ln x = A + B/(T/Κ)                                               (Eq. 3a) 
Table 3.1. Mole fraction solubility of caffeine in water at various temperatures 
.  
T/K Caffeine solubility (mg/mL) Mole fraction (103x) 
294 20.7 1.11±0.11 
313 26.4 1.43±0.05 
323 63.8 4.99±0.02 
333 92.5 7.18±0.05 
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Table 3.2. Mole fraction solubility of caffeine in six 0.04 M di-carboxylic acid solutions at 
294, 313 and 323 K. 
 
T/K Caffeine 
(mg/mL) 
Mole fraction 
(103x) 
(x-xcal)/x 
Maleic acid 
294 63.0 3.40±0.06 0.007 
313 126.7 6.82±0.17 -0.025 
323 132.7 7.14±0.15 0.017 
Malonic acid 
294 44.8 2.42±0.06 0.009 
313 100.7 5.43±0.08 -0.031 
323 102.4 5.52±0.06 0.021 
Oxalic acid 
294 32.8 1.77±0.12 0.001 
313 71.1 3.84±0.06 -0.004 
323 97.8 5.27±0.01 0.003 
Glutaric acid 
294 53.8 2.91±0.09 0.000 
313 101.0 5.44±0.08 0.001 
323 138.7 7.46±0.11 -0.001 
Tartaric acid 
294 31.5 1.70±0.04 -0.001 
313 51.0 2.76±0.06 0.003 
323 66.7 3.60±0.09 -0.002 
Succinic acid 
294 37.9 2.05±0.07 0.001 
313 94.7 5.11±0.10 -0.001 
323 144.5 7.77±0.13 0.001 
 
The relative standard deviations (RSD) and parameters A and B for each di-
carboxylic acid solution are listed in Table 3.3 and were calculated from equation 3b 
(Hu, Wang and Cai, 2009).  
                                                (Eq. 3b) 
Where, x
calc
 stands for the calculated values from the linear equation 3a and N is the 
number of experimental data points.  
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Figure 3.40. Experimental mole fraction solubilities of caffeine in di-carboxylic acid 
solutions and water (markers); calculated solubilities from equation 1 (linear). 
 
 
 
 
Table 3.3. A and B values and the root-mean –square deviations of the measured solubilities 
from the calculated results.  
 
Acid solution A B RSD 
Maleic acid 1.3464 -1116 0.018 
Malonic acid 1.6633 -1251.4 0.022 
Oxalic acid 2.5584 -1560 0.003 
Glutaric acid 2.0107 -1337.1 0.001 
Tartaric acid 0.8216 -1056.1 0.002 
Succinic acid 3.7715 -1898.8 0.001 
 
An increase in the trend of solubility was observed with temperature in all di-
carboxylic acid solutions and water. The solubility of caffeine shows the highest 
value from 294 to 323 K in maleic acid and the lowest in tartaric acid solution, 
which was probably due to their structures and interaction with water. The slight 
difference among the solubilities of CAF in each dicarboxylic acid solution might be 
unobvious due to the similar polarity. On the other hand, the mole fraction solubility 
of caffeine in water alone at range of temperatures was used for comparison. A 
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significant increase in solubility was observed in all di-carboxylic acid solutions 
except for tartaric acid and the increase was highest at the room temperature (294 K). 
Dicarboxylic acids can easily solvate in polar solvents due to the presence of 
hydrophilic groups and may self-associate or form H-bonding to induce solubility of 
insoluble organic substances. This enhanced solubility explains the hydrotropic 
nature of dicarboxylic acids which undergoes complexation with CAF (Guo et al., 
2009; Kumar, Raja and Jayakumar, 2014) via weak interactions. The solubility of 
CAF decreases in the order: MAL >GLU>MO>SUC> OX > TAR >water.  
CAF is assumed to self-polymerise in water and the formation of high order hydrates 
was thought to increase its solubility (Paruta, Sciarrone and Lordi, 1965). X-ray 
diffraction analysis was carried on the filtrate from these solutions to ensure any 
transformation of CAF into its hydrate form. The transition temperature from 
anhydrous to hydrous form for CAF is 45-55
o
C (Wikstrom, Kakidas and Taylor, 
2008); which was observed in water at 50
o
C (323 K) and 60
o
C (333 K). In the 
presence of di-carboxylic acids, hydrate peaks seem to emerge from MO, OX, GLU 
and TAR solutions at room temperature. The transformation was observed 
predominantly in oxalic acid solutions at all temperatures (Appendix I). But the 
extent of hydration could also be an important factor that needs to be considered.  
3.2.2. Organic solvents 
The solubility of CAF was further tested in selected organic solvents used in 
previous studies to investigate co-crystal formation with mal (Leyssens et al., 2012; 
Guo et al., 2009). The results obtained at room temperature are shown in Table 3.4. 
 
 
106 
 
Table 3.4. Solubility of caffeine (mg/mL) in organic solvents at room temperature. 
 
Solvent Methanol Acetone Ethyl acetate 
Solubility 
(mg/mL) 
15.6±0.02 16.2±0.06 7.2±0.01 
 
The observations clearly indicate low solubility of CAF in organic solvents than in 
water. The enhancement in CAF solubility by complexation in aqueous solutions of 
dicarboxylic acids was considered as a suitable approach to obtain co-crystal phases 
via a green route.   
 
3.2.3. Di-electric Constant (DEC) 
The change in relative permittivity of water in the presence of dicarboxylic acids 
which successfully produced co-crystals with CAF was determined as a measure of 
change in its chemical polarity affecting solubility. Firstly, DEC values were 
obtained for solutions saturated with respect to dicarboxylic acids at various points, 
starting from 0.04 M till they reach saturation point at room temperature, that is, 
MAL at 5M, GLU at 3.25 M, OX at 1 M and MO at 13.45 M (Table 3.5). Therefore, 
the solubility of dicarboxylic acid in water increases in the order: 
OX<GLU<MAL<MO.   
Table 3.5. DEC values at 0.04M and saturated solutions of dicarboxylic acids in water.  
 
Acid conc. Oxalic 
acid 
Glutaric 
acid 
Maleic 
acid 
Malonic 
acid 
0.04 M 77.2 77.6 77.2 77.9 
Saturated 
solution 
65.2 56.2 48.3 37.8 
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Figure 3.41. Graphical representation of DEC (Ԑr) values against the molar concentration 
of dicarboxylic acids. 
 
The results explain that at low concentrations i.e., 0.04 M, the relative permittivity is 
similar for all acids and it progressively decreases till they reach their saturation 
points. At a particular molar concentration, eg: 1 M, the DEC values were in order: 
OX<MAL<GLU<MO.   
Hildebrand’s theory on solubility correlates dielectric constant (Ԑr) with solubility 
parameters (δ) attaining a linear relationship expressed by the following equation: 
                                     δ = 0.22 Ԑr + 7.5                                                     (Eq. 3c) 
A close linear correlation was observed in solvents with same chemical behaviour or 
molecular associations. Paruta et al., (1962) found the best correlation for solvents 
that had tendency to associate via H- bonding. That is, solubility parameter vs DEC 
plots of solvents such as water, methanol, ethanol, ethyl acetate etc. produced a 
linear trend. Alongside linear correlation, a positive slope was noted for polar solute 
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in less-polar solvent, whereas, a negative slope was seen when a non-polar solute 
dissolved in high-polar solvents (Gorman and Hall, 1964). Similarly, a negative 
slope is illustrated in Figure 3.41 for all dicarboxylic acids due to its association with 
highly polar solvent, water. 
The inter- and intra-molecular H-bonding of a solute such as dicarboxylic acid gets 
obstructed when dissolved in water as the donor and acceptor molecules on the 
solute associate via H-bonding. Debye model representation has been used to explain 
the induced dipole moment (dipole relaxation motion of molecules) in solvents 
which illustrates their H-bonding potency. Polar liquid such as water undergoes 
dipole-dipole intermolecular interactions, thereby causing re-orientation of the 
molecular arrangement. Water has highest polarity with DEC value of 80 at 20
o
C 
which is attributed to its hydrogen bonding capacity. Hence, DEC can be used to 
estimate the polarity of a solution. Other hydrophobic liquids possess a DEC less 
than 15, due to low dipole moment or collisions (Book: Son, 2014).  
Paruta (1964) later examined an increase in solubility of range of solutes with the 
increase in the concentration of sucrose solution and simultaneous decrease in their 
DEC values. The decrease in DEC was indicative of solvency attributes of sucrose 
syrup and reduction in polarity. The association between solute and solvent 
molecules may transform the linearity of the plot i.e., producing a linear or flat non-
linear relationship. The plot above does not show the best linear trend for all the 
dicarboxylic acids at higher concentrations. The decline in DEC values explains the 
reduction in polarity of the solution as the dicarboxylic acid concentration increases. 
The solute with highest solubility (malonic acid) attains the lowest DEC value as it 
undergoes highest molecular association with water, reducing its dipole moment 
compared to other acids.  
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Secondly, DEC values were also collected for 0.04 M dicarboxylic solutions with 
addition of CAF in increments till it became saturated, as shown in Figure 3.42. The 
DEC values of saturated acid solutions are provided in Table 3.6 
 
 
Figure 3.42. A DEC plot against CAF concentration till the dicarboxylic acid (0.04M) 
solutions attained saturation point.  
 
 
Table 3.6. DEC values of saturated dicarboxylic acid (0.04M) solutions wrt. CAF. 
 
CAF 
Concentration 
DEC 
Oxalic acid Glutaric acid Maleic acid Malonic acid 
No CAF 77.2 77.6 77.2 77.9 
Saturated wrt. 
CAF 
74.4 73.5 72.7 73.9 
 
Apshingekar (2014) observed an increase in trend of CAF solubility with increase in 
MAL until the CAF to MAL ratio in the mixture was low i.e., CAF solubility 
decreased at higher mal concentrations. On the other hand, mal solubility was 
decreased with the increase in CAF concentration. It was suggested that polar 
compound like mal has potential to form hydrogen bonding with water, therefore, the 
DEC decreases. Further addition of CAF disrupts the association contributing to a 
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new dipole moment changing the overall DEC and hence, solubility. In this study, 
CAF’s solubility was examined at lower dicarboxylic acid concentration which 
agrees with the results of the study above. The DEC value of each dicarboxylic acid 
is same at 0.04 M concentration as described before, which illustrates that all the 
solutions exhibit same polarity regardless of the acids present. Further addition of 
CAF may possibly disrupt the molecular interaction which will vary for each acid 
solution, reducing its bonding capacity and hence polarity. The oxalic acid solution 
saturated at lower concentration compared to other solutions. The polarity of the acid 
solution is in order: OX>MO>GLU>MAL which complies with CAF’s solubility 
reported earlier, i.e OX<MO<GLU<MAL. Therefore, maleic acid solution depicts 
highest complexation rate with CAF, enhancing its solubility compared to other 
acids and its H-bonding capacity decreased due to high molecular association 
producing lowest DEC value. 
 
3.3. Fast evaporating techniques 
It must be noted that preliminary tests were performed in order to observe whether 
all dicarboxylic acid formed co-crystals via spray drying before progressing with the 
proposed study.  The trial test results did not generate co-crystals of CAF with SU 
and TAR and hence, were not included in this study. As mentioned before, no co-
crystal of CAF  has been reported with SU (Trask et al., 2005; Friscic et al., 2008) 
via grinding or from solution, but, a three component solvate co-crystal was reported 
with chloroform (Friscic et al., 2008). It was suggested that CAF: SU co-crystal 
show physical instability and may form weak bonds with solvent molecules. On the 
other hand, CAF: TAR could not be generated by grinding method (Trask et al., 
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2005), whereas, CAF:L-TAR and CAF:D-TAR were successfully produced by 
solvent grinding in nitromethane (Friscic et al., 2006). This could be due to the 
complexity of the chiral compound, TAR.  
3.3.1. Rotavap 
Rotavap was used as a pre-screening tool to predict the kinetically-driven co-crystals 
from large-scale spray dryer as it is continuous, fast and easy to operate, and possess 
similar mechanism of rapid evaporation. To investigate the formation of co-crystals 
by rotavap technique, stoichiometric ratios of CAF and co-formers were prepared. 
The solvents for CAF and MAL pair were selected based on solvent approaches by 
previous studies (Leyssens et al., 2012; Guo et al., 2010; Pagire et al., 2014) (Table 
3.8). The solutions were subjected to higher temperatures to solubilise the 
incongruently soluble starting components, hence, raising the solvent vapour 
pressure. Reduced pressure conditions were used to enable rapid evaporation. The 
vapour pressure of the solvent subjected to various temperatures was calculated 
using Antoine’s equation (Chapter 1, Eq. 1d). The parameter values for each solvent 
are provided for the temperature range used in the experiments as shown in the table 
below. 
Table 3.7. Antoine’s parameters obtained for each solvent to determine their vapour 
pressure (DDBST GmbH, n.d.).   
 
Solvent Antoine’s equation parameters 
A B C 
Water 8.1 1730.6 233.4 
Methanol 8.1 1582.3 239.7 
Acetone 7.1 1220.0 230.7 
Ethyl acetate 7.3 1369.4 235.5 
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Table 3.8. Experiments conducted for the production of CAF and dicarboxylic acid co-
crystals via rotavap. 
 
Solution 
Mixture 
Solvent Concent
ration 
(%) 
Bath 
Temp 
(
o
C) 
Vapour 
pressure 
of solvent 
(mbar) 
Reduced 
Pressure 
Applied 
(mbar) 
XRD 
CAF:MAL 
1:1 
 
Water 3.4 70 233 180 2:1+ M†† 
Water 3.4 70 233 65 2:1 + 1:1††+M† 
Methanol 2 50 555 200 1:1+2:1††+M† 
Ethyl 
acetate 
2 80 830 600 2:1 + M†† 
Acetone 2 70 1585 560 2:1 + M†† 
CAF:MAL 
2:1 
 
Water 1.7 75 384 123 2:1 + C†† 
Water 3.4 75 384 123 2:1 + C†† 
Methanol 2.4 60 844 200 C+ 2:1††+ 1:1† 
Ethyl 
acetate 
2.4 80 830 200 2:1 + C†† 
Acetone 2.4 70 1585 330 2:1 + C†† 
CAF:OX 
2:1 
Water 2 75 384 123 2:1* 
CAF:MO 
2:1 
Water 3.4 75 384 123 2:1* 
CAF:GLU 
1:1 
Water 5 75 384 123 1:1 FII* 
*---phase pure; †--traces; ††---minor; C --- CAF; M---MAL; FII---Form II 
 
3.3.1.1. CAF:MAL 
Surprisingly, fast evaporation of CAF:MAL 1:1 solution (Figure 3.43)  led to the 
nucleation of major 2:1 co-crystals with impurity of MAL. On the other hand, 
solutions of 2:1 stoichiometry generated major 2:1 co-crystal (Figure 3.44) with 
CAF impurity. Also, impurity of 1:1 was observed in water at a very low pressure 
condition and in methanol solutions. A report analysed phase pure co-crystals via 
rotavap for congruently soluble components. Selection of solvent was considered 
important in terms of polarity and solvency for successive nucleation of the 
components. It is generally assumed that crystallisation pattern follows Ostwald’s 
rule of successive stages where stable form is favoured under slow supersaturation in 
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contrast to accelerated conditions supporting the metastable form. This was 
confirmed by the production of curcumin (CUR) and phloroglucinol (PHL) 
metastable co-crystal via rotavap in a suitable solvent aiding congruent solubility 
(Chow et al., 2012).  
So far, it has been really difficult to obtain 2:1 co-crystals of CAF: MAL from 
solution at 25
o
C and hence, was claimed to be a metastable form (Guo et al., 2010). 
Due to rapid evaporation, the solution shoots up to point of uncontrolled co-
crystallisation, leaving insufficient time for either of the components to nucleate. In 
this case, three factors may seem to play a significant role, i.e. solubility, rate of 
evaporation and kinetics favouring metastable form. The rate of evaporation is 
dependent on the temperature and pressure conditions set as explained in chapter 
1.8.1.2. The vapour pressure of water at 70
o
C and 75
o
C is 233 and 384 mbar, 
respectively, and the pressure settings applied was less than these values (Table 3.8). 
The impurity of 1:1 was observed when the reduced pressure (65 mbar) was set too 
low than the optimum pressure (233 mbar) causing solvent foaming and hence, 
disrupting the consistency of rate of loss of solvent and nucleation.  
Additional tests were performed in organic solvents to check if we can reproduce 
CAF:MAL 1:1 co-crystal . Organic solutions containing CAF: MAL 1:1 and 2:1 
ratio produced major 2:1 with MAL and CAF impurity, respectively. However, 
impurity of 1:1 was only observed in methanol from both starting ratios of 1:1 and 
2:1. This is a true reflection of earlier report that recognised solvent- driven 
stoichiometrically diverse CAF: MAL co-crystals, where methanol addition to 2:1 
favoured 1:1 co-crystals (Trask et al., 2005). Even though, the solubility of CAF in 
organic solvents was low; presence of MAL increases its solubility due to 
complexation. Pagire et al., (2014) reported CAF solubiltity in 0.4 mM MAL 
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solutions of organic solvents. Water and methanol were found to be good solvents 
compared to acetone and ethyl acetate. It was established that methanol favoured 
almost phase pure 1:1 co-crystal under microwave irradiation. Therefore, methanol 
plays a convincing role in nucleation of 1:1 co-crystal form but kinetically driven 
technique may hinder this formation generating mixtures of both 1:1 and 2:1.  
 
 
Figure 3.43. PXRD pattern for CAF:MAL 1:1 solutions under rotavap: a) 3.4% water @ 
180Mbar; b) 3.4% water @ 65mbar; c) 2% methanol @ 200mbar; d) 2% ethyl acetate @ 
600mbar; e) 2% acetone @560 mbar. 
 
 
 
Figure 3.44. PXRD pattern for CAF:MAL 2:1 solutions under rotavap: a) 1.7% water @ 
123 mbar; b) 3.4% water @ 123 mbar; c) 2.4% methanol @ 200 mbar; d) 2.4% ethyl 
acetate @ 200 mbar; e) 2.4% acetone @ 330 mbar. 
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3.3.1.2. CAF and other dicarboxylic acids 
Unlike CAF and MAL, the aqueous solutions of CAF and other dicarboxylic acid 
produced pure co-crystals without any impurity as they only exist in one 
stoichiometric ratio. Rapid evaporation of CAF and GLU 1:1 solution favoured co-
crystal with polymorphic Form II (Figure 3.45). The results assured that spray drying 
can be used as a green system to design CAF and dicarboxylic acid co-crystals.   
 
 
Figure 3.45. PXRD patterns for co-crystal obtained via rotavap: a) CAF:OX 2:1; b) 
CAF:MO 2:1; c) CAF:GLU. 
 
3.3.2. Preparation of phase pure co-crystals via spray drying 
This study explores the use of water as a green solvent for the synthesis of co-
crystals and scale-up using spray drying. The incongruently soluble pair of CAF and 
di-carboxylic acids was spray dried as seen in Table 3.9. The stoichiometric ratios of 
CAF and acid (1:1 or 2:1) were dissolved in water and different strengths of 
solutions formed were spray dried. The spray drying system was optimised by 
altering parameters such as inlet temperature, feed concentration, feed temperature, 
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feed pump rate, atomisation, and aspirator rate.  
3.3.2.1. Spray dryer optimisation 
The first few test experiments were run with a range of inlet temperature between 
110
o
C to 250
o
C. For temperatures above 200
o
C, the product was found sticking to 
the walls of the chamber. These wall depositions were may be due to van der Waals 
and electrostatic forces, less crystalline product and other physical properties of the 
product such as solubility and flowability. Studies on crystallisation upon storage 
have shown material temperature above their glass transition temperature undergo 
such changes. Therefore, the degree of crystallinity depends on the operating 
conditions within the dryer and the feed properties, thereby, altering the drying 
environment inside the chamber (Chiou and Langrish, 2008).  
In addition, improving the capacity of the spray dryer can help overcome the issue of 
sticky material. That is, by increasing the difference between the inlet and outlet 
temperature in order to achieve maximum evaporation. The outlet temperature 
should be maintained in such a way that it is neither too low (not drying the product) 
nor too high; leaving excess capacity unutilised (Kent and McLeod, 2007). The 
evaporation process of the water from product uses the heat from the drying air and 
approaches the wet bulb temperature. As the particle further dries, the temperature 
increases and remains at or below the outlet air temperature. This rapid evaporation 
process and high heat transfer coefficients can effectively help drying at moderate 
temperatures. Furthermore, to avoid stickiness the droplet has to be dry while 
suspended in the chamber before hitting the walls. Therefore, reducing the feed rate 
and inlet temperature can maintain outlet temperature required to obtain dry product 
(Arpagaus and Schwartzbach, 2008).  
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The optimum temperature for the caffeine and di-carboxylic acid aqueous solution 
without any sticky material was 110
o
C-150
o
C. Therefore, all experiments were run at 
150
o
C to achieve maximum solvent evaporation and dry product. Moreover, 
hygroscopic material may readsorb the vapours if exposed to cold surfaces in the 
dryer, for example, non-insulated areas, collecting vessels and, during analysis 
(Arpagaus and Schwartzbach, 2008). The key process parameters: inlet, outlet 
temperature and feed rate were maintained, and the others having least process 
impact were attuned accordingly.   
3.3.2.2. CAF and MAL 
a) Aqueous system 
CAF solution in water was spray dried at high inlet temperature and surprisingly, no 
hydrate form was generated which could account for fast evaporation and well 
insulated system. Initial experiments were performed with high concentration CAF 
and MAL feed solutions (6.7%) heated at 45
o
C. In theory, heating the feed solution 
close to the inlet temperature is ideal to increase the heat capacity as less energy is 
required from heater to evaporate water (Kent and McLeod, 2007). The spray drying 
results of CAF and MAL 1:1 and 2:1 under incongruent condition were similar with 
minute impurities (Table 3.9). The co-crystals generated in both the cases were 2:1 
alongside unreacted MAL for 1:1 (Figure 3.46) and CAF for 2:1 feed solution in 
accordance to rotavap results (Figure 3.47). 
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Figure 3.46. PXRD pattern for spray dried CAF: MAL 1:1:a) 3.4% at 110
0
C; b) 3.4% at 
150
o
C; c) 6.7% heated at 110
o
C; d) 6.7% heated at 150
o
C. 
 
 
Table 3.9. Production of caffeine and di-carboxylic acid co-crystals by spray drying after 
optimisation of the experimental parameters. 
 
0.04 M acid 
solution 
Solubility of 
CAF at 294 K 
(mg/mL) 
Stoichiometric 
ratios 
Batch No. XRD result 
Maleic acid 63.0 1:1 1a 2:1 + M†† 
1b 2:1 + M†† 
1c 2:1 + M†† 
1d 2:1 + M†† 
2:1 1e 2:1 + C†† 
1f 2:1 + C†† 
1g 2:1 + C†† 
1h 2:1 + C†† 
1i 2:1 + C†† 
1j 2:1 + C†† 
1k 2:1 + C†† 
1l 2:1 + C†† 
1m 2:1** 
1n 2:1 + C† 
1o 2:1 + C†† 
1p 2:1 + C† 
1q 2:1 + C† 
Glutaric acid 53.8 1:1 2a 1:1 FI 
2b 1:1 FI 
2c 1:1 FI 
Malonic acid 44.8 2:1 3a 2:1 
3b 2:1 
Oxalic acid 32.8 2:1 4c 2:1 
**---Almost Phase Pure;††--- minor; †---traces; C---CAF; M---MAL; FI---Form I 
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The existence of the two starting components as impurity was also seen in case of 
solvent-driven stoichiometrically diverse co-crystal phases (1:1 and 2:1) by grinding. 
Moreover, the pure forms could not be matured via solution (Trask et al., 2005). 
Another report constructed ternary phase diagram of the three components: CAF, 
MAL and solvent to understand what regulates the existence of the two co-crystal 
forms. MAL was observed to enhance CAF solubility by 4.28% in acetone via 
complexation as CAF has weak solvation property. Only pure CAF:MAL 1:1 co-
crystal was generated from acetone solution, whereas, 2:1 was obtained by grinding 
with acetone. The phase diagram depicted narrow zones for 1:1 and 2:1 co-crystals. 
However, addition of acetone to 2:1 led to its conversion into a mixture of 1:1 and 
CAF; submerging the zones. Therefore, this form was considered metastable and not 
suitable for production from solution at 25
o
C (Guo et al., 2010). 
 
 
Figure 3.47. Powder x-ray diffraction pattern (PXRD) for spray dried CAF-MAL 2:1 with 
CAF impurity - a) 6.7% (heated feed at 45
o
C), 110
o
C inlet; b) 6.7% (heated feed), 150
o
C 
inlet; c) 3.4% feed, 1mL/min; d) 3.4%, 3mL/min; e)2.5%, 3mL/min; f) 1.7%, 110
o
C inlet; 
g)1.7%, 170
o
C; h) 1.7%, 40m
3
/hr; i) 1.7% (heated feed) k) 1.7%, 3mL/min; l) 1%, 1mL/min; 
m) 1% , 3mL/min. Almost phase pure 2:1 CAF:MAL - j) 1.7%, 1mL/min. 
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Ultrasound assisted study generated pure 2:1 co-crystals in high molar concentration 
of MAL i.e. when CAF: MAL ratio taken was 1:3.5 in methanol. It was suggested 
that cavitation induced by ultrasound caused simultaneous supersaturation of the two 
components, but higher proportion of MAL was required (Aher et al., 2010). 
Leyssen et al., (2012) reproduced CAF:MAL 2:1 from solution and thought that the 
effect of choice of solvent on phase diagram was neglected previously. It was 
established that ethyl acetate reduced the relative solubility of MAL versus CAF 
from 40 to 7 compared to acetone producing two different stoichiometries (1:1 and 
2:1) and also obtained a new polymorph of 1:1 i.e., Form II while screening from 
solution. Therefore, 2:1 metastable form prevailed at kinetically-driven high 
supersaturation levels breaking the intramolecular bond of MAL during nucleation 
which favoured strong intermolecular heterosynthons. The unreacted MAL obtained 
along with 2:1 co-crystal after spray drying 1:1 stoichiometry is self-explanatory. 
But, the transformation into 2:1 co-crystal in contrast to one’s anticipation of 1:1 
could be due to kinetically favoured high supersaturation conditions; altering the 
binding tendency of the two molecules, besides their solubility characteristics 
(Alhalaweh et al., 2013).  
Another unanticipated outcome from spray drying 2:1 CAF and MAL solution 
yielding 2:1 co-crystals and unreacted CAF was not easy to rationalise. Similar 
results were observed in study utilising microwave irradiation where supersaturation 
rate was accelerated by stimulating dipole rotation of the molecules and reducing the 
crystallisation time in slurry. Low solvent concentration, solubility and limited time 
were thought to restrict the adequate equilibrium condition and kinetics (Pagire et 
al., 2013). Furthermore, two solubility phase diagram for CAF and MAL was 
created in aqueous slurry and sonicated slurry solutions after establishing increased 
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solubility of CAF in aqueous solution of MAL. In aqueous slurry, 2:1 co-crystal was 
successfully produced at higher ratios of CAF: MAL i.e, 75:25. Phase pure zones for 
2:1 and 1:1 were depicted in the phase diagram. Ultrasound further augmented the 
solubility of CAF and MAL, but no difference was observed in the layout of this 
new phase diagram. On the contrary, no pure 2:1 co-crystals were formulated and 
1:1 co-crystal zone shrunk as opposed to one’s expectation. This was explained as a 
result of instability of co-crystal phase in slurry leading to dissociation due to 
differences in solubility (Apshingekar, 2014).  
Even though, MAL further dissolves CAF in water; the highest 2:1 solution 
concentration attained at room temperature was 3.4%. CAF’s concentration in this 
solution was above its intrinsic solubility, held by weak molecular complexation 
with MAL. The operating conditions were altered and a low concentration feed 
solution at room temperature was spray dried in an attempt to avoid impurity. A 
decrease in the caffeine peak was observed with the decrease in the strength of the 
solution and subsequent lowering of the feed rate. Due to the operating system 
limitations and the drying environment requisite for CAF: MAL co-crystal, only one 
condition successfully generated almost phase pure 2:1 CAF: MAL co-crystals 
(Figure 3.47, j). At 1.7% concentration, CAF exists freely at its intrinsic solubility, 
reducing the complexation with MAL in the solution. Secondly, reduced feed rate 
diminishes the droplet size and the energy required to evaporate the solvent causing 
immediate evaporation. Thus, signifying that inlet temperature, feed concentration 
and feed rate were essential to kinetically control spray drying of incongruently 
saturating systems and yield almost phase pure forms. Moreover, the operating 
system of spray dryer gives us an opportunity to make fine adjustments and control 
the kinetic environment which is not valid for rotavap.  
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Recently, a solvent-free continuous melt extrusion technique successfully 
reproduced CAF: MAL 1:1 and 2:1 co-crystals on a large-scale by controlling their 
stoichiometry. This technique surmounts the issue faced by solution based processes 
such as, solvation, nucleation and solubility.  It was observed that 1:1 could be 
converted into 2:1 by addition of CAF, but the opposite was not feasible by addition 
of MAL. Nonetheless, the reverse could only be achieved by melt seeding 2:1 with 
phase pure 1:1 (Kulkarni et al., 2015). The reason behind such a disparity in 
different methods is ambiguous and is believed to occur due to an unknown 
exchange between kinetics and thermodynamics of the co-crystallisation process. 
Interestingly, the drying kinetic conditions inside the spray dryer appear to offer a 
unique environment for the generation of CAF:MAL 2:1 from aqueous solution 
regardless of the starting components’ stoichiometry. 
b) Organic solvent 
Co-crystallisation experiments were also conducted in organic solvents in an attempt 
to form 1:1 co-crystals and to investigate reproducibility of rotavap results. Due to 
very low solubility of CAF in organic solvents only equivalent molar (1:1) solutions 
were used. These solutions were heated externally before being fed into the system 
to obtain minimal considerable strength (2-4%) that can retrieve product via spray 
drying. The PXRD results shown in  
Figure 3.48, demonstrate that metastable form 2:1 was favoured which complies 
with rotavap results. Due to the very low solution concentrations and solubility 
constraints in organic solvents, no further experiments were performed.  
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Figure 3.48. PXRD patterns for CAF and MAL1:1 solution in: a) methanol @ 70
o
C;           
b) methanol @ 90
o
C; c) acetone @ 70
o
C; d) ethyl acetate @ 80
o
C ; e) ethyl acetate @ 90
o
C. 
 
The co-crystals obtained from acetone and ethyl acetate produced 2:1 co-crystal with 
impurity of unutilised MAL. Whereas, minor impurity of CAF: MAL 1:1 was 
noticed in methanolic solutions. A trace of 1:1 form II was observed with 
characteristic peak at 7.36 at lower temperature condition (70
o
C). Solvent-grinding 
in methanol generated 1:1 co-crystal with impurity (Task et al., 2005). Leyssens et 
al., (2012) first found 1:1 form II which was stable in ethyl acetate solution for a 
week before it transformed into form I. Therefore, form I was considered the most 
stable form. In addition, microwave irradiation generated mixture of both form I and 
II in methanol, where form II appeared in the mixture at lower methanol 
concentration of 2-4% (Pagire et al., 2013). In contrast, ultrasound assisted co-
crystallisation in methanol favoured 2:1 co-crystal under excess MAL conditions 
(Aher et al., 2010). These results indicate that methanol assists selective growth of 
1:1 co-crystal; however, high supersaturation conditions can supersede the favoured 
phase and produce 2:1 as observed in ultrasound and spray drying. It is important to 
note that other factors such as solvent concentration and temperature in microwave 
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and spray drying, respectively, can affect crystallisation and produce traces of 1:1 
form II. 
c) Sodium Lauryl Sulphate (SLS) 
In an enthusiastic approach towards procuring phase pure 2:1 co-crystal, an anionic 
surfactant, SLS was introduced in the aqueous system. FDA approves the use of 
surfactant to solubilise drug products that are sparingly soluble in water as long as 
the amount is rationalised (FDA, 1997). In accordance to the regulations, SLS can be 
safely used as a surfactant in food products such as juices, dry beverages not 
exceeding 25 parts per million (equivalent to 25 mg/L) (FDA, 2015). Pharmaceutical 
products contain amounts ranging from 0.004 to 0.6 mg in oral dosage form; 0.01-
0.02% in oral liquid dosage forms and 0.1 to 12.7% in lotions, ointments and creams 
(Smolinske, 1992, p.359). Some of the dissolution methods found on FDA approved 
database have used SLS ranging from 0.25- 2% in water (FDA, n.d.).  
Solubility and DEC: 
Prior to spray drying, CAF solubility was determined in aqueous solutions of 1 and 
2% SLS as shown in table below.  
Table 3.10. Solubility of CAF in SLS solutions in comparison to water alone.  
 
Solvent Water 1% SLS 2% SLS 
CAF Solubility (mg/mL) 20.7 ±0.11 20.7 ±0.13 21.2± 0.05 
 
Unfortunately, no significant increase in solubility of CAF was noticed, even though, 
SLS acts as a powerful solubilising agent. The change in DEC observed for 1% SLS 
solution was 79.5±0.1 compared to water 80.2±0.02. This insignificant decrease 
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indicates that the two solutions acquire quite similar polarities. CAF and MAL 2:1 
molar concentration (3.4%) was prepared in 1% SLS solution and spray dried in an 
anticipation that the results can vary by introducing a surfactant. The PXRD pattern 
(Figure 3.49) shows almost phase pure 2:1 co-crystals with CAF impurity (235
0
C). 
However, DSC thermogram (Figure 3.50) indicates a melt endotherm for 2:1 co-
crystal (119
0
C) and at 273
0
C for SLS, with absence of CAF impurity. This could be 
due to low amorphous content of CAF as seen in PXRD (non-sharp, low intensity 
peak), which under thermal exposure gains mobility to form co-crystal. Therefore, 
addition of surfactant produced almost phase pure results at a higher concentration 
(3.4%) and higher feed rates (2mL/min); though, the solubility of CAF was almost 
similar. Thus, indicating that surfactant plays a major role in solubilising and 
associating poorly water soluble molecules. 
 
 
 
 
Figure 3.49. PXRD pattern for: a) SLS with characteristic peaks at 4.28, 6.44; b) almost 
phase pure CAF:MAL 2:1 from 1% SLS solution. 
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Figure 3.50. DSC thermogram representing heat flow as a function of temperature for CAF 
and MAL 2:1 solutions spray dried at: a) 1%, 3mL/min; b) 1.7%, 3mL/min; c) 1.7%, 
1mL/min; d) 3.4% in 1% SLS, 2mL/min. 
 
Surfactants usually undergo micelle formation in solution at a critical micelle 
concentration (CMC). Below CMC, surfactant forms a thin monolayer at the surface 
of water, which above CMC associates into colloidal clusters; reducing surface 
tension. SLS is an anionic surfactant which dissociates at the surface into active 
anion, CH3(CH2)11OSO3
-
 and cation, Na
+
. The hydrophilic OSO3
-
 are oriented facing 
inside towards the water at the surface, and the lipophilic hydrocarbon alkyl group, 
CH3(CH2)11 is directed outside. At CMC, the molecules self-aggregate and form a 
micelle with lipophilic core and anionic groups on the surface towards hydrophilic 
water. The micelles undergo constant dissociation and reformation due to kinetic 
factors such as surfactant concentration. The concentration used in this study was 
above SLS’s CMC value of 0.03% (Rahman et al., 2009). In water, molecules 
associate via H-bonding or dipole-dipole forces. A molecule in any liquid will 
experience equal attractive and repulsive forces in all directions, whereas, at surface 
these are not exhibited at one direction.  The asymmetrical forces give rise to surface 
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tension and therefore, polar solvents possess higher surface tension (Mandavi, Sar 
and Rathore, 2008).   
Surfactant helps to lower the surface tension and hence, solubilise the non-polar 
molecule trapped inside micelle. However, it has been suggested that presence of 
other molecules may alter the CMC value. In this case, hydrotropes such as MAL 
contains charged polar molecules that may interfere with the hydrophilic head group 
of the micelle. Due to their like charges, i.e. anions, repulsion might take place 
between ions; changing micelles shape, thereby, affecting the surface packing 
(Mandavi, Sar and Rathore, 2008). Other factors such as process parameters may 
also affect the arrangement of micelles holding CAF.  
3.3.2.3. Caffeine and other di-carboxylic acids 
The above optimised process parameters were successfully used to obtain phase pure 
co-crystals of caffeine with malonic acid, oxalic acid and glutaric acid (Figure 3.51). 
In case of glutaric acid, FI of 1:1 co-crystal was kinetically favoured as observed in 
an earlier study (Alhalaweh and Velaga, 2010). However, these results conflict with 
those of rotavap where FII of CAF:GLU co-crystals were generated. Trask et al., 
(2005) generated CAF:GLU FI in non-polar solvent, cyclohexane and FII in fairly 
polar, chloroform via solvent grinding. Whereas, solution growth led to simultaneous 
precipitation of the two conformational polymorphs. Further analysis of RH stability 
studies reflected conversion of CAF:GLU FI into FII at high RH conditions before 
dissociating into components. The incompatibility observed in the CAF: GLU results 
for the two evaporating methods could be due to the fact that the nucleating 
components in rotavap are still in contact with the solvent until it all gets vapourised 
(Figure 3.52). The increased residence time within the flask may lead to inter-
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conversion due to association and dissociation of the unstable components whilst 
drying.  
 
 
 
 
Figure 3.51. PXRD patterns for caffeine (CAF); glutaric acid (GLU); malonic acid (MO); 
oxalic acid (OX); a) CAF-GLU 1:1 Form I - 5% feed solution, b) 3.4 % solution, c) 1.7 % 
solution; d) CAF-MO 2:1 - 3.4 % feed solution, e) 1.7% solution; f) CAF – OX 2:1 - 1.7% 
feed solution. 
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Figure 3.52. Co-crystal nucleation under rotavap while in contact with the evaporating 
solution. 
 
Unlike CAF- MAL, other di-carboxylic acids possess one stoichiometry of co-
crystal; 1:1 or 2:1. Furthermore, the solubility of CAF with respect to each 
dicarboxylic acid decreases in the order of MAL>GLU>MO>OX; which 
corresponds to the highest feed concentration that can be spray dried (Figure 3.53). It 
is clearly observed that GLU forms the highest concentration solution with CAF at 
room temperature due to its 1:1 stoichiometric ratio, where only one caffeine 
molecule interacts with an acid molecule.  
 
 
Figure 3.53. Graphical representation of solubility of caffeine (mg/mL) in di-carboxylic acid 
solutions and water at temperatures ranging from 294 K (room temperature) to 323 K 
(50
o
C). 
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The complexity in CAF: MAL co-crystal production compared to other di-carboxylic 
acids can be due to the following reasons: 1) relative solubility of caffeine in di-
carboxylic acid solutions; 2) stoichiometric diversity; 3) chemical structure and 
complexation/solvation in the solvent. So far, CAF-MAL 2:1 has been formed by 
solvent drop grinding, slurry co-crystallisation, ultrasound, and hot-melt extrusion. 
The scale-up of the incongruently soluble co-crystals from solution is a vital issue. It 
is difficult to suggest the mechanism of instantaneous drying of the liquid, 
production of a solid form in one step and relate it to their stability zones in the 
phase diagram. The results restate that spray drying can be used as a green method 
suitable for the synthesis and scale-up of co-crystals of incongruently soluble 
compounds. However, this method involves careful control of process conditions to 
influence the co-crystallisation tendency, especially in case of CAF-MAL pair. 
Interestingly, surfactant produced almost phase pure CAF: MAL 2:1 without 
modifying the process conditions which indicates the importance of solubilisation in 
controlling successful nucleation of the stoichiometrically diverse incongruent pair. 
 
3.4. Product quality 
3.4.1. Water content/ Karl Fisher 
The quality of the product was determined by investigating the effect of process 
variables and material property in controlling the residual moisture content. The 
FDA centre of biologics evaluation and research sets a guideline for the examination 
of moisture content in dried biological products. The biologics regulation in 21 CFR 
610.13 states that freeze dried product with heterogeneous mixture have different 
ways in which water may be bound due to varying chemical and physical interaction 
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within the material and hence, should be evaluated and not exceed the set limits. Karl 
Fischer is an approved methodology which obtains both surface and bound water 
compared to gravimetric method. The standards set for residual moisture was low 
from less than 1% to 3%, protecting the stability and activity of the drug over long 
period of time. The exception to 1% limit is set for products where the stability, 
purity and potency of the product are established for the entire dating period (FDA, 
1990). Moisture content calculated for the spray dried products is as follows:  
Table 3.11. Moisture determination in spray dried samples using Karl Fischer methodology. 
 
Solution Inlet 
Temperature 
(
o
C) 
Feed 
Concentration 
(%) 
Feed Rate 
(mL/min) 
Aspirator 
(m
3
/h) 
Moisture 
content (%) 
CAF:MAL 
2:1 
150 1.7 1 60 0 
150 1.7 2 60 0 
150 1.7 3 60 0.62 ± 0.01 
150 1.7 1 70
 
0.42±0.02 
CAF:MAL 
2:1 + SLS 
150 3.4 2 60 1.45±0.09 
CAF:GLU 
1:1 
150 5 3 60 0.33±0.06 
CAF:MO 
2:1 
150 3.4 3 60 0.39±0.03 
CAF:OX  
2:1 
150 2 3 60 0.37±0.02 
 
Process parameters such as feed rate, inlet temperature, atomisation, and aspirator 
rate could affect the moisture content in the final product by varying the size of the 
droplet, resident time and heat exposure. CAF:MAL products subjected to various 
process parameters were analysed using Karl Fischer. The above table shows the 
absence of moisture for samples spray dried at very low feed rates (1-2 mL/min) and 
optimum aspirator condition. At a higher feed rate of 3mL/min, bigger droplets were 
exposed to heat; and at high aspiration rate (70 m
3
/h), the residence time of particles 
in the drying chamber was minimised, thereby, raising their water content levels. 
The percentage water in these samples was less than 1% which is well within FDA 
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criteria. However, over 1% moisture content was obtained with SLS even at low feed 
rate (2mL/min), which is indicative of the surfactant’s hygroscopic nature. 
Therefore, presence of surfactant can affect the stability of the product. Also, 
comparable results were obtained for CAF co-crystals with other di-carboxylic acids 
at 3 mL/min independent of the feed concentration utilised. 
Particle size distribution observed for CAF:MAL spray dried products are shown in 
Table 3.12. The results do not comply with the expected increasing size one would 
predict with increasing feed rate. The median particle dimension (X50) observed for 
feed rates of 1, 2 and 3 mL/min were 12.1, 6.2 and 7.4μm. The distribution curves 
observed were distorted and deviates from symmetry with the presence of some 
primary particles at a lower size range (Appendix II). However, SLS samples show a 
normal distribution with X50 of 4.1 μm. The microscopic images of samples depict 
some very small primary particles alongside big chunks of irregularly shaped 
particles (Error! Reference source not found. and Figure 3.55).  
Table 3.12. Particle size distribution of spray dried CAF:MAL co-crystals. 
. 
Conc. 
(%) 
Inlet 
Temp 
(oC) 
Feed rate 
(mL/min) 
Particle size distribution (μm) 
Method: Lens- R1 (0.1-35μm) 
Dispersive pressure: 4bar 
40mm/s 
Particle 
volume over 
particle size 
X10 X50 X90 VMD (Volume 
mean diameter 
in μm ) 
1.7 150 1 1.3±0.09 12.1±0.11 27.8±0.05 13.52 
1.7 150 2 0.9±0.03 6.2±0.04 19.4±0.17 8.29 
1.7 150 3 1.0±0.00 7.4±0.18 26.0±0.11 10.67 
3.4 1% 
SLS 
150 2 0.8±0.00 4.1±0.06 9.4±0.29 4.76 
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a)  
 
b)  
Figure 3.54  Microscopic image of CAF:MAL samples at a) 1mL/min; b) 2mL/min.  
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c)  
d)  
 
Figure 3.55.  Microscopic image of CAF:MAL samples at c) 3mL/min; d) SLS.  
 
To further understand the unusual distribution pattern, SEM images for 1 and 3 
mL/min samples and SLS were examined (Figure 3.56 and Figure 3.57). The 
samples produced by low feed rate (1mL/min) show small primary particles 
clustered together with a strongly bound texture. Whereas, at higher feed rate 
(3mL/min), the sample emerges as vague needle shaped like CAF clumped together 
with few indentations.  
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Figure 3.56.  SEM images of CAF: a1) 200x, a2)1000x; MAL: b1) 200x, b2) 1000x; 
CAF:MAL: 1mL/min c1) 200x, c2) 1000x; CAF:MAL 3mL/min: d1) 200x, d2) 1000x. 
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Figure 3.57.  SEM images of SLS: e1) 200x, e2) 1000x; CAF:MAL SLS: f1) 200x, f2) 1000x. 
 
It appears that the dispersive pressure of 4 bars used while determining particle size 
breaks the needle shaped structures more easily but not well enough to separate the 
smaller primary particles. In contrary, the particles developed with SLS are well-
defined and much more separated individual needle-shaped structures bound 
together, which is likely to get broken down into primary particles by the dispersive 
pressure utilised. However, as the laser diffraction is sensitive to spherical shaped 
particles, it may not process these rod-like irregular particles properly. Therefore, the 
data observed wasn’t a true reflection of the particle size or VMD for CAF: MAL 
co-crystals due to their crystal growth morphology. 
 
137 
 
Summary:  
Solubility of CAF in water was significantly improved in the presence of di-
carboxylic acids acting as a hydrotrope. However, its solubility in organic solvents 
was relatively poor than in water. DEC values were obtained to find a correlation 
between the chemical polarity of the solution and solubility. The values were similar 
for 0.04 M solutions of dicarboxylic acids utilised, depicting similar polarity. Upon 
CAF’s addition to these solutions, polarity decreased with an increase in CAF’s 
concentration, due to high molecular association with the solvent, reducing its dipole 
moment.  Experiments conducted using rotavap produced 2:1 CAF:MAL co-crystals 
with minor impurity in all solvents apart from methanol, where 1:1 traces were also 
observed. Interestingly, CAF:MAL 2:1 was generated from both 1:1 and 2:1 starting 
ratios of CAF and MAL solution. Pure co-crystals were obtained with OX and MO 
in water. Whereas, in case of CAF:GLU which exists in two polymorphic forms; 
Form II was favoured. Spray drying resulted in similar products yielding CAF:MAL 
2:1 with either CAF or MAL impurity depending on the starting component’s ratio. 
The process parameters were varied with the intention of reducing CAF impurity 
while preparing CAF:MAL 2:1 co-crystals from 2:1 solution mixtures. High inlet 
temperature, low feed rate and low solution concentration were important parameters 
reducing CAF’s impurity. Due to the restriction in parameter range, a surfactant 
(SLS) was introduced into the solution. Unfortunately, the impurity couldn’t be 
eradicated completely, but almost phase pure co-crystals were formed at higher feed 
concentrations. However, the hygroscopic nature of SLS resulted in high water 
content in the samples. Pure CAF co-crystals were obtained with OX, MO and GLU. 
Metastable CAF:GLU FI was favoured as opposed to rotavap, due to a better 
evaporating environment being offered.  
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CHAPTER 4 
4.  
THEOPHYLLINE AND DI-CARBOXYLIC ACIDS 
COCRYSTAL RESULTS 
This chapter utilises another methylxanthine like CAF, theophylline known as a 
bronchodilator for treating respiratory disorders such as asthma. It explores similar 
solubility behaviour in aqueous dicarboxylic acid solutions as observed for CAF. 
Due to low solubility compared to CAF; solubility in binary solvents was scrutinised.  
Co-crystals obtained from rotavap in the selected binary solvent were correlated to 
spray dried results.  
4.1. Crystal data 
4.1.1. Theophylline 
Despite being a chemical analogue to CAF, THEO acquires a good hydrogen 
bonding complexity due to the absence of one methyl group (Figure 4.1). The 
presence of hydrogen donor and acceptor makes it both weakly acidic (pKa 8.6) and 
basic (pKa11.5) in nature (Trask, Motherwell and Jones, 2006).THEO can exist as 
four anhydrous polymorphs and converts into a hydrate form under raised RH 
conditions. These polymorphs differ in their structural arrangement where FI is 
stable at higher temperatures and FII is most stable form at room temperature. FIII is 
regarded as highly metastable form which readily converts into FII. FIV has been 
recently identified by solvent mediated conversion of FI and FII and is considered as 
the most thermodynamically stable form with plate-like morphology. FI attains an 
orthorhombic structure belonging to Pna21 space group and cannot be produced by 
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solution method but via solid-state conversion at high temperatures 538-41 K. F IV 
is monoclinic with two asymmetric molecules and space group of P21/c (Khamar et 
al., 2011). The stable FII links THEO molecules into a chain via strong donor (N-H) 
bonding to basic nitrogen (N) belonging to Pna21 space group with unit cell 
dimension: a=24.61 (2) Å, b= 3.83 (4) Å, c= 8.50 (5) Å. The figures below show the 
crystal structure and PXRD pattern adopted from CSD. 
 
 
Figure 4.1 Crystal structure of THEO FII (CSD Ref: BAPLOT01). 
 
 
 
 
Figure 4.2. Molecular packing of THEO FII forming H-bonded ribbons (Trask, Motherwell 
and Jones, 2006).  
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Figure 4.3. PXRD pattern of THEO anhydrate (obtained from CSD). 
 
4.1.2. THEO monohydrate 
Introduction of a water as a competing hydrogen bond donor readily forms O-H...N 
hydrogen bond with THEO’s basic nitrogen. The N-H donor group builds up a 
secondary H-bond with the carbonyl oxygen in adjacent THEO (N-H...O) forming a 
cyclic dimer motif; 𝑅2
2(10) (Figure 4.5). This motif comprises of a hydrogen bonded 
ring with 10 atoms, of which 2 are H-bond donors and 2 are acceptors (Trask, 
Motherwell and Jones, 2006). The dimensions of the unit cell are: a= 4.47 (2) Å, b= 
15.36 (5) Å; c= 13.12 (5) Å, β= 97.79o with space group P21/n. The crystal structure 
and PXRD pattern are shown below. 
 
 
Figure 4.4. Crystal structure of THEO monohydrate (CSD Ref: THEOPH02). 
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Figure 4.5. Crystal arrangement of THEO monohydrate forming dimers (Trask, Motherwell 
and Jones, 2006).  
 
 
 
 
Figure 4.6. PXRD pattern of THEO monohydrate collected from CSD.  
 
4.1.3. Theophylline maleic acid 1:1 
THEO forms a co-crystal with MAL molecule via 𝑅2
2(7) hydrogen bond motif as 
observed in case of CAF:MAL 1:1 co-crystal, but no 2:1 structure is reported. The 
cis geometry of maleic acid is inclined to form an intramolecular hydrogen bond 
with the second carboxylic acid and the THEO molecules form dimers (Figure 4.8) 
(Trask, Motherwell and Jones, 2006). The triclinic crystal structure belongs to space 
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group P1 with unit cell dimensions: a=7.97 (16) Å, b= 8.61 (17) Å, c= 10.67 (2) Å, 
α= 69.5o, β= 72.5o and γ= 71.2o. The CSD crystal structure date and PXRD patterns 
are shown below.  
 
 
 
Figure 4.7. THEO: MAL 1:1 crystal structure (CSD Ref: XEJXEQ).  
 
 
 
 
Figure 4.8. Crystal packing of co-crystal THEO: MAL 1:1 (Trask, Motherwell and Jones, 
2006).  
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Figure 4.9. PXRD pattern collected for THEO:MAL 1:1 from CSD.  
 
4.1.4. Theophylline oxalic acid 2:1  
A 2:1 stoichiometry co-crystal is favoured where each oxalic acid binds via O-H...N 
intermolecular H-bond to THEO as observed in CAF:OX 2:1 co-crystal. However, 
due to the absence of a methyl group, THEO further binds to another THEO 
molecule to form homo-dimer of 𝑅2
2(10) motif (N-H...O interaction) creating H-
bonded ribbons (Figure 4.11), which is not the case in CAF:OX co-crystal. Due to 
this molecular arrangement, the molecules form analogous ring and are not co-planar 
(Trask, Motherwell and Jones, 2006). The crystal structure and calculated PXRD 
pattern are shown in Figure 4.10 and Figure 4.12, respectively. The dimensions of 
the monoclinic unit cell are: a= 5.82 (12) Å, b= 16.61 (3) Å; c= 9.81 (2) Å, 
β= 99.83o with space group P21/c.  
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Figure 4.10. Crystal structure of THEO: OX 2:1 co-crystal (CSD ref: XEJWUF). 
 
 
Figure 4.11. Ribbon like arrangement of THEO:OX 2:1 crystal packing (Trask, Motherwell 
and Jones, 2006).  
 
 
Figure 4.12.  PXRD pattern of THEO:OX 2:1 co-crystal collected from CSD.  
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4.1.5. Theophylline malonic acid 1:1 
This distinct 1:1 co-crystal has both primary intermolecular O-H...N bond between 
THEO and MO with additional secondary N-H...O bond forming THF dimer. The 
carbonyl groups of the neighbouring MO acids forms bisecting H-bonds, emerging 
as a step away from the plane of THEO dimer as shown in Figure 4.14 (Trask, 
Motherwell and Jones, 2006). The monoclinic crystal pattern exists with space group 
C 2/c with unit cell dimensions: a=17.88Å (4), b=8.39Å (2), c=17.63Å (4) and β = 
105.7
o
. The crystal structure and PXRD pattern are shown below. 
 
 
Figure 4.13.Crystal structure of THEO:MO 1:1 (CSD Ref: XEJXAM).  
 
 
 
Figure 4.14. Crystal packing of THEO:MO 1:1 co-crystal (Trask, Motherwell and Jones, 
2006).  
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Figure 4.15. PXRD data for THEO:MO 1:1 gathered from CSD.  
 
4.1.6. Theophylline glutaric acid 1:1 
THEO: GLU 1:1 co-crystal shows similar primary O-H...N bond between THEO and 
acid along with THEO dimerisation (Figure 4.17). No polymorphic form was 
observed as in case of CAF: GLU co-crystals. The crystal arrangement is similar to 
CAF:GLU FI with additional dimer bonds absent in case of CAF (Trask, Motherwell 
and Jones, 2006).. The monoclinic crystal structure belongs to space group P21/c 
with unit cell dimensions: a=9.60 (2) Å, b= 19.90 (4) Å, c= 15.33(4) Å 
and β= 107.90. The CSD crystal structure date and PXRD patterns are shown below. 
 
 
Figure 4.16.Crystal structure of THEO: GLU 1:1 co-crystal (CSD Ref: XEJXIU). 
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Figure 4.17. Crystal arrangement of THEO: GLU 1:1 co-crystal (Trask, Motherwell and 
Jones, 2006). 
 
 
 
Figure 4.18. PXRD pattern of THEO: GLU 1:1 co-crystal gathered from CSD. 
 
4.1.7. Theophylline co-crystal with tartaric and succinic acids 
No structural data available.   
An earlier attempt for generating THEO co-crystals with succinic acid and L-tartaric 
acid was a failure via both solid-state grinding and solution growth. Like results were 
obtained for structural analogue, CAF (Trask, Motherwell and Jones, 2006). 
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Previous spray drying trials and low solubility data clearly indicates that these 
molecules will not form co-crystals with THEO. 
 
4.2. Solubility 
Solubility of THEO in both aqueous dicarboxylic acid solution and organic solvents 
were determined to design experiments for successful co-crystallisation using spray 
drying.  
4.2.1. Aqueous solubility 
A calibration curve in accordance to Beer-Lambert law was plotted and a linear 
equation was deduced to calculate solubility results in different solvents (Figure 
4.19).  
 
 
Figure 4.19.Calibration curve of THEO concentration versus UV absorbance.  
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Like CAF, the mole fraction solubility (x) of THEO was measured in water and 
0.04M dicarboxylic acid solution at various temperatures as shown in Table 4.1 and 
Table 4.2, respectively.  
Table 4.1. Mole fraction solubility of theophylline in water at various temperatures. 
 
T/K Theophylline 
solubility 
(mg/mL) 
Mole fraction 
(10
3
x) 
294 6.5 0.38±0.02 
313 10.2 0.60±0.08 
323 26.1 1.52±0.12 
333 33.7 1.97±0.07 
343 67.6 3.93±0.06 
 
 
Table 4.2. Mole fraction solubility of theophylline in six di-carboxylic acid solutions 
between 294 and 323 K. 
 
T/K Theophylline 
(mg/mL) 
Mole fraction 
(10
3
x) 
(x-x
cal
)/x 
Maleic acid 
294 17.2 1.01±0.02 -0.002 
313 28.6 1.67±0.12 0.007 
323 40.6 2.37±0.15 -0.005 
Malonic acid 
294 11.8 0.68±0.07 -0.002 
313 17.5 1.02±0.04 0.007 
323 23.6 1.38±0.01 -0.005 
Oxalic acid 
294 16.2 0.95±0.01 -0.012 
313 21.9 1.28±0.02 0.038 
323 45.7 2.67±0.04 -0.029 
Glutaric acid 
294 14.2 0.83±0.03 -0.007 
313 22.1 1.29±0.01 0.024 
323 39.5 2.30±0.01 -0.018 
Tartaric acid 
294 3.7 0.21±0.01 -0.005 
313 9.0 0.53±0.01 0.019 
323 19.3 1.13±0.0.2 -0.014 
Succinic acid 
294 7.8 0.45±0.01 0.002 
313 22.6 1.32±0.02 -0.008 
323 33.3 1.94±0.01 0.006 
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The solubility measurements in di-carboxylic acid solutions were associated as a 
function of temperature from equation 3a and the following plot was created (Figure 
4.20). 
 
 
Figure 4.20. Experimental mole fraction solubilities of theophylline in di-carboxylic acid 
(markers); calculated solubilities from equation 3a (linear). 
 
The relative standard deviations (RSD) and parameters A and B for each di-
carboxylic acid solution are listed in Table 4.3 and were calculated from equation 3b.  
Table 4.3. A and B values and the root-mean –square deviations of the measured solubilities 
from the calculated results.  
 
 
Acid solution A B RSD 
Maleic acid 1.0646 -1196.4 0.005 
Malonic acid 0.0999 -960.9 0.005 
Oxalic acid 1.513 -1344.5 0.029 
Glutaric acid 1.6001 -1383.8 0.018 
Tartaric acid 4.1826 -2316.6 0.014 
Succinic acid 3.8314 -2108.2 0.006 
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All dicarboxylic acid solutions enhanced THEO’s solubility by almost two folds than 
in water alone. The solubility increased with rise in temperature in all solutions. In 
contrary, tartaric acid reduced its solubility. The solubility of THEO decreased in 
order of MAL > OX >GLU>MO>SUC> water > TAR. OX seems to aid in increased 
solubility of THEO compared to other acids conflicting with CAF’s results. 
Although, the overall solubility of THEO rose to two folds in dicarboxylic acid 
solution, its solubility was three to four times lower than CAF’s. The factor 
responsible is the structural difference, where CAF has an extra methylated group 
which readily participates in H-bonding. In addition to its basic nature, THEO also 
possesses a weak acidic nature due to the presence of H-bond donor at position 7 (N-
H) which has thetendency to form dimers. The perplexing effect of solubilityhas also 
been explained by electric dipole moments of the molecules, i.e., 3.70 and 3.94 D for 
CAF and THEO, respectively. Though, the dipole moment are quite similar for the 
two xanthines, the disparity in solubility can be interpreted possibly by tautomerism, 
i.e., shifting of hydrogen atom at N(7) and N(9) of THEO (Figure 4.21), which is not 
viable in CAF due to methylated groups (Weiler-Feilchenfeld and Neiman, 1970).   
 
 
Figure 4.21. Tautomeric effect at N7 and N9 of theophylline.  
 
The transition temperature from anhydrous to hydrous form for theophylline is 55-
65
o
C (328-338 K) (Wikstrom, Kakidas and Taylor, 2008).The X-ray diffraction 
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analysis carried out on excess filtered solid obtained from solubility experiments 
verifies non-conversion of THEO into its hydrate form at all conditions (Appendix 
I); even at higher temperature of 343 K in water.  
4.2.2. Organic solvents 
Due to very low aqueous solubility of THEO, organic solvents were involved for 
comparison and to establish appropriate methods in developing co-crystals with 
acids. The results obtained are shown in table below: 
Table 4.4. Thermodynamic solubility of theophylline (mg/mL) in various organic solvents.  
 
Solvent mg/mL 
DMSO (Dimethyl sulfoxide) 13.1±0.05 
Methanol 4.8±0.01 
Chloroform 3.0±0.03 
Ethanol 2.3±0.06 
Ethyl acetate 1.1±0.01 
Acetonitrile 1.4±0.02 
1,2-Dichloroethane 0.3±0.02 
Acetone 1.5±0.03 
 
It is noticeable that solubility of THEO in the above solvents is very low compared 
to water (6.5 mg/mL), except for DMSO. THEO’s solubility observed was highest in 
DMSO with DEC of 46.7, followed by water which is highly polar with DEC of 80. 
However, due to high boiling point of DMSO (189
o
C), its evaporation is difficult 
under rotavap and may decompose components, hence, it was not utilised in this 
study. The next closest solubility was observed in chloroform and methanol. 
Previous studies applied binary combination of chloroform (CHCl3) and methanol 
(MeOH) to generate theophylline co-crystals with acids via solution mediated 
growth (Trask, Motherwell and Jones, 2006; Zhang, 2010).Therefore, additional 
solubility tests were performed in different solvent ratios of CHCl3 and MeOH.  
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Another important consideration is the solvent classification in terms of 
manufacturing pharmaceutical products to combat toxicity and /or any other 
destructive environmental effect. CHCl3 is considered as a Class 2 solvent due to its 
toxicity with a permissible daily exposure (PDE) limit of 0.6 mg/day (ICH, 2012; 
Chemical-ecology, 2010). Therefore, ethyl acetate (Class 3) was applied as a safe 
replacement solvent for chloroform (polarity index = 4.1) bearing almost similar 
polarity index of 4.4 (FPN, n.d.), and a permissible boiling point for the 
experimental design. The ethylacetate (EtAc) and MeOH binary mixtures at various 
ratios were compared to mixtures of CHCl3 and MeOH and their DEC values 
recorded (Table 4.5; Figure 4.22).  
Table 4.5. Theophylline’s solubility and DEC values in binary mixture of solvents:- 
chloroform: methanol and ethyl acetate: methanol.  
 
Solvent 
Ratio 
Chloroform/ methanol  
mixture 
Ethyl acetate/ methanol 
mixture 
DEC mg/mL DEC mg/mL 
1:9 22.85 4.7±0.04 22.44 1.2±0.01 
2:8 18.70 6.9±0.04 21.20 2.2±0.01 
3:7 17.30 10.3±0.01 20.62 3.0±0.02 
4:6 14.84 18.8±0.09 18.13 3.5±0.01 
5:5 12.91 24.2±0.01 16.60 3.7±0.02 
6:4 11.39 31.0±0.05 14.28 4.3±0.01 
7:3 9.89 42.1±0.01 12.58 4.9±0.05 
8:2 8.49 43.4±0.02 10.38 5.3±0.05 
9:1 6.89 44.8±0.01 8.39 5.45±0.01 
DEC values:  Chloroform=4.8, Ehtyl acetate=6.02 and Methanol = 32.7 
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Figure 4.22. Graphical representation of DEC values and THEO’s solubility in binary 
mixtures of EtAc+ MeOH and CHCl3+ MeOH.  
 
 
Hansen solubility parameters 
A three dimensional solubility parameter (δ) concept describes solvent properties in 
terms of hydrogen bonding forces (δh), polar bonding forces (δp) and dispersion 
forces (δd) (Hansen, 1967). These forces collectively hold a liquid together and 
explain its solubility. The three parameters for the selected solvents are depicted in 
table below: 
Table 4.6. Hansen’s solubility parameters for three solvents used in binary mixtures: 
MeOH, EtAc and CHCl3 (Hansen, 1967). 
 
Solvent Solubility Parameters 
 Dispersion forces 
(δd) 
Polar forces  
(δp) 
Hydrogen bond forces 
(δh) 
Methanol 7.4 6.2 11.0 
Ethyl acetate 7.4 2.6 4.5 
Chloroform 8.7 1.8 2.8 
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CHCl3 and EtAc possess similar polarity index; yet the difference in THEO’s 
solubility observed is explained via factors such as their individual binding 
parameters (hydrogen and polar forces). The decreasing hydrogen bond and polar 
bond association capacity is in the order: MeOH<EtAc<CHCl3. London dispersion 
forces which are weak induced dipole forces were almost similar in case of MeOH 
and EtAc and slightly higher for CHCl3. When solvents are combined these forces 
may vary and affect their properties or interaction with the solute. For instance, it 
may decrease or increase the overall association forces, δa (δh + δp). Hansen also 
proposed that two bad solvent when mixed lying at the centre of Hansen solubility 
parameter (HSP) sphere emerge as a good solvent. The variation in these forces of 
binary solvent mixtures was calculated using HSP solvent blend tool (Table 4.7; 
Appendix III) (Hansen-solubility, 2015).  
Table 4.7. Three solvent parameters for solvent blends: a) CHCl3+methanol; b) ethyl 
acetate+ methanol (Hansen-solubility, 2015). 
 
a) 
 Solvent δd δp δh 
S1 Chloroform 8.7 1.8 2.8 
S2 Methanol 7.4 6.2 11 
% S1 % S2  
100 0 8.7 1.8 2.8 
90 10 8.57 2.24 3.62 
80 20 8.44 2.68 4.44 
70 30 8.31 3.12 5.26 
60 40 8.18 3.56 6.08 
50 50 8.05 4 6.9 
40 60 7.92 4.44 7.72 
30 70 7.79 4.88 8.54 
20 80 7.66 5.32 9.36 
10 90 7.53 5.76 10.18 
0 100 7.4 6.2 11 
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b) 
 Solvent δd δp δh 
S1 Ethyl acetate 7.4 2.6 4.5 
S2 Methanol 7.4 6.2 11 
% S1 % S2    
100 0 7.4 2.6 4.5 
90 10 7.4 2.96 5.15 
80 20 7.4 3.32 5.8 
70 30 7.4 3.68 6.45 
60 40 7.4 4.04 7.1 
50 50 7.4 4.4 7.75 
40 60 7.4 4.76 8.4 
30 70 7.4 5.12 9.05 
20 80 7.4 5.48 9.7 
10 90 7.4 5.84 10.35 
0 100 7.4 6.2 11 
 
The results in Table 4.5 indicate an enormous increase in THEO solubility in 
CHCl3+MeOH mixture compared to EtAc+MeOH mixtures. The solubility was 
enhanced with high concentrations of CHCl3 and EtAc in the mixtures, the highest 
being at 9:1 (CHCl3/EtAc:MeOH) ratio. At this ratio, solubility accelerates from 3 to 
44.8 mg/mL in CHCl3+MeOH and 1 to 5.5 mg/mL in EtAc+MeOH. MeOH alone 
exhibits higher solubility and higher association forces [δp (6.2) +δh (11)] compared 
to the other two solvents (Table 4.6). Even though, the calculated association forces 
of 9:1 mixture was slightly higher than that of the two bad solvents (CHCl3 and 
EtAc), it gave a much better solubility than MeOH. It must also be noted that the 
dispersion forces in case of EtAc/MeOH remains the same (7.4), whereas, it varies in 
CHCl3/MeOH mixtures.  
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DEC 
MeOH being a polar solvent possesses higher DEC value of 32.7 than CHCl3 (4.8) 
and EtAc (6). The DEC values generated for the two solvent mixtures did not show a 
significant variation. It decreased with decrease in MeOH’s concentration as it 
enhances THEO’s solubility by association, thus, reducing the polarity of the 
solution (explained in chapter 3.2.3). The polarityis further supported by decline in 
the calculated association forces in the solvent mixtures. 
Binary mixture: Type of solvents 
Another distinguishing feature to be observed in a binary mixture is the type of polar 
solvent involved: protic and aprotic solvent. This explains varying polarity denoted 
by DEC, its tendency to form H –bonding (Son, 2014, p.117), and/or its participation 
as a nucleophile. Polar protic solvents have high H-bonding tendency as they contain 
O-H or N-H bonds which can lose protons, example, water and methanol. Water 
contains both H-donor and acceptor properties indicated by its high DEC value and 
dipole moment. It also behaves as a nucleophile due to the presence of electron pair 
on oxygen which has tendency to form bonds with strong electrophile such as acids. 
Aprotic solvents are polar as they contain strong dipole-dipole interaction, but do not 
undergo hydrogen bonding due to lack of H atom next to O or N, for example, 
DMSO. EtAc is a slightly polar aprotic solvent with DEC >5. Whereas, chlorinated 
solvent such as CHCl3 (DEC <5) transforms into a singlet carbene in the presence of 
a strong base, acting as both electrophile and nucleophile due to a filled sp2 and an 
empty p orbital (Figure 4.23) (Hultin, 2002; Master Organic Chemistry, 2015).  
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Figure 4.23. Chloroform undergoes α-elimination reaction in presence of strong base 
forming a singlet carbene (Hultin, 2002).  
 
Microscopic solvent properties in binary mixture 
Understanding the solute and solvent in a binary mixture is very difficult as the 
extent to which a solute may react each component of mixture varies. Mancini et al., 
(2000) analysed effect of binary mixtures of aprotic H-bond acceptor (EtAc) with co-
solvents: aprotic H-bond donor, CHCl3 and strong protic H-bond donor, MeOH. 
Further studies examined their association using solvatochromatic indicators such as 
polarisability (SPP), hydrogen bond donor acidity (SA) and acceptor basicity (SB). 
The parameters of the binary mixtures components are provided in Table 4.8. The 
observation of variability in parameters at different co-solvent concentrations were 
reported (Figure 4.24) (Mancini et al., 2003).  
Table 4.8. The three microscopic solvent properties of EtAc, CHCl3 and MeOH (Mancini et 
al., 2003). 
 
Solvent SPP SB SA 
EtAc 0.795 0.542 0 
MeOH 0.857 0.545 0.605 
CHCl3 0.786 0.071 0.047 
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Figure 4.24. Plots of SPP, SB and SA parameters against mole fraction of co-solvent: a) 
MeOH; b) CHCl3 (Mancini et al., 2003). 
 
The SPP values of polarity were same in both the binary mixtures, but varied in their 
SA and SB values. The SA values increased in MeOH rich region, whereas, value 
corresponding to CHCl3 was unimportant. In contrary, the SB values produced 
synergistic effect for all MeOH concentrations and for CHCl3 below 0.50, but 
decreased rapidly above 0.50 CHCl3 co-solvent concentration (Mancini et al., 2003). 
Our observations of highest solubility in EtAc+MeOH mixtures were at lowest co-
solvent concentrations indicating very low SA property. Similarly, looking at the 
table values above, we can estimate that CHCl3+MeOH mixtures at high MeOH 
concentration will obtain a high SA and SB values and vice-versa. Therefore, THEO 
was preferentially solvated by CHCl3+MeOH mixture at almost negligible SA and 
SB values slightly above 0.047 and 0.071, respectively.  
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4.3. Fast evaporating techniques 
Solubility measurements of THEO neither produced convincing results in water with 
dicarboxylic acids nor in organic solvents. However, a drastic increase was observed 
in binary solvent mixture of CHCl3+ MeOH and hence, further studies were 
commenced in this suitable media for the production of THEO co-crystals.  
4.3.1. Rotavap 
Rotavap experiments of THEO and dicarboxylic acid were conducted, but the vapour 
pressure of the binary mixture could not be obtained. However, the vapour pressure 
of individual solvent was calculated to get an estimate using the parameters shown in 
Table 4.9. The ratio of solvents differs for each dicarboxylic acid as MeOH required 
to dissolve each acid relates to their polarity and solubility collectively along with 
the varying stoichiometric ratios.  
Table 4.9. Antoine’s parameters for MeOH and CHCl3 solvent to determine their vapour 
pressures (DDBST GmbH, n.d.).   
 
Solvent Antoine’s equation parameters 
A B      C 
Chloroform 6.9 1171.0 226.2 
Methanol 8.1 1582.3 239.7 
 
All solutions prepared for rotavap experiment were subjected to 45
0
C water bath 
temperature (Table 4.10). The calculated vapour pressure for CHCl3 and MeOH was 
434 and 334 mbar, respectively.  The pressure was reduced to 250 mbar to enable 
fast evaporation of the binary mixture. The PXRD pattern collected from the rotavap 
experiments are shown in Figure 4.25. 
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Table 4.10. Experimental set up and XRD results for THEO and dicarboxylic acid solutions.  
 
Solution Mixture Solvent (CHCl3:MeOH) Concentration (%) XRD 
THEO:GLU 1:1 
 
CHCl3+MeOH; 
20+27 mL (~1:1) 
4.4 1:1+ T† 
THEO: MAL 1:1 
 
CHCl3+MeOH; 
25+6mL (~4:1) 
4.8 1:1 + T† 
THEO: MO 1:1 CHCl3+MeOH; 
30+7 mL (~4:1) 
5.1 1:1+T† 
THEO:OX 2:1 CHCl3+MeOH; 
30+15 mL (2:1) 
3.3 2:1+ T† 
†----minor impurity; T---theo anhydride 
 
 
 
Figure 4.25: PXRD patterns of theophylline and dicarboxylic acid solutions under rotavap: 
a) 1:1 glutaric acid; b) 1:1 maleic acid; c) 1:1 malonic acid; d) 2:1 oxalic acid. 
 
Trask et. al., (2006) obtained THEO: MAL 1:1 co-crystal with excess impurity of 
THEO anhydrate after filtration. However, the precipitate from the filtrate generated 
phase pure co-crystals. In their second attempt, excess maleic acid was used in 
acetonitrile to attain single crystal under slow evaporation. Co-crystals of malonic 
and glutaric acids from solution were assisted by seeding with phase-pure co-crystals 
formed via grinding followed by slow evaporation of the filtrate. The above results 
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above depict co-crystals with impurity of THEO anhydride which could be due to 
variation in evaporation of binary solvents involved.  
The existence of azeotrope of methanol (b.p. 64.7
o
C) and chloroform (61.7
o
C) 
mixture is illustrated via plot of vapour and liquid phase composition against the 
boiling point (Figure 4.26) (PHYWE, n.d.). When the boiling and condensate curve 
coincide at XMeOH = 0.35, similar composition of solvents is observed in both liquid 
and vapour phase.  
                                   
 
Figure 4.26. Plot of liquid and vapour curves of MeOH/CHCl3 system against boiling point 
(PHYWE, n.d.).  
 
Under rotavap, the composition of these two solvents changes continuously 
decreasing the proportion of more volatile component in the liquid phase until it 
attains azeotropic state as an equilibrium or final composition. Hence, the 
components held in the solution may vary until it reaches the azeotropic point 
affecting crystallisation.  
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4.3.2. Spray drying – inert loop  
The co-crystal component solutions in binary mixture of CHCl3/MeOH were 
introduced into the experimental design with a safe, closed, recirculating inert loop 
(Chapter 2, Fig. 2.3). The solvent evaporated was condensed within this recirculating 
N2 loop straight after evaporation and collected in solvent bottle. The inlet 
temperature was kept higher than the boiling points of the two solvents and the other 
parameters used were similar as optimised in chapter 3.3.2, i.e. aspirator speed (60 
m
3
/hr), atomisation (1.5 bar), and feed rate (3 mL/min) (Table 4.11). The outlet 
temperature stretches from 33-35
o
C to which the final product gets exposed. Powder 
X-ray analysis confirm pure co-crystals in all cases (Figure 4.27).  
Velaga et al., (2013) used spray dryer to prepare co-crystals of THEO with urea, 
saccharin and nicotinamide and compared its aerosolisation properties against milled 
co-crystals. Though the surface energy of spray dried material was lower than the 
milled product, the aerosol efficiency was better demonstrated by spray dried co-
crystals due to their physicochemical properties. Also, co-crystallisation of 
incongruent mixtures in binary solvent via spray drying surpasses the hindrances 
incurred by rotavap producing phase pure forms. Though, co-crystals produced via 
rotavap are not pure, it can still be used as a screening tool to depict the co-crystal 
formation under spray drying.  
Table 4.11. Experimental set-up for THEO and dicarboxylic acid in an inert loop.  
 
API + co-former CHCl3 + MeOH 
(mL) 
Feed 
Concentration 
(%) 
XRD result 
THEO:GLU 1:1 58 +20(~3:1) 5.6 1:1
 
THEO:MAL 1:1 72 + 12 (6:1) 4.7 1:1  
THEO:MO 1:1 60 + 15 (4:1) 5.1 1:1 
THEO:OX 2:1 71+ 33 (~2:1) 2.9 2:1 
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Figure 4.27. PXRD pattern of a) THEO:GLU 1:1; b) THEO:MO 1:1; c) THEO:OX 2:1 and 
d) THEO:MAL 1:1. 
 
DSC 
A study investigated thermal stability of THEO: amide co-crystal and suggested that 
an amino-pseudo-amino synthon was favoured between THEO and 
primary/secondary amide in a cis configuration with 𝑅2
2(9) motif. The thermal 
stability of co-crystals with this interaction gave a melting point different from the 
co-formers. It was found out that in an open heated system, these co-crystals 
dissociate due to loss of amide at lower temperature than their melting point. The 
amide co-former sublimes while dissociation occurs, followed by residual 
crystallisation of theophylline (Eddleston et al., 2015). Similarly, in case of co-
crystals with dicarboxylic acids (OX, MO and MAL), two endotherms were 
observed (Figure 4.29).  
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Figure 4.28.  DSC endotherms: a) THEO; b) MAL; c) MO; d) GLU; e) OX. 
 
 
 
 
Figure 4.29. DSC endotherms: a) THEO: MAL; b) THEO:MO; c) THEO:GLU; d) 
THEO:OX. 
 
THEO: OX DSC thermogram shows an endothermic peak around 230
o
C and second 
at 271.2
o
C. The first endotherm differs from anhydrous OX’s, which undergoes 
sublimation at 98.3
o
C and melts at 191.5
o
C. Oxalic acid disintegrates into carbon 
dioxide and formic acid (Zhang, 2010). Therefore, the first endothermic peak 
represents the co-crystal and OX sublimes as a gas leaving the co-crystal and the 
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remaining THEO generates the second endothermic peak. Glutaric acid has two 
endothermic peaks at 77.0
o
C and 97.2
o
C, and THEO: GLU co-crystal peak melts 
over the temperature range of 115
o
C till 116
0
C. None of these peaks overlaps with 
the known THEO and GLU values. The two endothermic peaks for MAL are at 
143
o
C and 146
o
C corresponding to its melting temperature and an unknown 
endothermic process. The two melts of THEO: MAL co-crystal was observed at 
142
o
C and 271
o
C corresponding to THEO. Malonic acid has a melt onset at 135
o
C 
which is absent in the co-crystal DSC thermogram of THEO: MO 1:1. Two 
endothermic peaks obtained at 157
o
C and 272
o
C relate to co-crystal and THEO melt, 
respectively.  
Particle size 
The particle distribution for THEO co-crystal with GLU, MO and MAL was 
irregular and skewed (Appendix IV) which can be attributed to its morphology and 
inability of the primary particles to break under dispersive pressure of laser 
diffraction as explained in Chapter 3.  Hence why, the particle size illustrated in the 
table below is not a true result.  
Table 4.12. Particle size distribution for THEO co-crystals.  
 
Conc. (%) Particle size distribution (μm) 
Method: Lens- R1 (0.1-35μm) 
Dispersive pressure: 4bar 40mm/s 
Particle volume over 
particle size 
X10 X50 X90 VMD (Volume mean 
diameter in μm ) 
THEO:GLU 3.8±0.08 15.1±0.56 28.1±0.30 15.61 
THEO:MO 1.19±0.03 9.7±0.04 27.6±0.17 12.43 
THEO:OX 0.72±0.00 2.6±0.18 4.03±0.11 2.56 
THEO:MAL 2.8±0.19 15.1±0.46 28.5±0.31 15.47 
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Also, the microscopic images (Figure 4.30 and Figure 4.31) display big clusters of 
co-crystals with GLU and MAL corresponding to their high median particle 
dimension (X50 = 15.1 μm). Whereas, co-crystal with OX show a symmetrical 
gaussian curve (Appendix IV) with X50 = 2.6 μm where small primary particles can 
be visualised under microscope (Figure 4.31; c).  
SEM image in Figure 4.32a illustrate huge clusters of partially spherical primary 
particles clumped together in case of THEO:GLU co-crystals. The primary particles 
in case of THEO:MO (Figure 4.32b) are not as distinguishable and adhere to each 
other forming big irregular rod-like structures. THEO:OX 2:1 (Figure 4.33a) exhibits 
tiny spherical primary particles which seem to be readily separated and detected via 
laser diffraction. On the other hand, THEO:MAL (Figure 4.33b) 1:1 appears like 
layers of flat structures joined together, corresponding to a larger particle size 
detection or perhaps, an invalid result via laser diffraction. 
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Figure 4.30. Microscope images of co-crystals: a) THEO:GLU; b) THEO:MO. 
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Figure 4.31. Microscope images of co-crystals: c) THEO:OX and d) THEO:MAL. 
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Figure 4.32. SEM images of THEO: GLU 1:1 a1) 200x, a2) 400x, a3) 1000x, a4) 2000x; 
THEO: MO 1:1 b1) 100x; b2) 200x; b3) 400x; b4) 1000x  
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Figure 4.33 SEM images of THEO:OX 2:1 c1) 200x, c2) 400x, c3) 1000x, c4) 4000x; 
THEO:MAL 1:1 d1) 200x, d2) 400x, d3) 1000x.  
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Summary:  
Unlike CAF, THEO being an analogue did not show a significant improvement in its 
solubility in the presence of dicarboxylic acids. In addition, its solubility in organic 
solvents was poor, apart from DMSO. DMSO could not be involved in this study 
due to its high boiling point which would have been difficult to process in the two 
evaporating techniques. Surprisingly, a 15 fold increase and 5 fold increase was 
observed in binary mixtures of 9:1 CHCl3:MeOH and EtAc:MeOH, respectively. 
This increase in solubility was supported by Hansen’s solubility parameters, namely, 
hydrogen bonding forces, polar bonding forces and dispersion forces present in a 
solvent blend. CHCl3:MeOH solvent mixtures were utilised to form co-crystals of 
THEO and dicarboxylic acids. The rotavap successfully formed co-crystals with 
minor impurity of THEO anhydrate. Spray drying resulted into pure co-crystals 
overcoming the issue of starting component impurity.  
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CHAPTER 5  
5.  
CARBAMAZEPINE AND SACCHARIN 
COCRYSTAL RESULTS 
This chapter encompasses formation of co-crystals of carbamazepine (CBZ) and 
saccharin (SAC) via fast evaporating techniques. CBZ attains low solubility and 
high permeability belonging to BCS Class II category. It has been used as an 
analgesic and antiepileptic and is a very challenging API as it exists in four different 
polymorphic forms and readily converts into its dihydrate and solvate when exposed 
to water and other organic solvents, respectively (Tomaszewska et al., 2013). Its 
complex with saccharin as a co-crystal has been extensively studied to overcome the 
problems of solubility, polymorphism, scale-up and solvate formation. A solvent-free 
approach using twin-screw extruder for scale-up of CBZ: SAC 1:1 co-crystal, lead to 
its degradation and polymorphic transformation under high temperature conditions 
(Joshi, 2012). Therefore, this compound is also susceptible to degradation and 
requires controlled procedures. In this study, we investigate co-crystal formation via 
spray drying and obtain metastable FII of CBZ:SAC 1:1. Further tests were 
performed to analyse degradation upon storage which is supported by a hypothesis 
suggested in this study. 
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5.1. Introduction 
Previous attempts of attaining CBZ: SAC 1:1 co-crystal have adopted various 
solution based strategies avoiding solvate mediated phase transformation (SPMT) 
such as solvent mixtures, anti-solvent, spherical co-crystallisation, sonic slurry and 
introduction of polymers. Hickey et al., (2007) examined CBZ’s solubility in 
mixture of ethanol and methanol, and deduced a scale-up method without employing 
seeding. This was achieved in 62.5:37.5% v/v EtOH: MeOH mixture under reflux 
and then cooled; nucleating 1:1 co-crystal. Interestingly, application of polymorphs 
while evaporating equimolar solution of CBZ and SAC in ethanol resulted in crystal 
growth of new polymorphic form II of CBZ: SAC 1:1 co-crystal.  Form II was 
favoured by evaporation of methanolic solution containing beads of poly(4-methyl-
1-pentene) (Porter, Elie and Matzger, 2008).  
 
Mixed solvents were also used to enhance the transformation kinetics, that is, trigger 
nucleation rate higher than in pure solvents. It was observed that solubility was 
enhanced in solvent mixtures compared to individual bad solvent and reduced 
incongruent solubility of the components. In addition, excess of CBZ in saturated 
solutions of SAC was subjected to ultrasound in order to overcome solvate 
formation. Solvent mixture of acetone and dioxane generated FII co-crystal and, 
ethylene glycol and DMSO led to FI co-crystal (Rager and Hilfiker, 2010). Also, 
sonic slurry method using equimolar ratio of CBZ and SAC in ethylacetate formed 
CBZ: SAC co-crystals (Tomaszewska et al., 2013). Another study utilised anti-
solvent approach to achieve highly pure co-crystals and found methanol as a suitable 
solvent for dissolving CBZ and SAC, followed by co-crystal nucleation with 
addition of water as anti-solvent (Wang et al., 2013).  
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Spherical co-crystallisation (Chapter 1.3.2) investigated factors affecting 
supersaturation such as, proportions of good and bad solvents, introduction of 
bridging solvent and ratio of components used. DMSO, ethanol and methanol were 
selected as good solvents; where methanol depicts more congruent solubility for the 
pair (Table 5.1). Whereas, form II was generated at high co-former concentration, 
high proportion of bad solvent and delayed addition of bridging solvent; inducing 
high supersaturation levels (Pagire et al., 2013). 
 
Table 5.1. Solubility of CBZ and SAC in good solvents: DMSO, methanol and ethanol 
(Pagire et al., 2013). 
 
Solvent Solubility (M/L) 
CBZ SAC 
DMSO 0.345 5.397 
Methanol 0.264 0.389 
Ethanol 0.0804 0.268 
 
Recently, solvent-free HME generated CBZ: SAC co-crystals using PAT tool to 
monitor temperature conditions and demonstrated increase in its dissolution rate 
which was dependant on temperature utilised (Moradiya et al., 2013). However, 
another HME study observed degradation under temperature and induced sheer 
conditions (Joshi, 2012). Hickey et al., (2007) earlier found equivalent chemical 
instability of CBZ: SAC to the marketed carbamazepine product (Tegretol) where 
both co-crystal and CBZ FIII in Tegretol depict slow degradation pattern at higher 
humidity conditions. Recently, CBZ: SAC conversion into its dihydrate form was 
inhibited using HPMC (hydroxypropyl methylcellulose) based tablets (Qiu and Li, 
2015). In addition, the metastable co-crystal FII was kinetically favoured via 
roatavap with traces of FI (Bag, Patni and Reddy, 2011). This study investigates co-
176 
 
crystallisation and chemical stability of CBZ: SAC using rotavap and spray dryer 
with range of solvents showing both congruent and incongruent solubility of the pair.  
5.2. Crystal data 
5.2.1. Carbamazepine, anhydrous Form III (CSD Ref: CBMZPN10) 
Carbamazepine (CBZ) exists in four different polymorphic forms: two monoclinic, 
one trigonal and one triclinic. Out of these, P- monoclinic form (Form III) is the 
most thermodynamically stable polymorph. Polymorph Form IV is a C-lattice 
monoclinic form which is an enantiotropic pair to P-monoclinic form. Form I 
(triclinic) was observed during high temperature modification. Trigonal Form II is 
the least stable form and undergoes fast transformation. For all the forms, molecular 
conformation and hydrogen bonding pattern were similar and the difference only lies 
in the pattern of 𝑅2
2 (8) carboxamide dimer units (formed via hydrogen bond between 
carboxamide donor and carbonyl acceptor). The unit cell of Form III is in P21/n 
space group with cell length: a=7.53(1), b=11.15(2), c=15.47(2) and angle 
β= 116.2(1)o (Harris et al., 2005; Grzesiak et al., 2003). The calculated PXRD 
pattern and crystal structure is shown in Figure 5.1and Figure 5.2, respectively. 
 
 
Figure 5.1. Crystal structure of CBZ Form III (obtained from CSD). 
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Figure 5.2. PXRD pattern of CBZ Form III (CSD ref: CBMZPN10).  
 
5.2.2. Carbamazepine dihydrate (CSD Ref: FEFNOT02) 
The dihydrate form is monoclinic with space group P 21/c and unit cell dimensions: 
a = 10.07(2) Å, b = 28.72(5) Å, c = 4.83(1) Å and β = 103.45o. The asymmetric unit 
contains one CBZ molecule and two water molecule (Figure 5.3). The dimers of 
CBZ are linked via pair of hydrogen bond at N-H...O alongside hydrogen bond 
network between amino group and water molecules forming double layers. The 
hydrophilic water molecules are present at the core of the layer forming channels and 
the hydrophobic CBZ present outside (Figure 5.4) (Harris et al., 2005). The PXRD 
pattern for CBZ dihydrate is shown in Figure 5.5.  
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Figure 5.3. Crystal structure of CBZ dihydrate (CSD Ref: FEFNOT02). 
 
 
                                  
 
Figure 5.4. CBZ dihydrate hydrogen- bonded network arrangement with stacks of CBZ 
molecules (Harris et al., 2005).  
 
 
Figure 5.5. PXRD pattern for CBZ dihydrate (CSD Ref: FEFNOT02). 
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5.2.3. Saccharin (CSD Ref: SCCHRN) 
The saccharin (SAC) crystal structure (Figure 5.6) is monoclinic and lies in P 21/c 
space group with a = 9.56(4) Å, b=6.91(3) Å, c=11.82(4) Å and β = 103.85(17)o. The 
crystal structure forms centrosymmetric dimer molecules via N-H----O H-bond 
between keto oxygen and imide nitrogen of the five-membered rings. The hydrogen 
bond around the centre of symmetry forming the six-sided ring and narrow angle at 
C-S-N alleviate the strain from the molecule making it a planar structure (Okaya, 
1969).  Figure 5.7 illustrates the PXRD pattern for SAC.  
 
 
Figure 5.6. Crystal Structure of SAC attained from CSD Ref: SCCHRN. 
 
 
 
 
Figure 5.7. Calculated PXRD pattern for SAC obtained from CSD Ref: SCCHRN. 
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5.2.4. CBZ:SAC 1:1 
5.2.4.1. CBZ: SAC 1:1 Form I  
This triclinic form of CBZ: SAC 1:1 relates to space group P-1 with unit cell 
dimensions: a 7.52(11) Å, b 10.45(15) Å, c 12.68(18) Å, and angles: 
α= 83.64(2)o, β= 85.70(2)o, and γ= 75.41(2)o (CSD Ref: UNEZAO). The crystal 
packing consists of homosynthons between two CBZ carboxamide groups. Ana 
additional hydrogen bonded homodimer is present between SAC N-H and CBZ 
carboxyl group, and anti-NH of CBZ urea with S=O of SAC (Porter, Elie and 
Matzger, 2008). The crystal structure and PXRD data is shown in Figure 5.8 and 
Figure 5.9, respectively. 
 
 
 
Figure 5.8. Crystal structure of CBZ:SAC 1:1 Form I (CSD Ref: UNEZAO) 
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Figure 5.9. PXRD pattern obtained from CSD for CBZ: SAC 1:1 Form I with characteristic 
peak at 2θ = 6.88o. 
 
5.2.4.2. CBZ: SAC 1:1 Form II 
This monoclinic form lies in the space group C 2/c with unit cell dimensions: 
a= 35.72(10) Å, b= 6.84(2) Å, c=16.11(5) Å and β = 98.03(2)o (CSD Ref: 
UNEZAO01). The molecules form heterosynthon via H-bonding of CBZ (C=O) with 
SAC (N-H) and SAC (N-H) with CBZ (C=O). It further links anti N-H of CBZ urea 
with S=O of SAC (Porter, Elie and Matzger, 2008). The crystal structure and PXRD 
pattern collected are shown in Figure 5.10 and Figure 5.11, respectively. 
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Figure 5.10. Crystal structure of CBZ:SAC Form II (CSD Ref: UNEZAO01). 
 
 
 
Figure 5.11. PXRD data collected from CSD for CBZ: SAC Form II with characteristic peak 
at 2θ = 4.80o.  
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5.3. Fast evaporating techniques 
Co-crystals of CBZ: SAC 1:1 were examined in three organic solvents: ethanol, 
methanol and acetone, and solvent mixture of ethanol and methanol (Hickey et al., 
2007). A reverse proportion of this solvent mixture was also investigated, i.e. 
MeOH: EtOH 62.5:37.5% v/v.  
5.3.1. Rotavap 
Equimolar concentration of CBZ and SAC were dissolved in solvents and subjected 
to evaporation under rotavap. The vapour pressure of the three solvents was obtained 
using the Antoine’s equation parameters as shown in Table 5.2. Unfortunately, the 
vapour pressure of the solvent mixtures could not be generated and was believed to 
lie between the individual solvent values. 
Table 5.2. Antoine’s parameters obtained for each solvent to determine their vapour 
pressure (DDBST GmbH, n.d.).   
 
Solvent Antoine’s equation parameters 
A B C 
Methanol 8.1 1582.3 239.7 
Acetone 7.1 1220.0 230.7 
Ethanol 8.2 1642.9 230.3 
 
The temperature and reduced vapour pressure applied to each solution are shown in 
Table 5.3. The calculated vapour pressure of EtOH and MeOH was 294 and 554 
mbar at 50
o
C, respectively. Therefore, pressure applied for solvent mixture was 
below the pressure values of the two solvents, i.e. 150 mbar to initiate rapid 
evaporation.  PXRD results are illustrated in Figure 5.12. 
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Table 5.3. Experiments conducted for the production of CBZ and SAC co-crystals via 
rotavap.  
 
Solvent CBZ: SAC 
1:1 
Concentra-
tion (%) 
Bath 
Temp 
(
o
C) 
Vapour 
pressure 
of solvent 
(mbar) 
Reduced 
Pressure 
Applied 
(mbar) 
XRD 
Acetone 2.6 50 814 150 FI 
Methanol 4.2 50 554 200 FI 
Ethanol 2.8 50 294 150 FII + FI 
EtOH:MeOH 
(62.5:37.5) 
5.6 50 -- 150 FI 
MeOH:EtOH 
(62.5:37.5) 
5.6 50 -- 150 FI 
Form I-----FI; Form II------FII 
 
 
 
 
Figure 5.12. Calculated PXRD pattern of CBZ:SAC 1:1 spray dried in a) acetone;                
b) MeOH; c) EtOH:MeOH; d) MeOH: EtOH; e) EtOH. 
 
All the solvents except ethanol, produced CBZ: SAC co-crystal FI. This result is in 
agreement with earlier rotavap attempt with dimorphic CBZ: SAC 1:1 in ethanol 
which generated metastable FII and traces of FI (Bag, Patni and Reddy, 2011). 
Although, fast evaporation under rotavap should favour metastable form and 
eradicate any solvent mediated transformation, solvent selection seems to be closely 
associated in generating kinetically-favoured metastable FII.  
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5.3.2. Preparation of phase pure co-crystals via spray drying 
Solutions containing equimolar CBZ and SAC were spray dried using an inert loop 
at feed rate of 3mL/min, atomisation of 1.5 atm and aspiration rate of 60 m
3
/hr. The 
inlet temperature conditions were varied with solvents used and their boiling points, 
accordingly. The outlet temperature varied between 35-45
o
C. The co-crystals formed 
were characterised and compared using four different techniques: XRD, DSC, 
Raman and FTIR (Table 5.4). The observations from XRD, Raman and FTIR show a 
unanimous result, i.e. formation of metastable CBZ: SAC 1:1 FII. Whereas, DSC 
scan rate of 10
o
C/min generated one endothermic peak in agreement with FI.  
Table 5.4. Spray dried results for CBZ: SAC co-crystals. 
 
Solvent Feed 
(%) 
Inlet 
Temperature 
(
o
C) 
XRD 
result 
DSC 
slow 
10
o
C/min 
DSC 
rapid 
40
o
C/min 
Raman FTIR 
Ethanol 2.8 80 FII FI FI+FII FII FII 
Methanol 3.3 
 
70 FII FI FI+FII FII FII 
80 FII FI FI+FII FII FII 
EtOH: 
MeOH  
2.6 85 FII FI FI+FII FII FII 
MeOH: 
EtOH  
1.8 85 FII FI FI+FII FII FII 
Acetone 2.8 65 FII FI FI+FII FII FII 
2.8 75 FII FI FI+FII FII FII 
Form I -----FI; Form II------FII 
 
The XRD results in Figure 5.13 displays a characteristic peak at 2θ = 4.80o for FII in 
all solvents which do not comply with rotavap results. DSC results were somewhat 
misleading with an endothermic peak at 174
o
C for CBZ: SAC FI (Good and 
Rodrigeuz-Hornedo, 2009) in all solvents at heating rate of 10
o
C/min (Figure 5.14). 
The results did not coincide with DSC of CBZ which produces two endotherms. The 
first endotherm for CBZ form III (stable) lies between 162 and 175
o
C, which 
transforms into Form I subsequently melting between 189 and 193
o
C (Grzesiak et 
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al., 2003). A single endotherm for SAC at 224
o
C (Wang et al., 2013) was also 
absent.  
 
 
Figure 5.13. PXRD pattern of CBZ:SAC 1:1 co-crystals spray dried using a) MeOH @ 
70
o
C; b) MeOH @ 80
o
C; c) acetone @65
o
C; d) acetone @ 75
o
C; e) EtOh:MEOH @ 85
o
C; 
f) MeOH:EtOH @85
o
C; g) EtOH @ 80
o
C. 
 
 
 
 
Figure 5.14. DSC endotherms obtained for CBZ and SAC 1:1 spray dried solutions at slow 
and fast heating rates, i.e., 10
o
C/min and 40
o
C/min, respectively.  
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Due to disparity in results, a fast DSC scan at 40
o
C/min was also investigated which 
liberated two endothermic peaks at around 166
o
C and 176
o
C as shown in Figure 
5.14. These results correspond to DSC trace for FII followed by FI. Similar 
transition was observed for DSC scan of CBZ: SAC FII discovered by polymer 
induced heteronucleation from a single solvent (Porter, Elie and Matzger, 2008).  
 
Prototype of CBZ: SAC FI for comparison 
A prototype of CBZ: SAC 1:1 FI was prepared using solvent method by Hickey et 
al., (2007) (Chapter 2.4.6) for comparison with the predicted FII results above. The 
PXRD and DSC results for FI are shown in Figure 5.16 and Figure 5.15, 
respectively. The PXRD pattern displays a distinct characteristic peak at 2θ= 6.88o 
confirming formation of FI. In addition, the DSC results at 10
o
C/min and 40
0
C/min 
produced only one endothermic peak of 174
o
C and 177
o
C, respectively. Due to very 
fast scan rate of 40
o
C/min, a slight forward shift in the melting peak was observed. 
In contrary, the spray dried results gave two endothermic peaks:  FII melt followed 
by FI endotherm. This could be due to thermally induced polymorphic 
transformation of compounds into their stable form when subjected to DSC. Hence, 
DSC results were not a true indication of the product obtained.  
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Figure 5.15. PXRD for the prototype, CBZ: SAC 1:1 FI formed via solvent mixture.  
 
 
 
Figure 5.16. DSC thermogram for CBZ: SAC FI prototype at slow and fast scan rate for 
comparison with spray dried results.  
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FTIR 
 
FTIR was used to examine the interaction between molecular components of CBZ, 
SAC and the co-crystal formed. The structural packing of CBZ, SAC and CBZ: SAC 
1:1 FI form homomeric H-bonding between two dimers where N-H donor binds to 
C=O acceptor (Figure 5.17). Additional bonding with SAC is observed in co-crystal 
FI, where the homomeric bonding of SAC (SAC N-H---C=O SAC) gets replaced by 
heteromeric bonding (SAC N-H---C=O CBZ), leaving SAC’s carbonyl group free. 
In addition, SAC’s S=O forms weak hydrogen bonds with CBZ’s N-H and SAC’s C-
H (Jayasankar et al., 2006).  
 
 
Figure 5.17. Molecular interaction in crystal structures of a) CBZ; b) SAC and c) CBZ: SAC 
FI (Jayasankar et al., 2006). 
 
On the other hand, FII CBZ: SAC co-crystal forms heteromeric dimer of CBZ and 
SAC (explained in crystal data) with additional H-bond between anti N-H of CBZ 
and S=O of SAC (Porter, Elie and Matzger, 2008). Due to heterosynthon formation, 
carbonyl group of SAC is not free and SAC’s S=O forms only one weak H- bond 
with N-H of CBZ. The FTIR spectra observed shows difference in various bond 
stretches (Figure 5.18).  
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Figure 5.18. FTIR spectra of CBZ: SAC spray dried co-crystals compared to pure CBZ, 
SAC, CBZ:SAC 1:1 physical mixture (PM) and CBZ:SAC 1:1 FI.   
 
FTIR spectra of SAC at 3098 and 1716 cm
-1
 relates to NH and C=O stretch of 
secondary amide. The SO2 symmetric and asymmetric stretches were observed at 
1333 and 1775 cm
-1
. In contrary, peak shift of free C=O of SAC and H-bonded C=O 
of CBZ was observed at 1726 and 1639 cm
-1
 for co-crystal FI. Whereas, the spray 
dried FII co-crystals gave carbonyl stretches for SAC and CBZ at 1721 and 1655 cm
-
1
. The peak shift of NH stretch from 3464 cm
-1
 (CBZ) to 3498 cm
-1
 (CBZ: SAC FI) 
is in agreement with the previous study (Jayasankar et al., 2006).   
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Figure 5.19. FTIR N-H band spectra for spray dried co-crystals.  
 
Table 5.5. FTIR N-H band stretches from 3400 to 3250 cm
-1
.  
 
Sample N-H Bands (cm
-1
) 
CBZ 3464 3354 3280 
SAC   3098 
PM 3464 3350 3282 
CBZ:SAC FI  3498 3313 3184 
MeOH @70
o
C 3456 3330 3264 
MeOH @80
o
C 3455 3330 3263 
EtOH 3456 3330 3268 
EtOH: MeOH 3456 3330 3268 
MeOH: EtOH 3456 3331 3268 
Acetone @65
o
C 3456 3331 3269 
Acetone @75
o
C 3455 3331 3268 
 
A drastic change in N-H vibrational bands of CBZ: SAC FI (3498 and 3313 cm
-1
) 
and spray dried co-crystals (3455 and 3330 cm
-1
) was observed (Table 5.5 and 
Figure 5.19), depicting the formation of co-crystal FII. Similar decrease in N-H 
vibrational band energy of co-crystal FII was noticed in comparison to FI, as a result 
of shorter H-bond distances in FII (Porter, Elie and Matzger, 2008). None of the N-H 
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vibrational stretches for spray dried co-crystals coincided with the starting 
components. The N-H stretches of CBZ: SAC 1:1 physical mixture was similar to 
CBZ: SAC 1:1 FI co-crystal.  
Raman 
Analysis of CBZ, SAC, CBZ: SAC 1:1 FI and FII co-crystals by Raman 
spectroscopy produced spectra with difference in their peak positions and intensities. 
Therefore, spectral region between 1500 and 1700 cm
-1
 was evaluated for any 
polymorphic variation (Figure 5.20). The vibrational bands of the two co-crystal 
polymorphs were quite closely related and compared to CBZ as shown in the table 
below. 
Table 5.6. Raman bands to molecular vibrations for CBZ, CBZ: SAC FI and CBZ: SAC FII 
(O’Brien et al., 2004). 
 
Vibrational mode CBZ CBZ:SAC 1:1 FI CBZ:SAC 1:1 
FII 
(C=O) stretch absent 1724w 1718w 
non aromatic (C=C) 
stretch 
1624s 1624s 1620s 
Secondary amide (N-H) 
bend 
1600w sh 1598s 1599m sh 
aromatic (C=C) stretch 1566s 1566s 1566s 
aromatic (C-H) bend, in-
plane 
1022 and 1024m 
sh 
1028m sh 1028m sh 
Tertiary amide (C-N-C) 
stretch 
723m 697 and 705w 
sh,721m 
730m, 703m 
s: strong; m: medium; w: weak; sh: shoulder 
 
The carbonyl (C=O) vibrational stretch was a good indicator of CBZ: SAC co-
crystal formation. This stretch was higher for CBZ: SAC 1:1 FI (1724 cm
-1
) 
compared to spray dried CBZ: SAC 1:1 FII (1718cm
-1
), as observed earlier in co-
crystals from solvent mixtures (Rager and Hilfiker, 2010). The secondary amide 
bend intensity at 1600 cm
-1
 increases in co-crystals as opposed to weak shoulder 
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observed in CBZ. The amide bend of the two co-crystal forms are distinguishable as 
FII bend forms a medium frequency shoulder on C=C non- aromatic stretch and FI 
produces a strong N-H bend.  
 
 
Figure 5.20. Raman spectra comparison of the spray dried co-crystal and CBZ:SAC 1:1 FI.  
 
The above results obtained from XRD, Raman and FTIR are in good agreement with 
the formation of CBZ: SAC 1:1 FII via spray drying. DSC results were ambiguous 
due to thermally induced polymorphic transition. The CBZ: SAC co-crystal forms 
generated via two closely related fast –evaporation techniques varied and therefore, 
suggests that spray dryer is a better technique for production of co-crystals that 
require polymorphic control and always favours the metastable form.  
5.3.3. Chemical stability  
According to the United States Pharmacopoeia (USP) standards for chemical 
substances and drug preparations, the limit set for CBZ related impurities is not more 
than 0.2% (USP Convention, 2015). The impurity examined in this study is a CBZ 
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degradation product, iminostilbene. The degradation into iminostilbene of the spray 
dried product was examined using HPLC over a period of 5 months. A calibration 
curve was constructed to determine the amount of degraded product as shown in 
Figure 5.21. 
                    
 
 
Figure 5.21. Calibration curve for iminostilbene concentration against the peak area 
obtained from HPLC analysis.  
 
 
 
 
Figure 5.22. Chromatogram for CBZ and iminostilbene showing peak elution at 8 and 11.2 
minutes, respectively.  
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Figure 5.22 shows two well separated peaks obtained from the developed HPLC 
method for CBZ and its degradate at retention times of 8 and 11.2 mins, respectively. 
The % iminostilbene impurity in each sample was calculated after obtaining their 
peak area values at three time intervals: 1st month, 3rd month and 5th month (Table 
5.7).                    
Table 5.7. Degradation results: Percentage iminostilbene in spray dried sample.  
 
Spray dried CBZ:SAC Iminostilbene (%) 
Month 1 Month 3 Month 5 
MeOH @70
o
C 0.049±1.6E-03 0.064±2.3E-03 0.132±3.2E-05 
MeOH @80
o
C 0.072±3.8E-03 0.090±1.5E-03 0.111±5.8E-04 
EtOH@80
0
C 0.019±1.4E-04 0.074±6E-04 0.111±9.9E-04 
EtOH: MeOH@85
o
C 0.004±6.1E-05 0.079±1.5E-03 0.169±3.3E-05 
MeOH: EtOH@85
o
C 0.013±3.4E-04 0.073±9.4E-04 0.132±1.9E-04 
Acetone 65
o
C 0.024±1.8E-04 0.085±5.2E-04 0.117±1.2E-03 
Acetone 75
o
C 0.102±2.6E-03 0.125±1.0E-03 0.142±9.8E-03 
 
The HPLC results show the presence of iminostilbene in all the samples which 
gradually increases over time. The amount of degradate observed after one month 
was lowest in case of sample obtained from solvent mixture, EtOH: MeOH. 
However, the impurity levels rose to same amounts as others on the 3
rd
 and 5
th
 
month. For the first three months, the % impurity observed was highest in co-crystal 
obtained from acetone at high temperature of 75
o
C. But, over 5 month period, the 
results were quite identical for all the samples ranging from 0.11 to 0.17%. In earlier 
studies, process parameters were observed to play a significant role in CBZ’s 
degradation. In case of twin screw extruder, high temperature conditions and heat 
imparted due to shear at the screw surface led to impurity formation (Joshi, 2012). 
Likewise, parameters such as high temperature, microwave irradiation power, and 
high exposure time elevated degradation levels in microwave-assisted co-
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crystallisation of CBZ: SAC (Pagire et al., 2013). In addition, ultrasound-assisted 
slurry co-crystallisation also attributed to CBZ degradation below the USP levels 
(Apshingekar, 2014). However, these studies did not examine the increase in 
impurity levels over prolonged time period. Conversely, comparable and gradual 
increase in iminostilbene levels obtained in spray dried co-crystals dictates its non-
dependency on process parameters alone, but rather an additional influence due to 
external factors or inherent property of the compound.  
This gradual increase in iminostilbene content during storage is supported by the 
hypothesis that CBZ undergoes a two-step conversion into iminostilbene under 
atmospheric humid conditions and sunlight. The first step conversion involves 
hydrolysis of CBZ, splitting the primary amide and forming carboxylic acid (Figure 
5.23) (Avagadro, 2000-2007). The second step is followed by simultaneous 
decarboxylative reduction induced by factors such as sunlight and temperature. The 
latter was implicated in a study where photoredox catalysis was induced by visible 
light causing excitation (single electron transfer) in α-amino acids leading to its 
decarboxylation (Cassani, Bergonzini and Wallentin, 2014).  
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Figure 5.23. Proposed two-step degradation of CBZ due to atmospheric conditions. 
 
3.3.4 Physical property – dispersive surface energy 
Inverse gas chromatography (iGC) was utilised to investigate the impact of feed rate 
on the measured dispersive surface energy of CBZ: SAC co-crystals generated via 
spray drying. The experimental set-up targets a range of surface coverages to obtain 
comparable results between samples, overcoming any differences in probe coverage 
due to variation in particle properties such as surface area. The dispersive component 
of surface energy depicts the apolar interactions due to the forces between two 
dipoles calculated from the retention time of n-alkane probes. The impact of various 
feed rates on the surface property of CBZ: SAC co-crystals are shown in Figure 5.24. 
A reduction in dispersive surface energy was observed with the increase in feed rate 
of the spray dryer. This shift is attributed to change in surface area due to variation in 
particle size distribution, altering the probe interaction. For instance, large particles 
with low surface area will have less energetic sites available for interaction. 
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Moreover, low probe interaction also signifies low exposure to crystalline sites with 
higher energy. The shape of heterogeneity distribution determines the availability of 
range of energetic sites, suggesting the increase in higher energy sites at 0% 
coverage.  It has been proposed that increase in surface area leads to probe 
interaction with narrow range of high energy sites, thereby increasing its mean 
dispersive surface energy value (Gamble et al., 2012). The lowest feed rate of 
1ml/min would further narrow down probe interaction and result in large number of 
sites available for interaction.  
                      
 
 
Figure 5.24. Surface energy heterogeneity graph showing dispersive surface energy over 
fractional surface coverage of spray dried CBZ: SAC 1:1 sample processed at feed rates:  a) 
3 mL/min; b) 2 mL/min and c) 1 mL/min.  
 
The particle size distribution (PSD) for CBZ:SAC co-crystal are presented in Table 
5.8. The results obtained for all samples were quite similar with X50 values lying 
between 4 and 6 μm. However, the particle dimension corresponding to 90% 
undersize distribution (X90) was high for EtOH: MeOH, resulting in an overall high 
VMD value. The distribution graph in this case was distorted (Appendix V), and 
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SEM image (Figure 5.27, b) illustrate a unique morphology where small circular 
particles are embedded on a big irregular shaped particle. The particles obtain more 
or less of a spherical geometry for other samples as seen via SEM images (Figure 
5.28). Therefore, the PSD results for CBZ: SAC sample is valid except for co-
crystals via EtOH:MeOH. The microscopic images further supporting PSD has been 
demonstrated in Figure 5.25 and Figure 5.26. 
Table 5.8. Particle size distribution of CBZ: SAC spray dried samples.  
 
Conc. (%) Particle size distribution (μm) 
Method: Lens- R1 (0.1-35μm) 
Dispersive pressure: 4bar 
40mm/s 
Particle volume 
over particle size 
X10 X50 X90 VMD (Volume mean 
diameter in μm ) 
MeOH 3 
mL/min@70
0
C   
0.80±0.04 4.29±0.20 12.53±1.43 5.85 
MeOH 3 
mL/min@80
0
C  
0.81±0.04 4.27±0.24 12.59±2.19 5.81 
MeOH 1mL/min 1.30±0.07 5.65±0.47 15.57±1.05 7.23 
EtOH  0.81±0.00 4.35±0.28 12.29±2.59 5.73 
EtOH: MeOH  0.89±0.02 4.51±0.16 26.59±0.96 9.62 
MeOH: EtOH  0.85±0.01 4.43±0.00 12.72±1.06 5.95 
Acetone @65
0
C 1.25±0.05 3.88±0.21 7.47±0.87 4.24 
Acetone @75
0
C 1.13±0.08 4.22±0.02 9.64±0.34 5.38 
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Figure 5.25. Microscopic images of CBZ:SAC co-crystals: a) MeOH; b) EtOH:MeOH 
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Figure 5.26. Microscopic images of CBZ:SAC co-crystals: c) MeOH:EtOH; d) acetone 
@65
o
C. 
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Figure 5.27. SEM images for CBZ: SAC co-crystals: a) MeOH: a1- 100x, a2- 400x, a3-
4000x; b) EtOH:MeOH: b1-100x, b2-400x, b3-4000x. 
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Figure 5.28. SEM images for CBZ: SAC co-crystals: c) MeOH:EtOH: c1-400x, c2-1000x, 
c3-4000x; d) acetone: d1-400x, d2-1000x, d3-4000x.   
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Summary: 
CBZ and SAC exhibit two co-crystal polymorphs of CBZ:SAC 1:1: the most stable 
FI and metastable FII which has been hard to achieve. CBZ itself has four 
polymorphic forms and is susceptible to solvate formation and degradation.  Its 
solubility in water is poor, therefore, good solvents such as methanol, ethanol and 
acetone known from previous studies were utilised. Rotavap resulted in FI co-
crystals in acetone, methanol and ethanol:methanol mixtures. However, evaporation 
under ethanol gave mixtures of the two polymorphic forms, depicting the importance 
of solvent selection. In contrast, spray drying resulted in FII as illustrated by PXRD 
results. However, DSC results proclaimed formation of CBZ:SAC FI. Therefore, 
characterisation tools such as Raman and FTIR were involved to clarify these 
ambiguous results. Raman and FTIR indicated the formation of metastable FII. In 
addition, a protoype of FI was formed using previously reported method of solvent 
co-crystallisation for comparison. Furthermore, DSC scan at a fast rate had 
demonstrated two peaks for CBZ:SAC FI and FII in all spray dried products. 
Whereas, the protoype had only shown one characteristic peak for FI at a fast DSC 
scan rate, suggesting, thermal transformation of FII into FI for spray dried co-
crystals. Degradation studies were also carried out for all the samples at 1 month, 3 
month and 5 month period. The degradant slowly increased over time at ambient 
conditions for all samples and was just under FDA limit of 0.2%. A two-step 
degradation reaction due to atmospheric humid conditions and sunlight was 
proposed. Physical properties such as dispersive surface energy of the co-crystals 
reduced with an increase in the feed rate of the spray dryer.  
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CHAPTER 6 
6.  
CONCLUSION AND FUTURE WORK 
Utility of spray dryer as a scale-up technique for co-crystals from solutions was 
illustrated using series of co-crystals of CAF and THEO with dicarboxylic acids, and 
CBZ with SAC. Co-crystals of CAF and THEO with succinic and tartaric acids were 
not formed by this technique. Attempts were made to enhance solubility of the 
incongruent pairs of CAF and THEO for scale-up purpose and to attain pure crystal 
forms. Interestingly, the hydrotropic nature of dicarboxylic acids enhanced solubility 
of CAF and THEO. However, THEO’s solubility was best attained in binary mixture 
of CHCl3 and MeOH.  
Rotavap was applied as a pre-screening tool by simulating fast evaporation under 
reduced pressure. Though pre-screening via rotavap resulted in impurities, it gave a 
good indication of co-crystal form that can be expected from spray drying. However, 
this wasn’t achieved in case of CAF: GLU 1:1 and CBZ: SAC 1:1 co-crystals, where 
polymorphs exist within the same stoichiometry, leading to limitation of its efficacy. 
CAF co-crystals were successfully accomplished from aqueous solutions, fabricating 
spray dryer as a green technique. CAF: MAL 2:1 co-crystals were always favoured 
over 1:1 independent of the starting component stoichiometry in solution. The 
foremost process parameters that seem to generate almost phase pure CAF: MAL 2:1 
reducing CAF impurity were: optimum inlet temperature, feed concentration and 
feed rate. Introduction of surfactant (SLS) resulted in almost phase pure CAF: MAL 
2:1 at higher concentrations, but, the product was susceptible to moisture uptake due 
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to surfactant’s hygroscopic nature. In contrast, organic solvents produced mixtures of 
co-crystals with starting component impurity; therefore, solvent selection is crucial.  
Solubility of CAF analogue, THEO with dicarboxylic acids was best achieved in 
binary mixture of organic solvents (CHCl3+MeOH) than in water. Rotavap produced 
co-crystals with minor impurity of THEO which was attributed to variation in phase 
composition of the two solvents and longer residence time during evaporation. Spray 
dryer emerged as a suitable fast evaporating environment for the production of pure 
THEO co-crystals from solvent mixtures. This kinetically-driven technique always 
favoured metastable form of co-crystals as observed in case of CAF: MAL, CAF: 
GLU and CBZ: SAC. The metastable CBZ: SAC FII was only observed in ethanol 
via rotavap, indicating importance of solvent selection. Whereas, spray dryer 
surpassed the solvent barrier and produced CBZ: SAC FII for range of solvents and 
their mixtures regardless of the congruent and incongruent nature of the two starting 
components. In addition, orthogonal testing performed on CBZ: SAC co-crystals 
using various characterisation tools illustrate non-reliability of DSC results due to 
thermal influence on the product. Furthermore, escalation in CBZ co-crystal 
degradate content over time was considered to be influenced by external factors such 
as humidity, sunlight and temperature. Although, spray dryer provides a unique 
environment with high supersaturation levels ideal for achieving pure co-crystals 
from incongruently soluble components, its usage as scale-up is atrocious due to low 
feed concentrations, despite achieving enhanced solubility for the above co-crystal 
pairs.  
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Future work 
To further improve the strategy, other surfactants should be involved to enhance 
solubility and reduce the high solvent concentration utilised. Solubility enhancement 
experimentation using other mixture of solvents must be explored. Residual solvent 
evaluation can also be implemented to comprehend product’s quality and 
degradation. Safety issues in regards to toxic solvents such as chloroform should be 
considered. Spray dried products obtained are mostly amorphous in nature; therefore, 
effect of process parameters on crystalline content can be elucidated. To further 
understand and develop the spray drying process, new models based approaches 
representing QbD should be introduced to define a process operating space.  
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8.  
APPENDIX 
I.  PXRD patterns of caffeine and theophylline filtered after solubility tests from di-carboxylic acid solutions. (Caff = Caffeine). 
                        
 
 229 
 
                       
 
 
                      
 230 
 
                       
 
 
                    
 
 231 
 
                       
 
                           
 
 
 
 232 
 
II. Particle size distribution of CAF:MAL 
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III. Screen shot of Hansen Solubility webpage with HSP calculation tool 
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HSP Blend Tool used to determine solubility parameters for: Ethyl acetate and methanol binary mixture at various ratios. 
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IV. Particle size distribution of THEO co-crystals 
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V. Particle size distribution for CBZ:SAC co-crystals 
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